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Preface to ”Microfluidics for Biosensing and
Diagnostics”
We are pleased to present this Special Issue on sensing and diagnostics with microfluidics.
Efforts to miniaturize sensing and diagnostic devices and to integrate multiple functions into one
device have caused massive growth in the field of microfluidics and this integration is now recognized
as an important feature of most new diagnostic approaches.
The field of microfluidics is exceptionally diverse. It attracts interest and contributions from
physicists, chemists, and biologists as well as electrical, mechanical, chemical, and biomedical
engineers. Working in such a diverse community poses many challenges arising from different
training, different terminology, and different standards and expectations for data. This brief collection
of papers highlights the spread of expertise that is involved in research aimed at developing
biosensing and diagnostics using microfluidics.
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Abstract: In this work, we report on the development of a newly synthesized photoactive reversible
azobenzene derived surfactant polymer, which enables active and fast control of the merging of
microdroplets in microfluidic chambers, driven by a pulsed UV laser optical stimulus and the well
known cis-trans photo-isomerisation of azobenzene groups. We show for the first time that merging
of microdroplets can be achieved optically based on a photo-isomerization process with a high
spatio-temporal resolution. Our results show that the physical process lying behind the merging of
microdroplets is not driven by a change in surface activity of the droplet stabilizing surfactant under
UV illumination (as originally expected), and they suggest an original mechanism for the merging of
droplets based on the well-known opto-mechanical motion of azobenzene molecules triggered by
light irradiation.
Keywords: microdroplets; photo-isomerisation; photokinetics; opto-mechanics; conformational states
1. Introduction
Many lab-on-a-chip (LoC) applications have become possible thanks to the ability to control
mixing of different droplet contents, which enabled the sequencing of many complex bio-chemical
and biological reactions with a high level of control and flexibility over the last decade; see for
a review [1–7]. Hence, among all manipulation schemes allowed by droplet-based microfluidics
technology [8–16], active merging of microdroplets (AMD) is probably one of the most important.
It is generally achieved using a high alternating current (AC) voltage [17], or using a direct current
(DC) voltage [18]. Nevertheless, light-driven merging of droplets is a more attractive approach since
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light provides not only high temporal and spatial resolutions but also wavelength and intensity
tunability [19–21].
Recently, Dunkel et al. [22] showed that active merging of microdroplets can be achieved optically
and very selectively using the photolysis process of photolabile surfactants [22]. In the present study,
we consider a new strategy based on the photo-isomerization process (Figure 1) of a newly synthesized
azobenzene derivative surfactant polymer, whose structure is given in Figure 2 and which is named
in this study KryAz600, to achieve an active merging of water-in-oil (W/O) microdroplets using a
picosecond (ps) pulsed UV laser.
This study was inspired initially by a previous work carried out by Takahashi et al. [23], who
reported that a light-induced destabilization of an overall emulsion based on the photo-isomerization
process of azobenzene-derived photosensitive surfactants, through the light induced interfacial activity
change of gemini-like azobenzene derived surfactants and the conversion between a higher surface
activity trans isomer and a lower surface activity cis isomer. This resulted in a destabilisation of the
overall emulsion without the aim of achieving spatial differentiation and requesting several minutes
of irradiation.
Our approach is different and is far from trivial. In fact, the dynamics of the change of azobenzene
surfactants surface activity at the microscale, at which new interfaces are produced involve both the
change of surface tension driven by the photo-isomerisation process and the diffusion of the new
surfactant molecules to the interface, as well as the adsorption on the droplet surface, each partial
step adding a typical time and length-scale [24]. Our approach is also different from the recent study
reported by Dunkel et al. [22] as the mechanisms lying behind the two merging processes involved
in the two studies are completely different. Moreover, photo-isomerization of azobenzene is fully
reversible, which makes this new approach particularly suitable for the reuse of the photo-sensitive
surfactant, which is generally produced in a small quantity.
Figure 1. Light-driven merging process principle. (a) Targeting droplets and change of surface activity
of the surfactant molecules at the droplet surface under laser irradiation, (b) depletion of the surfactant
molecules at the the droplet interface, (c) merging induced following UV laser irradiation and the trans
to cis photo-conversion, (d) targeted droplets after merging.
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Figure 2. Stable trans form (left) and metastable cis form (right) of the synthesized KryAz600 molecule;
trans to cis transition occurs under UV irradiation and back to trans occurs under visible light.
2. Materials and Methods
2.1. Chemicals
Azobenzene derived molecules possess two stable geometric isomers: an energetically stable trans
form and a meta-stable cis form. For most azobenzenes, molecules can be optically isomerized from
trans to cis using light in the near UV and Visible: upon absorption of a photon with a wavelength
in the near UV (around 330 nm), molecules convert, with high efficiency, from the trans isomer into
the cis isomer. A second photon with a wavelength in the visible range (around 440 nm) can induce
the back-conversion. UV illumination can also enable conversion of azobenzene molecules from a cis
form to a trans form as photons of UV light have higher energy than visible light, which is sufficient to
induce cis to trans isomerization. Azobenzene photo-isomerization is completely reversible and both
forward and reverse photoisomerizations typically exhibit picosecond timescales. The trans isomer is
thermodynamically more stable than the cis isomer, by approximately 50–100 kJ/mol and the energy
barrier for thermal isomerization is in the order of 100–150 kJ/mol. Hence, in the dark, the cis isomer
thermally relaxes back to the trans isomer on a timescale ranging from milliseconds to hours, or even
days, depending on the substitution pattern around the azobenzene group and the local environment
of the molecules.
We synthesized a new fluorinated azobenzene derivative surfactant polymer, named in this study
KryAz600. It consists of a triblock copolymer surfactant, composed of a perfluoro-polyether (PFPE)
hydrophobic chain, linked to a polyethylene-glycol (PEG-600) hydrophilic chain (Sigma-Aldrich,
Saint-Quentin Fallavier, France) through an azobenzene group, as shown in Figure 2. The PFPE
hydrophobic chain was derived from a commercially available carboxy-terminated fluorinated polymer,
namely Krytox 157-FSH (Dupont) and linked to the azobenzene group following a similar procedure
as described in detail by Lee et al. [25], see also supporting information at (S1) for details.
2.2. Experimental Setup
Nemesys syringe pumps (Cetoni GmbH, Korbussen, Germany) were used to fabricate
monodisperse drops of size range 50 μm to 150 μm depending upon the need. To study and sort
droplets, the optics part consists of a ps-pulsed UV laser source, with a peak wavelength at 355 nm
and delivering 15.4 μJ of energy per pulse. In order to make the laser spot size adequate, the laser
beam was cleaned and band-limited for enhanced detection (20 nm filter F). Figure 3 illustrates the
optical path for the laser source. After the filter, the source was staged up and reflected by dichroic
mirror (DM) (Tx = 506 nm, Semrock, Rochester, NY, USA) to the sample where a microscope objective
(2×, 4×, or 10× Olympus Inverted Microscope) targets and acquires the reflected/scattered signal
from the droplet under observation. At the detection side we used a standard speed camera for
recording and visual inspection of the droplet generation, manipulation, and merging. For detection,
a photo-multiplier tube (Hamamatsu) was used to monitor droplet generation frequency. For optimized
100 μm drop-size (500 μL/h and 100 μL/h for the continuous and dispersed phase), the droplet
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frequency was found to be about 250 drops/second (scheme for droplet frequency was derived from
the method discussed in [15]).
Figure 3. The setup containing the droplet generation assembly, optics and detection unit. On the
optical path, the ps-pulsed source (355 nm), F (filter), M1 and M2 mirrors for step-up, dichoric mirror
(DM) (506 nm), camera with notch filter, BS (beam splitter) to reflect the acquired signal to detector
(setup adapted from [15]).
2.3. Design and Microfabrication
Droplets were generated in a flow-focusing microfluidic device, which was fabricated using the
standard soft-lithography technique, employing PDMS (Polydimethylsiloxane) for replica molding.
The constructed microfluidic device had a square drive channel (guide length after the drop-maker)
and a rectangular micro-analysis chamber constructed by stepper lithographic pattern. The advantage
of the dual stage chamber is to facilitate the droplet in maintaining a spherical shape, which in turn
reduced the pressure coalescence of microdroplets. Droplet stability can be increased by providing extra
time to the surfactant molecule in order to localize around the droplet (exterior) wall. This attribute
was achieved by increasing the drive channel length to almost three times the length of the drive
channel mentioned in previous work [22].
The drive channel length was set to about 2100 μm (Figure 4a), which is long enough to allow the
oil soluble surfactant molecules to build a stabilizing monolayer around the droplets before the droplet
come in contact with each other at the entrance, where they may merge. After the drive channel,
droplets enter a rectangular chamber of the dimensions 4000 × 1200 μm (Figure 4b) acting as droplet
storage and an analysis chamber. At the end of the device assembly, a zig-zag channel leads to output
for the droplet collection (Figure 4c). The advantage of droplet collection is to utilize the reversibility
of the photo-active reversible compound and to perform off-chip micro-particle studies.
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Figure 4. The fabricated flow-focusing assembly, (a) drive channel with width W and length L,
(b) droplet generation at 500 uL/h and 100 uL/h for drive and dispersed phase, (c) output channel for
droplet frequency monitoring, (d) micro-analysis and storage chamber.
In order to make the device interior compatible with the oil-phase, the interior walls of the
complete assembly was functionalized by commercially available surface coating agent, which
consisted of a 2% solution of perfluoroctyl-dimethylsiloxane dissolved in HFE7100 fluorocarbon
oil (3M). This coating enhanced the wettability of the channel walls and also reduced the risk of
diffusion of the surfactant molecules to the PDMS. For the droplet generation, we used a fluorinated
oil phase (HFE 7500, 3M, density 1.62 g/cm3).
Photochromic reactions were induced in-situ by a continuous irradiation Hg/Xe lamp
(Hamamatsu, LC6 Lightningcure, 200 W) equipped with narrow band interference filters of appropriate
wavelengths. The irradiation power was measured using a photodiode from Ophir (PD300-UV).
The photochromic quantum yields were determined by probing the sample with a Xenon lamp during
the course of the light irradiation. Absorption changes were monitored by a charge coupled device
(CCD) camera mounted on a spectrometer (Ocean Optics, Largo, FL, USA).
3. Results and Discussion
3.1. KryAz600 Surfactant Photokinetics
Likewise, most azobenzene derivatives, KryAz600 molecules switch under UV illumination from
a stable trans form (t-KryAz600) to a metastable cis form (c-KryAz600). The trans form is characterized
by a large absorption band with a maximum absorption around 335 nm (in HFE 7500 oil), while
c-KryAz600 form has a weaker absorption band with a maximum absorption around 440 nm, as shown
in Figure 5.
Our results show that KryAz600 molecules transit spontaneously in the dark from the cis form to
the trans form with a constant time as small as 10−5/s. This value was deduced from the exponential
fit of the absorption curve of c-KryAz600 at 330 nm versus time, as shown in Figure 5. It corresponds
to a half-life t1/2  18 h. It is worth noting that the relatively long half-life of KryAz600 molecules is of
great importance in our study since the cis form relaxes back very slowly to the trans form, if no UV
illumination is used.
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Figure 5. (Upper) Conversion of the surfactant state under UV illumination, Top curve (red) being the
first measurement with no UV treatment and subsequent state change transition of surfactant by 10 s of
exposure to a UV lamp with power of 6.7 mW at 365 nm wavelength; (Bottom) slow exponential rise
of the 335 nm absorption band intensity of the t-KryAz600 form in dark, this corresponds to a half-life
t1/2  18 h of the c-KryAz600 → t-KryAz600 transition.
3.2. Microdroplets Stability Versus Surfactant Conformation and Concentration
Monodisperse microdroplets with a size of about 100 μm were prepared using different surfactant
concentrations dissolved in HFE7500 oil, ranging from 1 mM down to 15 μM.
In order to quantify the effect of the cis and trans conformations on the stability of droplets,
a control experiment was first conducted. Two samples of equal concentration of 1 mM (C0) were
prepared, one was left in the dark (overnight) in order to allow for all surfactant molecules present in
6
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the solution to transit to the thermodynamically stable trans state, and the other sample was illuminated
with a 235 nm UV lamp for 1 h.
Droplets that were prepared using the non irradiated surfactant solution exhibited long term
stability (Figure 6a) where as the droplets prepared using UV illuminated surfactant solution merged
immediately in the observation chamber (Figure 6b). This shows that cis conformation of KryAz600
molecules is not suitable to ensure droplet stabilization. A quick glance at the molecule structure
of Figure 2 shows that the cis conformation is less suitable to achieve a close packing of surfactant
molecules at the droplet interface, than could be done using the trans isomer. In other words, cis isomer
molecules lead to a lower surface density of surfactant molecules around the droplet and hence to a
higher interfacial tension.
It is worth noting, that UV illuminated surfactant solution, when left in the dark overnight,
enables us again to produce stable droplets. This demonstrates the reversibility of the process and the
possibility to reuse surfactant solution for further experiments. Our observations show also that the
merging of microdroplets under laser illumination is not the result of the thermo-capillary effect of the
laser beam, since thermal effects are present for both droplets, prepared with the two types of isomers.
Figure 6. Surfactant KryAz600, (a) mono-disperse (water-in-oil) droplets of stable trans state, (b) effect
of UV exposure, unstable cis state causing coalescence of micro-droplets.
Also, because at the micrometer scale, the diffusion of surfactant molecules cannot be neglected,
we found it necessary to investigate the relation between the merging time and the concentration of
the surfactant molecules in the carrier fluorocarbon oil. This is particularly important in our study
since a focused pulsed laser with a micrometer sized footprint is used for photo-isomerization.
Water-in-oil (W/O)droplets were produced and collected in an on-chip micro-analysis chamber
with different surfactant concentrations, decreasing from 1 mM (C0) to 15.6 μM. This process depends
on the kinetics of the depletion of surfactants under laser illumination. The first concentration,
C0 = 1 mM of the surfactant, was found to lead to very stable microdroplets with no merging process
with irradiation times smaller than 10 min, whereas a fast merging (∼1 s) could be achieved with a
concentration value of 25 μM. It is worth noting that for smaller concentration values of surfactant
(c < 25 μM), a spontaneous merging of droplets is observed, which indicates that there are not enough
surfactant molecules in the carrier oil solution for droplets stabilization. Successive dilutions of the
surfactant solution resulted in a decrease of the merging time from about 10 min for C0 (1 mM) to 1 s for
25 μM. For lower concentrations, droplets were observed to be highly unstable. These results clearly
indicate a decrease in merging time as the concentration of surfactant molecules decreases. Merging
reduced sufficiently from almost 6 s for 62.5 μM to 1 s for 15.6 μM. This result may be interpreted as
follows. As the concentration reduces, the number of idle-molecules in bulk drive phase take more
time to replace the targeted molecules. Also, since the surfactant molecules are not oriented in a
specific order, so the lower the concentration, the higher the diffusion time for the idle molecules to
reach the depleted area.
To better understand these results, let us first calculate the flow time, t f low, that each droplet
takes to reach the observation micorchamber; t f low corresponds to the flight time of droplets along the
7
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drive channel, from the nozzle to the end of the main channel, above which droplets start to collide
with each other. Considering the length L = 2100 μm of the drive channel and the mean velocity of
microdroplets in this region, v  30 mm/s, one finds:
t f low =
L
v f low
 70 ms. (1)
To ensure droplet stability, t f low should be greater than the diffusion time, tdi f , which is
approximately the necessary time lapse for building a stabilizing surfactant layer around the droplets
to prevent their coalescence. Indeed, during t f low, a given number of surfactant molecules diffuse from
the bulk phase and adsorb arround the flowing droplet interface to form a stabilizing surfactant layer.
Considering the total area Sdrop = 4πR2 of a microdroplet with a radius R ( 50 μm), the maximum
packing of surfactant molecules, with a typical lateral dimension δ ∼ 2 nm, i.e., with a molecular area
A ∼ δ2, at the interface of the droplet is achieved with n molecules when 4πR2 ∼ nδ2. Droplets will
be stable when the number of molecules at the interface is larger than a fraction 0 < f < 1 of the
maximum packing; therefore, the stability condition reads




According to Baret et al., [26] microdroplets become stable when the number of molecules at
the interface becomes larger than a fraction f ∼ 0.1 of the maximum packing; therefore, the stability





The number of free surfactant molecules required for the stabilization of the droplet interface, n,
can be assumed to be dispersed in a volume Vε = 4πR2ε surrounding the droplet over a distance ε
from the interface (ε << R). Hence, n can be estimated as n ∼ 4πR2εcNA, where NA is Avogadro’s
number. In a diffusion limited process, surfactant molecules confined in the volume Vε will reach the
droplet interface within a time tdi f given by the diffusion law: ε2 ∼ D × tdi f . It is possible thus to
estimate an experimental value for the diffusion time tdi f according to the following equation:
tdi f ∼ 0.01(NAcA)2D . (4)
Hence, for c = 25 μM, one finds tdi f ∼ 30 ms (< t f low), whereas for c = 15 μM, one finds tdi f ∼ 70 ms
( t f low). These results are in good agreement with the observed surfactant concentration threshold
for droplet stability, which was found to lay in the 25–15 μM range.
To further analyze the merging behavior of microdroplets under irradiation, different sweeps
of the laser beam over the whole micro-chamber were performed and first and second merging of
the one drop to its neighbor and later (second merging) with the two times big merged drop to its
neighboring droplet. Results presented in Figure 7 show a non-uniform but correlated first and second
merging times. The rationale behind two merging observations relates to the change in volume and a
slight increase in the merging time. Consider Figure 7, on left, two drops selected for merging and
on right the big merged drop. For two separate drops of 100 μm, the calculated volume was 0.5 nL
each, while after merging the the big drop had a volume of 4 nL, thus eight times increase in volume.
From the classical inverse relation of concentration with volume, the overall change in concentration
of big merged drop was 0.125 times the concentration of the drive phase. Upon targeted merging of
that droplet with the usual droplet caused a slight increase in merging time, depicted as a green curve
in Figure 7.
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Figure 7. (Upper) Merging time scale of irradiated droplets, maroon (triangles) for first merging and
green (squares) for second merging, (Bottom) optical micro-graphs of the first and second merging and
resulting change in targeted droplet volume.
3.3. Suggested Opto-Mechanical Model for Droplet Merging Mechanism
Unlike in the work reported by Takahashi et al. [23], where a broad UV illumination during
several minutes of the overall emulsion resulted in a destabilisation of the overall emulsion,
photo-isomerization is achieved in our study using a ps UV laser which is focused on a very tiny
fraction of the emulsion. It lasts only a few seconds before droplet merging is achieved. At such time
and space scales, the change in the activity of surfactant molecules involves both a change of surface
tension driven by the photo-isomerisation process and the diffusion of new surfactant molecules from
9
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the bulk solution to the interface, as well as the adsorption on the droplet surface. If one considers a
diffusion limited merging process mechanism, to achieve droplet interface destabilization and merging,
the rate of photoisomerized surfactant molecules under pulsed UV laser illumination should be higher
than the diffusion rate of non irradiated surfactant molecules from the bulk solution to the target
droplet interface. Nevertheless, in the particular case of photo-isomerization, one should take account
of the fact that the higher energy UV illumination can induce not only isomerization from trans to cis
form but it can also induce the reverse transformation on cis molecules present under the UV light
spot. Hence, when a pulsed UV laser is used, if one illuminates locally, for instance, a population of A
isomers during a first pulse to B isomers, then the transformed B isomers would go back to their initial
conformation (A) under illumination during the following pulse, unless diffusion is fast enough to
deplete the illuminated region of B isomers during the first pulse of the UV laser.
Though UV light can drive both cis to trans and trans to cis photo-isomerizations, one should
emphasize that a longer term UV illumination of azobenzene molecules would not lead in average to a
mixture of 50% of molecules in each state. Indeed, the forward (trans to cis) and backward (cis to trans)
photo-reactions of azobenzene molecules do not show the same quantum yield, i.e., the probability of
inducing the photo-reaction after absorption of a photon. Therefore, the ratio of trans and cis isomers
upon long term UV irradiation can be much higher than 50%. In the present case, this ratio is higher
than 85% under 365 nm illumination as can be deduced from the absorbance curves of KryAz600
molecules around 335 nm after 90 s of illumination vs. their absorbance before irradiation (0 s),
as shown in Figure 5.
Let us calculate the diffusion distance ε of surfactant molecules in the oil solution during the time
lapse τpulse of a first single pulse, which is equal to 1 ms in our experiments (and which should not
be confused with the duration of a pulse  400 ps). Using diffusion law, and considering a typical
value of the diffusion coefficient of surfactant molecules in HFE7500 oil, about D  10−10 m2/s [26,27],
one finds a mean diffusion distance of
ε ∼
√
Dτpulse ∼ 0.3 μm, (5)
During the time lapse of one pulse. Even if considering a diffusion coefficient which is two orders
of magnitude higher than the previous one, as reported by Dunkel et al. [22], one would find a mean
diffusion distance of about ε ∼ 3 μm during each pulse. It is interesting to note that such values are
much smaller than the size of the illuminated area with the focused laser beam, which is, ∼30 μm in
our experiments. This rough estimation of the diffusion of surfactant molecules during the time lapse
between two successive illuminations shows that a large proportion of isomerized molecules during
the first pulse will be still present in the illuminated area when the following light pulse triggers and
hence cis isomers will recover their initial conformation (trans) under this second UV laser pulse.
Consequently, one should conclude that the observed merging process of droplets cannot be
attributed to a change of surface activity of surfactant molecules under illumination, as surfactant
molecules switch continuously from trans to cis and from cis to trans under successive UV laser pulses.
The merging process should be based on opto-mechanical effects due to the well-known change of
the length of the cis and trans azobenzene groups under illumination. Photo-isomerization reduces
the distance between the 4 and 4’ positions of azobenzene groups from 0.99 nm in the trans state to
0.55 nm for the cis state [28]. Consequently, UV laser illumination produces geometric changes in the
azobenzene group, which should translate into larger-scale motions extending to the overall surfactant
droplet interface layer. After approximately one second of illumination, the oscillation of the droplet
interface should lead to the merging of the droplets.
4. Conclusions
Active merging of microdroplets is one of the most important manipulations enabled by
droplet-microfluidics, as it enables for on demand droplet targeting and sequencing of complex
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chemical and biological reactions. Nevertheless, the standard voltage-based methods are generally
limited to spatially isolated pairs of droplets, as the long-range effect of the applied electric field
does not have the potential to differentiate between flowing or confined droplets. We developed an
optofluidic approach, which overcomes such limitations and allows for a rapid controlled coalescence
of targeted microdroplets thanks to the application of a ps UV pulsed laser. Our approach is based on
the photo-isomerization process of an azobenzene-derived surfactant. The success of such controlled
coalescence is far from trivial. In fact, the dynamics of the change of surface tension at the microscale
driven by photo-isomerisation processes; the diffusion of the new surfactant molecules to the interface;
as well as the adsorption on the droplet surface, are complex and not well understood. By incorporating
light activated switching in the surfactant, release or mixing of droplets contents could be programmed.
In this study, we present the fast and dynamic switching of azobenzene derived surfactant for controlled
coalescence of spatially selectable microdroplets as proof of concept.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6374/9/4/129/s1,
Figure S1: Chemical synthesis procedure of KryAz600 surfactant molecules.
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Abstract: Inexpensive simple medical devices allowing fast and reliable counting of whole cells are
of interest for diagnosis and treatment monitoring. Magnetic-based labs on a chip are one of the
possibilities currently studied to address this issue. Giant magnetoresistance (GMR) sensors offer
both great sensitivity and device integrability with microfluidics and electronics. When used on a
dynamic system, GMR-based biochips are able to detect magnetically labeled individual cells. In this
article, a rigorous evaluation of the main characteristics of this magnetic medical device (specificity,
sensitivity, time of use and variability) are presented and compared to those of both an ELISA test
and a conventional flow cytometer, using an eukaryotic malignant cell line model in physiological
conditions (NS1 murine cells in phosphate buffer saline). We describe a proof of specificity of a GMR
sensor detection of magnetically labeled cells. The limit of detection of the actual system was shown
to be similar to the ELISA one and 10 times higher than the cytometer one.
Keywords: diagnostic; GMR sensor; whole cell
1. Introduction
Routine diagnosis, treatment monitoring and treatment choice would greatly benefit from
inexpensive and easy to use versatile devices capable of counting a small amount of whole cells
of interest (cancer cells or bacteria) in different matrices [1–4]. A good example of the lack of adapted
screening is breast cancer. Indeed, while it can be cured if detected early, it remains the most lethal
cancer for women in developed countries [5].
The flow cytometry, developed since 1965 [6], is the gold standard for whole cell study and
labeling. It continues to improve and allows for an increasing number of biological characterizations.
The understanding of many biological processes like immune response or cell cycle, the screening of
drug efficacy and the enrichment of the data bank about antigen distribution in different cell types
are some examples of the huge impact of this technology on the field of fundamental biology [7].
In addition to its wide and growing interest for research purpose, flow cytometry has become routinely
used in clinical laboratories over the last 20 years for different pathologies [7–9]. This technology is
mainly applied in hematology but also in immunology and oncology. For these different disciplines,
flow cytometry is used with different purposes like diagnosis, prognosis or treatment monitoring.
The main advantages of this technology are the sensitivity and its possibility to measure simultaneously
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more than 20 parameters per cell [7]. It can also be applied to any cell type from bacteria to circulating
tumor cells and to many different biological matrices (blood, bone marrow, solid tissues etc.) [8].
However, this technology still has some drawbacks preventing it from its use for clinical purposes:
(i) these devices remain costly, bulky, the data treatment need skilled professionals and cannot be
efficiently automated, (ii) the use of fluorescent antibodies makes this technique even more expensive
and technically heavy as it necessitates washing steps and (iii) flow cytometry was not developed
primarily to count cells but rather to recognize certain cell sub-populations. Some cytometers can give
an absolute cell count but discrepancies between devices are common [10].
For early diagnosis purpose and the quantification of disease markers, several other techniques
are already available in hospitals and clinical laboratories. Most of detection techniques like mass
spectrometry, Western blots or techniques based on Polymerase Chain Reaction require lysis of cells to
work with their inner DNA or proteins. In the context of whole cell study however, methods detecting
specifically cells by their membrane markers are more relevant. The ELISA test (enzyme-linked
immunosorbent assay), largely used, is typically applied to determine the concentration of molecular
species in a suspension [11]. This technique is easily transposed to antigens expressed at cell surface
as it has been done previously with bacteria [12]. The advantage of ELISA test is its simplicity, high
throughput and relative low cost. However, this test still requires trained staff and requires relative
long incubation time to reach its nominative performance (for instance the accuracy and reproducibility
of the results depend on the reaction time [13]).
Several methods of easy to use cheap sensitive cell counters are being developed by numerous
research groups. The development of micro-technologies for biological studies has paved the way
for the creation of new devices relying on different detection systems for fast diagnosis. Different
solutions are being developed to miniaturize flow cytometers and to simplify its use [14,15]. Optical
detection is extremely performant but it requires lasers, precise alignments and interference with
some matrices is a common problem either due to their auto-fluorescence or because of solubility
issues [16]. Thus, alternative electrochemical or magnetic measurements using simpler detection
systems have been proposed and even commercialized [17–22]. However these static methods imply
washing steps and are conceived for proteins, DNA, RNA or small bacteria detection rather than for
eukaryotic cells [23–26]. Moreover, non-specific interactions remain numerous with this type of devices,
leading to reduced sensitivity [27,28]. Taking advantage of the high sensitivity of superconducting
quantum interference device (SQUID) or fluxgates, several groups developed static techniques based
on magnetorelaxometry [29–31]. These tools eliminate the need for washing steps as they discriminate
free from bonded magnetic labels. However, SQUID operate at low temperature and their production
is quite expensive [32]. Fluxgate-based techniques recently offered proof of their potential by detecting
C-reactive protein in serum in 30 min. Still, the electronic circuitry needed for results analyze must be
further miniaturized [33]. Other approach are developed in parallel with simpler, less sensitive sensors.
Dynamic methods using magnetic detection have been developed first on ferrofluid droplets [34] and
raised an increasing interest since Loureiro et al. showed the ability of such devices to detect magnetic
objects one by one [35,36] and thus their potential to reach an extremely low detection limit [37].
In addition, the sample can be prepared and tested without any washing step because of the dynamic
magnetic detection, insensitive to matrix optical properties [38]. Nevertheless, if washing steps were
needed anyway (eg. complex matrices or sample concentration requirements), the system could still
offer this possibility as washings can be performed easily with the use of a simple permanent magnet
allowing to immobilize beads from the matrix and which is a field-compatible method.
Several methods of magnetic detection have been proposed based on magnetic resonance effect,
susceptibility measurements, giant magnetoimpedance (GMI), Hall Effect, Tunnel Magneto Resistance
effect (TMR) or Giant Magneto Resistance effect (GMR) [24,39–44]. As biological objects are not
magnetic and cannot be detected alone using magnetic sensors, the target must first be bound to
magnetic particles (MPs or beads). This is possible thanks to antibodies (Abs), whose MPs are coated
with, recognizing the target. The very high specificity of antibodies provides an easy way to target
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precisely the analyte of interest. Moreover the production of polyclonal as well as monoclonal
antibodies (mAbs) directed against a given target is now a well-handled procedure in biology
labs [45,46]. In a typical magnetic detection process, the mixture of the sample and mAbs-coated MPs is
introduced into a microchannel where it flows above the sensors that detect the passage of magnetically
labeled biological objects. Several groups worked with GMI sensors, using superparamagnetic particles
and Helmoltz coils to generate the AC signal [42,43]. The use of GMR sensors is also a convenient
choice for small objects detection due to their high sensitivity and their ease of production [25,39,47–50].
GMR sensors can now be produced industrially and their size tuned to match the target’s and thus
optimize the sensitivity. Moreover, they do not need an AC field to detect the passage of magnetic
beads and thus their instrumentation can be simple.
Although several very interesting developments of this technique have been achieved, some
difficulties remain [25]. In particular, the binding of the MPs to the target implies mixing the sample
with a highly concentrated beads suspension to ensure that the target will meet and bind MPs in a
reasonable time. Consequently a lot of free unbound MPs will linger in solution. Moreover, when
the target analyte is a living cell, there is inevitably a discrepancy of distribution of the number of
magnetic beads bound to each cell. This is due to the natural distribution variation of the number of
epitopes per cell recognized by mAbs. Since MPs tend to agglomerate in physiological conditions, the
signals created by cells have to be compared not only to those created by single MPs but also to those
created by MP aggregates whose sizes depends on the bead type and concentration and on the matrix
used. Furthermore, as the signal amplitude depends greatly on the distance between the object and
the sensor, it is possible that a small aggregate of beads, moving above the sensor at a short distance
gives the same signal as a biological object covered with numerous MPs but flowing further above
it. In an attempt to overcome this limit, some ideas have been recently proposed. One consists in
using flow focusing to concentrate the detected objects in the bottom half of the channel and avoid this
uncertainty [51–53]. Yet, while screening tools must remain simple, the use of flow focusing adds a
sheath fluid whose flow must be judiciously adjusted. Another idea relying on chip design combining
mechanical and magnetophoretic guiding has been proposed to drag all magnetic material at the
bottom of the channel without the need of sheath fluid. This method requires precise adaptation to
each system and has not been evaluated on any biological model yet [54].
In this work, we suggest a third technique to discriminate specific signals from aggregates,
consisting in heightening the floor of the channel above the magnetic sensors so that single beads or
small aggregates cannot be detected. We present a complete and reliable process of detection, including
negative controls to evaluate specificity, a sensitivity study and a variability evaluation. We have
developed a magnetoresistive cell counting device using murine myeloma cells as a biological model.
The results have been compared with two standard methods of detection mentioned previously, a
microplate sandwich ELISA immunoassay and flow cytometry using the same reagents (mAbs, buffer,
samples), which is the only reliable way to compare accurately methods. Similar performances were
obtained for the ELISA test and the GMR test while flow cytometry obtained a ten times lower limit
of detection.
2. Materials and Methods
2.1. Sensor Fabrication
The spin valve layers are deposited on a 300 μm thick silicon wafer. The thin films arrangement
can be described as follows: Ta(3)/Ni80Fe20(3.5)/Co90Fe10(1.5)/Cu(2.3)/Co90Fe10(2.1)/Ru(0.85)/Co90
Fe10(2.0)/Pt50Mn50(18)/Ta(3)/Ru(3) where the thickness of layers is given in nanometers and the
target composition is given in percentages. The sensors are then patterned by UV photolithography
in a positive resin S1805 and then etched by ion beam etching (IBE). The contact pads are deposited
by evaporation of a bilayer Ti(3 nm)/Au(100 nm), after having been designed by photolithography
in S1813 positive resin. Finally, a passivation bilayer of 150 nm thick Al2O3 and 150 nm thick Si3N4
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are deposited by sputtering on the whole chip surface except on the contact pads. The usual sensor
resistance was around 600 Ω. This passivation layer insures a good lifetime of the sensors in aggressive
matrices.
2.2. Microfluidic Channel Fabrication
The microfluidic channel has been realized by using a classical protocol [55]. A layer of PDMS
of an expected thickness of 6 μm is spin-coated (5 min, 2700 rpm, 300 rpm/s) on the sensors after a
plasma O2 treatment (15 s, 40 mW, 0.1 mbar) to improve the adhesion. The device is then heated at
110 ◦C during 20 min and at 60 ◦C at least for 45 min. In parallel, the 25 μm high and 100 μm wide
PDMS channel was molded over an SU-8 mold obtained by UV photolithography and measured by a
mechanical profilometer (Alpha-Step, KLA Tencor, Mipitas, CA, USA). After demolding, the injection
holes are made in the PDMS using a puncher. After the same aforementioned plasma treatment,
the channel is aligned above the sensor using an MJB4 aligner and put in contact with the substrate.
The chips are then heated for 20 min at 120 ◦C and for 1 h at 60 ◦C.
2.3. Cell Culture
Two cell lines were used for the study: first, the NS1, murine myeloma cells, showing an average
diameter of 6 μm and expressing at their surface the CD138 protein (Syndecan-1) and second, the
Chinese Hamster Ovary cells (CHO) with an average diameter of 10 μm that do not express the CD138
protein. The cell culture media were from Gibco R©, Life Technologies, Carlsbad, CA, USA.
NS1 cells were cultivated in Dulbecco’s medium with 15% of fœtal bovine serum, 1% of
non-essential amino acids, 1% of antibiotics (penicillin and streptomycin) and 1% of L-glutamine
at 37 ◦C under a controlled atmosphere containing 7% of CO2. They were centrifuged at 1000 RPM
(centrifuge diameter 344 mm) for 10 min at 9 ◦C and then diluted in PBS (Dulbecco’s Phosphate Buffer
Saline, Gibco, Life Technologies) in which the tests were carried out.
CHO cells were cultivated in Ham F-12 Nutrient Mixture with 10% of fœtal bovine serum, 1% of
non-essential amino acids, 1% of antibiotics (penicillin and streptomycin) and 1% of L-glutamine at
37 ◦C under a control atmosphere containing 5% of CO2. They were washed two times in PBS, let in
a solution of 0.25% trypsin-EDTA for 5 min at 37 ◦C and were centrifuged at 1000 RPM (centrifuge
diameter 344 mm) for 5 min at 9 ◦C. Finally, they were diluted in PBS before use.
2.4. Production of IpaD-315 Antibodies
Six to 8-week-old female BALB/c mice were purchased from Janvier Labs, France and maintained
in accordance with the French and European regulations on care and protection of laboratory animals
(European Community [EC] Directive 86/609, French Law 2001-486, 6 June 2001) and with agreement
of the ethical committee (CETEA) no. 15-055 delivered to S. Simon and agreement D-91-272-106 from
the Veterinary Inspection Department of Essonne (France). Up to eight mice were kept in each cage
and housed in a temperature-regulated-room and had free access to food and water. All animals’
experiments were performed to minimize suffering according to the guideline of the CETEA committee.
IpaD-315 murine monoclonal antibody was produced in the LERI laboratory (SPI/CEA Saclay, France).
It was raised in BALB/c mice by repeated intranasal immunizations with 20 μg of purified recombinant
IpaD protein expressed in E. coli BL21DE(3) [56]. Ipad gene was amplified from Shigella flexneri (CIP
82.48T) and cloned into the IPTG inducible pET22b(+) vector (Novagen) allowing insertion of a
poly-histidine tag sequence at the 3’ end of the gene used for protein purification. Hybridomas were
produced by fusing spleen cells of immunized mice with NS1 myeloma cells, according to Köhler and
Milstein [45]. IpaD-315 monoclonal antibody was then produced in ascite fluids in BALB/C mouse
and further purified by protein A affinity chromatography. The purity of IpaD-315 mAb was assessed
by SDS-PAGE in reducing and non-reducing conditions and its isotype determination was performed
using Pierce rapid ELISA mouse antibody isotyping kit (Thermo Scientific).
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2.5. Particle Functionalization
Dynabeads My One Streptavidin T1 were selected. They are 1 μm diameter homogeneous polymer
particles embedding superparamagnetic iron oxide nanoparticles. They have been functionalized
with two different monoclonal antibodies of the same IgG2a isotype: a rat anti-CD138 mAb (BD
Pharmingen) and a murine mAb, IpaD-315 (described in Section 2.4), according to the commercial
protocol after their biotinylation and purification.
For mAb biotinylation, 100 μg of antibodies were diluted in 400 μL of 0.1 M borate buffer pH
9.0 containing 6 μL of biotin (Sigma-Aldrich) in DMF at 1 mg/mL and incubated for 30 min at room
temperature. Then, 100 μL of 1 M Tris HCl buffer pH 8.0 were added and incubated for 15 min. Finally,
the biotinylated mAb was purified from free biotin on Zeba Desalt Spin column (Thermo Scientific)
in 0.1 M potassium phosphate buffer pH 7.4 with 0.15 M NaCl. The absorbance of the final solution
was measured between 280 and 320 nm to determine the concentration of the purified biotinylated
antibody. Biotinylated antibodies were then mixed at room temperature with streptavidin coated
beads for 30 min, washed four times in PBS 0.1% BSA and stored in PBS 0.1% BSA at 4 ◦C until use.
2.6. MP Cell Labeling
Several cell concentrations have been used: 105, 3 104, 104, 3 103 and 103 cells/mL while the MP
concentration was set to 23 μg/mL corresponding to 2 107 antibodies-coated beads per milliliter.
Indeed, the beads concentration must be independent of the cell concentration as this value is
unknown in a real sample. In addition to the positive samples with the targeted MP-labeled cells with
concentrations described above, three negative samples were prepared and used in experiments: (i)
1 mL of buffer containing only the 23 μg of beads functionalized with anti-CD138 antibody, (ii) 1
mL of buffer containing 105 NS1 cells and 23 μg of the beads functionalized with control IpaD-315
antibody and (iii) 1 mL of buffer containing 105 CHO cells and the 23 μg of beads functionalized with
anti-CD138 antibody. Indeed, the detection of typical signals does not mean necessarily that a myeloma
cell has been detected: it could also be an aggregate of beads or some MPs bound via non-specific
interactions on another kind of cells. A comparison with negative samples is thus needed. The Table 1
summarizes the samples used.
Table 1. Summary of used samples.
Sample Type Cells/mL Antibody Beads Coating
Positive
1 × 105 NS1 anti-CD138
3 × 104 NS1 anti-CD138
1 × 104 NS1 anti-CD138
3 × 103 NS1 anti-CD138
1 × 103 NS1 anti-CD138
Negative
1 × 105 NS1 IpaD315
1 × 105 CHO anti-CD138
No cell anti-CD138
The cells of each sample have been counted at the beginning of each experiment to check the
nominal concentration using a Malassez cell. After mixing the MPs with cell suspensions, the samples
were incubated at room temperature under a slow rotation for two hours.
2.7. Experimental Set-Up
In an experiment, superparamagnetic objects (labeled cells, unbound MPs and MPs aggregates)
magnetized by a permanent magnetic field are flowing above the sensor in a microfluidic channel. The
magnetic field must be as homogeneous as possible. Indeed, magnetic gradients, by exerting locally
a magnetic force on the particles, can lead to local accumulation of beads in the channel and even
clog it. The chips and the inlet and outlet reservoirs are thus inserted in the permanent field created
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by two ferrite magnets of 3 × 3 × 10 cm3 on sides closed with two soft 8 mm iron sheets on top and
bottom (see Figure 1a). Using this device, the magnetic field varies by less than 1 mT over the entire
surface of the chip (which is 1.5 cm long by 5 mm wide) (see Figure 1b), while the vertical magnetic
field reaches 90 mT. The chip is fixed on a support whose angles can be finely tuned to maximize
the sensor sensitivity (see Figure 1c). The sensitivity is maximal when the external field is rigorously
perpendicular to the sensor surface. At the beginning of each experiment, the position of the sensor is
set using a calibrated coil fixed on the magnet which generates a 1 kHz in-plane reference magnetic
signal. The aim of this positioning is to maximize the sensitivity and to minimize the noise of the
resulting signal. Indeed, the precise location of the sensor influences the random telegraphic noise that
appears in some configurations. Then, these two characteristics are measured. The smallest detectable
signal, called threshold, is defined as having an amplitude exceeding three times the noise level. In
a typical experiment, the sensor noise was evaluated at 50 nT/
√
Hz, there was 6 μV of noise on the












Inlet reservoir Chip Permanent magnetμ-metal
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Figure 1. Experimental set-up and data. (a) The chip, the reservoir and the collecting vial are inserted
in a homogeneous magnetic field. A computer program is controlling the flow using a pressure driver.
The applied pressure is set to 300 mbar. Homemade electronic boxes deliver power to the sensor,
amplify and filter the signals before sending the data outside the low-noise chamber to the acquisition
card. (b) Chip photograph. (c) Positioning angles.
The device and electronic boxes were used in a magnetically shielded room (2.9 × 2.9 × 2.3 m3)
made of three μ-metal layers and three aluminum layers. In this environment, the noise level is
of 1 nT
√
Hz which is low compared to the intrinsic sensor noise. In a real commercial device, a
reference GMR sensor (outside of the microfluidic channel) is enough to substract environmental noise,
mainly the 50 or 60 Hz magnetic field created by power lines as it has already been done by some
groups [57,58].
The flow is driven by a pressure controller (MFCSTM-EZ: Microfluidic Flow Control System,
Fluigent R©) and the pressure is set to 300 mbar, typically a sample of 1 mL is flowed in 30 min.
The liquid sample is directly injected at the top of the inlet reservoir, made of polyoxymethylene to
minimize cells and beads adhesion on its walls. This reservoir is set in vertical position to insure that
sedimentation would not impede some cells to go into the channel. The wet part of the reservoir is
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completely localized in the gap between the two magnets to minimize magnetic forces exerted on
the content.
2.8. Electronics
The electronics is battery supplied to avoid 50 Hz noise. The sensors are biased at voltages
between 1 to 2 V and the output signal is amplified 500 times by a low noise preamplifier and filtered
at 15 kHz with an additional gain of 20. The signal is then oversampled at 200 kHz using a Data
Translation R© acquisition card controlled by a homemade software. A schematic view of this set-up is
presented in Figure 1a. Then, a homemade software identifies the signals from the total recording and
discriminate them from noise artifacts. Numerical parameters were evaluated on a cohort of several
thousands of examples from different experiments. For each spotted point above the threshold, the
local minimum and maximum are determined by repeatedly incrementing the interval of interest by 15
points until the maximum (imax, Vmax) and minimum (imin, Vmin) determined are more than 20 points
from each edge of the interval. The user determines the direction of signals (k = 1 if imax − imin < 0
and k = −1 if imax − imin > 0) and the detection threshold (Vthr). Several checks are then carried out
to validate the recording of this peak in the processed file. They must be bipolar (|Vmin| > 1/3Vthr
and |Vmax| > 1/3Vthr) with the right orientation (k(imax − imin) < 0), their width (imax − imin) must be
coherent with the flow velocity (between 25 μs and 2.5 ms) and they must be sufficiently symmetric
(|Vmax−VminVmax+Vmin | < 0.4). This last criteria was added to better discriminate signals from radiotelegraphic
noise occurring in some experiments. Experimental data before and after treatment are presented
respectively in Figure 2a,b.
Figure 2. Experimental data. (a) Raw experimental recording. (b) Recording of the software-selected
portions (the same 3 signals are shown).
2.9. Comparative ELISA Tests
96 wells plates were coated with anti-CD138 antibody. In each well, 100 μL of a suspension of 10
μg/mL of antibodies in potassium phosphate buffer at 50 mM, pH 7.4 were deposited and incubated
overnight at 20 ◦C. The following day, wells were emptied and filled with 300 μL of EIA buffer (100
mM potassium phosphate buffer pH 7.4 containing 0.1% bovine serum albumin, 0.15 M NaCl and
0.01% sodium azide). The plates were sealed and stored at 4 ◦C until use.
The day of the experiment, the coated plate was washed once in a washing buffer (50 mM
potassium phosphate buffer pH 7.4), 100 μL of serial dilutions of NS1 cells (3 106; 106; 3 105; 105; 3
104; 104; 3 103; 103 cells/mL) in PBS were added per well and incubated under agitation at room
temperature for 2 h. Then, the plate was washed three times in the washing buffer and 100 μL of a
suspension of biotinylated antibody anti-CD138 at 200 ng/mL in EIA buffer without sodium azide
were added per well for a 2h-incubation step under agitation at room temperature. The plate was
then washed three times in the washing buffer and 100 μL of a solution of streptavidin conjugated
with polymers of horseradish peroxidase (Thermofisher Scientific, Waltham, MA, USA) diluted 15,000
fold in EIA buffer without azide was added into the wells. Finally, after 30 min of incubation under
agitation at room temperature, the plate was washed 5 times in the washing buffer and 100 μL of
3,3′,5,5′-Tetramethylbenzidine (TMB, Thermofisher Scientific) were added per well. After 30 min at
room temperature under agitation, 100 μL of 2 M sulfuric acid were added per well and the absorbance
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of each well was measured at 450 nm (wavelength of absorption of the reaction product) and 620 nm
(noise measurement).
The substraction of these two measurements yields the specific signal directly proportional to
NS1 cell concentration. The theoretical limit of detection is defined as the lowest cell concentration
giving a signal greater than the non-specific binding (mean of eight measurements of EIA buffer) + 3
standard deviations (99.7% confidence). The theoretical limit of quantification is defined as the lowest
cell concentration giving a signal greater than the non-specific binding (mean of eight measurements
of EIA buffer) + 10 standard deviations (99.9% confidence).
2.10. Comparative Flow Cytometry Tests
For flow cytometry analysis, NS1 cells were washed once with PBS/0.5% BSA and 200 μL of serial
dilutions of cells (105; 3 104; 104; 3 103; 103 cells/mL) were incubated for 2 h at 4 ◦C with anti-mouse
CD138 labeled with Phycoerythrin (BD Biosciences). After incubation, cells were washed twice with
PBS/0.5% BSA and resuspended in 200 μL of PBS/0.5%BSA. The fluorescence was finally assayed for
the total volume of 200 μL using a Novocyte flow cytometer (ACEA) and the number of stained cells
was evaluated by comparison with cells incubated with buffer alone. Results were analysed using
NovoExpress software.
3. Results and Discussion
3.1. Simulations of Single Magnetic Beads and MP-Labeled Cells
A GMR sensor is composed of two ferromagnetic metallic layers separated by a nonmagnetic one
as shown in Figure 3a. The magnetization of one of these layers is pinned in one direction while the
magnetization of the other one is free to rotate in its plane. As the speed of propagation of electrons in
a metal strongly depends on the relative orientation of its spin and the magnetization of the metal, this
spintronic device will have different properties for spin up and spin down electrons. Depending on
the angle between the magnetizations of the two ferromagnetic layers, the overall resistance of the
sensor varies as shown in Figure 3b. During the detection process, the MPs themselves are magnetized
perpendicularly to the sensor plane by a field created with a permanent magnet and emit a dipolar
field. Only the in-plane component of the dipolar field created by the beads is detected by the magnetic
sensor since thin-film GMR sensors are insensitive to out-of-plane field variations (z direction) below a
critical value. The sensor yoke geometry, designed especially to have just one magnetic domain [59], is
shown in Figure 3d and presents a high aspect ratio. This strong asymmetry between the length and
width of the device will tend to align all the moments from the free layer according to its length to
reduce the magnetostatic energy by moving the two poles created as far as possible from each other.
The free layer magnetization is thus along the x axis at zero field, while the other layer is pinned along
the y axis. The device is in its most sensitive configuration at zero field and is sensitive only to the y
component of the field. Moreover, improving the alignment of moments from the free layer results in
a more linear behavior of the sensor. GMR sensors response to small magnetic fields variations are
linear on a range of about ±2 mT around zero field (see Figure 3b), which includes the whole range of
fields needed for this application.
The situation to be modeled is presented in Figure 3c. Magnetized objects circulate above the
sensor in a laminar flow in a microchannel and induce magnetic field variations that are detected by
the sensor. Three types of magnetic objects are modeled: single magnetic beads, aggregates of beads
and MPs-labeled cells.
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Figure 3. Giant magnetoresistance (GMR) sensor. (a) Scheme of the main components of a GMR stack.
Free and pinned layers are ferromagnetic and their magnetization are represented by arrows. The
spacer is a diamagnetic conductor. (b) Experimental sensitivity curve with schematic representation of
the relative orientations of the two ferromagnetic layers. This sensor shows a sensitivity of 2 %.mT−1
and no hysteresis on its linear portion. (c) Schematic of the experiment: Labeled objects are moved by
the laminar flow at a given height crossing the sensor at constant speed. The sensor detects variations
of the magnetic field due to the induced dipolar field of the beads. The beads are magnetized by a field
normal to the sensor plane created by a permanent magnet. (d) Photograph and scheme of a processed
GMR sensor in yoke shape. The sensor measures 120 μm along the x axis and 4 μm along the y axis.
The signal corresponding to a single bead moving above the sensor is proportional to the integral
over the whole sensor surface of the y-component of the local dipolar field induced at each successive
position. For a MP in position (xB, yB, zB) with a moment μ making an angle θ withz and φ with x

























































− yB yl = − l2 − yB
























Biosensors 2019, 9, 105
After several simulation tests (data not shown), it has been concluded that the influence of the
spatial distribution of the moments in the aggregates was negligible. Signals from aggregates of N
beads are simulated as N times the signals coming from a single bead with the same parameters.
On the contrary, the distribution of MPs on the cell surface was proven to have an influence on
the generated signals, as presented in Figure 4b. Cells are thus simulated as spheres with several
magnetic beads distributed randomly on their surfaces and with a random angle θ between the
direction of their moment and the vertical axis with the constraint of a total magnetization equal to the
experimentally measured one (see Section 3.2). This observation leads to the conclusion that detecting
one passage with one single sensor cannot be sufficient to deduce precisely the nature and the details
of the detected object.
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Figure 4. (a) Simulation results of the magnetic object detection demonstrating the influence of the
three main parameters: distance between object and sensor (Z), number of magnetic particles (MPs)
(N) and moment orientation (θ). Curves are labeled by the triplet (Z,N,θ). (b) Simulation results for a 6
μm diameter cell at 6 μm height covered by 10 MPs, with four sets of random positions of the beads on
the cell surface.
However, our objective is to discriminate the MP-labeled cells from the aggregates of magnetic
beads. Three experimental parameters must be chosen together to optimize the discrimination: (i) the
chip design, (ii) the permanent magnet, (iii) the magnetic particles. Indeed, with fixed values for
these three settings, the values of the two parameters determining the signal shape (the height of the
magnetic object and its magnetic moment) are framed. The object distance from the sensor has the
largest importance on the amplitude of the signal as shown on Figure 4a. As a consequence, to increase
the impact of the number of MPs per object on the resulting signal (value correlated to the nature of
this object), the object distance from the sensor needs to be the most homogeneous as possible, hence,
the channel must be the smallest possible. This parameter was set to 25 μm, the lowest value at which
the channel would not clog after 2 h of use. The permanent magnet must be chosen so that its field
is sufficient to have a small average angle θ between the beads magnetic moments and the vertical
axis but must be low enough not to pull the pinned layer of the sensor out of plane. This value was
set at 90 mT as it was a good compromise knowing the MPs magnetization curves. The choice of the
magnetic beads and of the chip design are explained in the following paragraphs.
3.2. Deduction of Best Experimental Conditions
The chip design was optimized by testing different configurations of the sensor and microchannel
geometries on simulated samples. The main idea was to make some static changes that would not
complicate the use of the device but would enhance the discrimination between “positive” and
“negative” samples. Samples are called “positive” if they are supposed to contain MPs-labeled cells
(they contain a specific complex mAbs-coated beads/cells possessing antigens targeted by the mAbs)
and “negative” if they are not, see Table 1.
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3.2.1. Sample Characterization
The two kinds of samples had thus to be experimentally characterized to make a proper model.
Five sorts of commercial magnetic beads ranging from 200 nm to 2.8 μm in diameter from three
companies were tested for the preparation of these samples. Indeed, the choice of MPs is important.
Ideal beads should have a magnetic moment sufficiently high to be attracted by a permanent magnet
within few minutes to enable simple and quick washing steps (required for mAbs functionalization of
MPs before performing the test). They should also have a low saturation field so that a permanent
magnet of 90 mT is enough to reach quasi-saturation and, above all, they must present the lowest
propensity to aggregation. All these properties were investigated as follows.
First, the magnetic moment of 50 μL of each of the MPs suspensions has been measured using a
Vibrating Sample Magnetometer (VSM) and, using the manufacturer number of beads information,
the saturation magnetic moment of a single bead has been calculated and the saturation field
was determined.
Then, each type of beads was functionalized with antibodies. After this step, their kinetics of
cell labeling and their aggregation were studied in parallel. Different concentrations of each type of
MPs have been mixed in PBS and with 105 NS1/mL in PBS. For 2 to 3 h, regularly, 100 μL of these
suspensions were poured into a well and let to sediment for 15 min. Pictures were then taken under
optical microscope. For each cell-containing sample, the distribution of the number of beads per cell
was evaluated by visual counting. For the samples without cells, hundreds of these photographs were
analyzed with the ImageJ software. They were binarized before the software counted the number of
pixels in each aggregate. From these data, the distribution of beads in aggregates was deduced.
Finally, Dynabeads MyOne Streptavidin T1 superparamagnetic have been chosen for the present
study (Figure 5, results for the 4 other investigated types of beads can be found in Appendix A). They
are 1 μm polymer beads containing maghemite clusters and have a sufficiently high moment that
they can be attracted by a permanent magnet within 2 min, thus washing steps (required for mAbs
functionalization of MPs) are extremely simple and quick. The saturation magnetic moment of a single
bead has been calculated to be 2.1 10−11 emu per bead and reached at a field of 700 mT but at 90 mT
these beads already have an average magnetic moment of 1.6 10−11 emu per bead (data not shown).
They are easily functionalized with any kind of purified biotinylated antibodies with high efficiency,
with the protocol described in Section 2.5. Moreover the number and size of bead aggregates in the
commercial suspension were the lowest of the 5 studied MP types (93% of the objects in the suspension
are composed of less than 7 beads, 99% less than 15 beads, the complete curve is presented on Figure 5f)
and the distribution of beads per cell was satisfying with an average of roughly 50 MPs per cell (the
distribution and the 100 magnification photographs are shown on Figure 5).
3.2.2. Chip Design
The objective is to find the most favorable conditions to discriminate labeled cells from aggregates.
As described in details in the Section 3.1, the signals are determined by the dipolar field created by the
detected object which depends mainly on the magnetic moment of the object and its height from the
sensor. The expression of the dipolar field Hdip created in B and sensed in C is given by Equation (2)
where μ is the magnetic moment of a bead and N is the number of beads of the detected object.





On the Figure 5f, the distributions of beads in cells and in aggregates are given for our system. By
using Equation (2), it can be calculated that, between the smallest object in negative samples (1 bead)
and the most labeled cell (around 100 beads), the signal is multiplied by 100. Between a height of 1 μm
from the sensor and of 10 μm from the sensor, the signal is divided by 1000. Thus, when the channel is
directly placed at the top of the sensor, even a signal from a single bead (at 1 μm height) cannot be
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discriminated from a signal coming from a labeled cell further away from the sensor in the channel,
independently of the detection threshold.
Figure 5. Labeling and aggregation study. Four sample photographs (magnification 100) were taken
under optical microscope and illustrate beads repartition. (The scale bars represent 5 μm.) (a) Group of
two NS1 cells labeled with Dynabeads MyOne functionalized with anti-CD138 mAbs. (b) Group of two
NS1 cells after two hours-contact with Dynabeads MyOne functionalized with control IpaD-315 mAbs.
(c) CHO cell after two hours-contact with Dynabeads MyOne functionalized with anti-CD138 mAb
(d) Dynabeads MyOne functionalized with anti-CD138 mAbs in Phosphate Buffer Saline (PBS). (e)
Adapted spacer layer thickness estimation. In this illustration, the detectivity is set to 2.2 μT. Relation
between the number of beads covering an object and the maximum height at which it can be detected.
Objects below the red curve are detectable while objects above are not. (f) Corresponding detectable
population of cells and aggregates. Graph of the observed cumulative frequency of the number of MPs
per NS1 cell and per aggregate in decreasing order. Estimation based on the study of 309 cells in a
solution containing 105 NS1/mL and 23 μg/mL anti-CD138 functionalized MPs/mL after 2h-contact
and of 18,630 aggregates in a suspension containing 23 μg/mL anti-CD138 in PBS.
Knowing the detectivity of the sensor (experimental characterizations are given on Table 2),
the maximal distance from the sensor at which an object composed of N beads can be detected is
deduced and plotted in the Figure 5. Above this distance, all the aggregates containing less than N
MPs are undetectable. While 98% of NS1 are labeled with more than 7 beads, only 7% of aggregates are
composed of more than 7 beads. This minimum number of beads seems to be a good discrimination
factor. The Figure 5e shows that objects of 7 beads are undetectable from 6 μm above the sensor.
Adding a separation layer between the sensor and the bottom of the channel eliminates most of
the nonspecific signals (from small aggregates and single beads) and improves the discrimination on
the number of beads by reducing the importance of the height parameter. Indeed, between 7 and 16
μm height, the signal is divided by approximately 12 only. Without this supplementary layer, objects
of small magnetization could still induce large amplitude signals that could be mistaken for labeled
cells.
This study leads to the conclusion that the best configuration for our system is the addition of
a 6 μm thick separation layer between the sensor and the channel. The thickness of the separation
layer needs to be optimized for each couple bead/biological target, because it depends strongly on the
expected moment per target and thus on the number of antigens expressed by the target.
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3.3. Performance of the GMR Chip Test
Seven experiments (See Table 2 and Figure 6a) were realized on six days using 4 similar chips
with different sample volumes ranging from 200 to 400 μL and the number of events was normalized
to a volume of 1 mL. To avoid biased results, samples have been injected in the chip in different orders
at each experiment and between two samples the chip was washed with deionized water and dried.
For each experiment, the sensitivity and the noise level of the sensor have been measured and the
detection thresholds were deduced (given in Table 2). In order to coherently treat data from these
seven experiments, only signals above the highest detection threshold (2.2 μT) were considered.
Table 2. Experimental conditions of the seven experiments. The threshold of each experiment is defined
as the lowest detectable signal (with a signal to noise ratio at 3). Results are given as a number of events
above 2.2 μT detected per milliliter of sample. The average count is given with its standard deviation
(SD) for each sample. Control samples are presented at the bottom of the table, separated from positive
samples. The highest count in negative samples, in bold, is obtained for anti-CD138 beads in PBS for
which the average value added to three standard deviations gives 3.6 103 counts.
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Summary
Sensor Sensor A Sensor B Sensor C Sensor D Different
Separation layer thickness 6.2 μm 6.4 μm 5.7 μm 5.5 μm devices,
Channel height 26.5 μm 27.4 μm 25.3 μm 23.1 μm samples and
Beads batch 1 2 3 4 5 5 conditions.
Threshold (μT) 1.6 1.8 2.2 0.47 0.46 0.48 Same
Sample volume (μL) 400 200 300 300 300 300 300 experimenters
Cells mAbs Counts of signals above 2.2 microteslas per milliliter Average ± SD
105 NS1 anti-CD138 12,123 14,700 10,367 1.2 × 104 ± 1.8 103
3 104 NS1 anti-CD138 3463 5173 6180 5070 5.0 × 103 ± 9.7 102
104 NS1 anti-CD138 2867 1223 1927 1597 1.9 × 103 ± 6.1 102
3 103 NS1 anti-CD138 467 630 517 607 5.6 × 102 ± 6.6 101
103 NS1 anti-CD138 500 977 280 353 5.3 × 102 ± 2.7 102
105 NS1 IpaD315 895 60 660 637 723 313 520 5.4 × 102 ± 2.6 102
105 CHO anti-CD138 690 380 367 4.8 × 102 ± 1.5 102
∅ anti-CD138 1665 375 2213 310 1.1 × 103 ± 8.2 102
Between 60 and 2200 counts per milliliter were found in each type of negative control samples
in PBS (14 measurements in total). Studying these results allow us to determine a count threshold
characterizing the test. The count threshold above which the sample can be considered positive (the
detection threshold) is calculated as the average of the values obtained for the negative test having
the most counts (thus, the anti-CD138 beads) added to three times their standard deviation. This
method concludes to an average non-specific count of 1.1 103 counts per milliliter and a detection
count threshold of 3.6 103 counts per milliliter.
Looking at the positive sample results, this threshold corresponds to a concentration between 1
and 3 104 NS1 per milliliter.
3.4. ELISA Test Sensitivity
The ELISA test was repeated in three independent experiments in order to compare its detection
limit to the one of the GMR sensor. Results are presented in Figure 6b. For this 5 h-test in PBS
suspensions, the detection limit (the lowest concentration at which the test can determine positivity of
the sample) was found equal to 2.0 104 NS1/mL ± 1.8 104 while the quantification limit (the lowest
concentration at which the test can give a correct estimation of the sample concentration) was found at
6.7 104 NS1/mL ± 2.9 104.
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3.5. Flow Cytometry Results
The number of NS1 cells was evaluated by flow cytometry using a specific monoclonal antibody
against the CD138 surface molecule. The living cells were selected by size and cell granularity and the
number of CD138+ cells in each sample was evaluated by comparison with cells incubated with buffer
alone. As can be seen in Figure 6c, the evaluation of the number of positive cells for the CD138 marker
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Figure 6. Experimental results of the three tests. All were performed in different days, thus the same
samples were not tested with the three techniques. (a) Experimental results of the GMR test. Red
dashes represent the mean of the experiments. Error bars represent standard deviations from the
experiments. (b) Experimental results of the ELISA tests. Different concentrations of NS1 cells in PBS
were detected using the homologous sandwich ELISA involving anti-CD138 mAb as capture and tracer
antibody in a 5 h sequential format. The signal to noise ratio was calculated from the mean of eight
measurements of PBS alone. Red dashes represent the mean of the three independent experiments,
each performed in duplicate. Error bars represent standard deviations from the three experiments.
The insert shows the low concentration part of the curve. (c) Experimental results of flow cytometry
presented as counts per milliliter for each concentration. Red dashes represent the mean of the three
independent experiments. Error bars represent standard deviations from the three experiments.
4. Conclusions
In this article, the different steps of the conception of a magnetoresistive chip cell-counter were
detailed. This detection technique has a great potential. The production, use and integrability of GMR
sensors are easy and the tool allows for the detection of targets one by one. This test was evaluated
regarding several essential qualities of diagnostic tools (sensitivity, specificity, reproducibility and
duration) on a biological model, murine myeloma cells immunocaptured by commercial magnetic
beads of 1 μm in diameter. The reached sensitivity of about 104 cells/mL is equivalent to that of an
ELISA test realized with the same reagents (NS1 cells, mAbs, buffer . . . ). Our test is simpler to perform
than an ELISA test. Indeed, the GMR test can be performed within 2h30 (2 h of labeling as assessed by
our kinetic study, briefly described in Appendix A and 30 min/mL of sample for the test) without any
washing steps, while the compared ELISA test requires several washing steps. Data treatment can be
done in a few minutes for ELISA test and can be integrated in the acquisition chain and done in real
time for the GMR test. One can note that both techniques can benefit from large parallelization of tests.
Moreover, the time of the GMR test can be further reduced by increasing the flow rate in the channel.
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The labelling processes strongly depends on the target, the beads and the biological probe and other
groups reported times between 30 and 180 min [51,53,57]. This time will have to be optimized on the
final system, in the real biological sample.
Flow cytometry, although not optimized to give absolute cell counts, have a sensitivity ten times
lower than the GMR test. However, this method is more complicated, with washing steps, causing
loss of cells and thus discrepancies in counts. The Figure 7 shows the extrapolated number of cells
counted by both techniques in positive samples of 1 mL as a function of the expected counts. The
agreement between the two techniques is remarkably good for all concentrations except at 103 NS1/mL.
Our technique however, presents the interest that the count of signals can be automated while flow










Figure 7. Experimental results of flow cytometry (in blue) compared with experimental results of the
GMR test (in red). Mean values and standard deviations are represented.
The relatively high limit of detection of some 104 cells/mL is due to two main phenomena.
First, some specific events are missed. Indeed, some less efficiently labeled cells are flowing high in
the channel and cannot be detected specifically. Secondly, the detection count threshold has a high
value. This can be explained both by the number of beads aggregates, increasing the average number
of non-specific signals and by the variability of experimental parameters, increasing the standard
deviation of the number of non-specific signals. These uncertainties rise from the use of 5 distinct
batches of functionalized beads for the experiment, the random order in which the samples were
passed and the involuntarily fluctuations in channel geometry.
This study shows the importance to take into account the biological parameters (antigen
distribution, labeling efficiency, cell survival, matrix effect, etc.) in the test evaluation. The high
detection count threshold value demonstrates the crucial importance of having negative controls and
to repeat experiments in different conditions several times in order to define correctly performances
of such technologies. The development of diagnostic tests are based on these two pillars (physical
and biological parameters) and correct definitions of performances of a test should systematically
integrate these cross-cutting aspects. Here, the focus was set on a rigorous evaluation of non-specific
signals measured by the GMR sensor. The study showed that these non-specific signals were due to
the detection of beads aggregates.
To lower the detection threshold without complicating the device, the challenge is to diminish
drastically the number and the sizes of the MP aggregates. As a matter of fact, decreasing the number
of beads in aggregates would enable great changes in the chip design. The separation layer, added
to reduce the impact of non-specific events, could be thinned and thus less efficiently labeled cells
would be easier to detect. A better understanding of these aggregation phenomena and development
of solutions to reduce the number of these non-specific events will help to reach a better reproducibility
and sensitivity.
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The elimination of aggregates can be performed by microfluidics sorting techniques relying on
hydrodynamic or magnetodynamic forces [61–65] but this would necessarily waste a certain amount
of expensive mAbs-coated beads. Another way to deal with these beads suspensions instabilities
would be to address directly the cause by a better design of the magnetic beads, such as adding a PEG
coating [66].
The real solution may lie in designing magnetic beads tuned especially for this application and
thus, to continue the development of this diagnosis tool, the natural next step should be to add
chemistry as a third project pillar.
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Appendix A. Magnetic Particles Aggregation Study
Figure A1. (A) Kinetic of NS1 labeling for 4 types of microbeads. (B) 20 magnification photographs of
NS1 cells incubated 2 h with: (i) Dynabeads 2.8 μm (ii) Micromod 1.5 μm (iii) Dynabeads 1 μm (iv)
Micromod 0.5 μm (v) Adembeads 200 nm.
mAbs-functionalized 200 nm carboxyl-Adembeads (Ademtech R©), 500 nm streptavidin
nanomag R©-D (Micromod), 1 μm DynabeadsTM MyOneTM Streptavidin T1 (InvitrogenTM), 1.5 μm
streptavidin sicastar R©-M (Micromod) and 2.8 μm DynabeadsTM M-280 Tosylactivated (InvitrogenTM)
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suspensions were analyzed in terms of aggregate distribution (data not shown). Then, cell
immunocapture kinetic studies were realized with an optical microscope. Data from 200 nm beads
were hardly exploited but it was clear that beads aggregated considerably while no excessive labeling
was visible at cell surface (Figure A1B(v)). The other 4 types of MPs gave quantified results presented
on Figure A1 as plots of average number of beads per cell against time. The 500 nm-diameter Micromod
beads labelled poorly the cells after 2 h. 1.5 μm diameter Micromod beads labelled the cells correctly
but aggregates were far too numerous for those beads to be of any interest. The best options were
the two kinds of DynabeadsTM. The estimation of number and size of aggregates for these beads
showed that 1 μm beads seemed to form labeled cells more distinguishable from beads aggregates
than the 2.8 ones. However, to confirm that, there were attempts to decrease the number of aggregates
for 2.8 μm beads as they reached the maximum cell labeling quicker. They were sonicated for 30
s to 1 minute for 1 to 3 times before use with no conclusive results. Then, they were vortexed and
sonicated alternatively 3 times with cycles of 2 and 1 min respectively. Finally they were added to
several detergent alone or in combinations at 0.1% each (SDS (sodium dodecyl sulfate), tween 20, triton
X-100, CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate)) either in PBS or in
deionized water before being submitted to the 3 cycles of sonication-vortices described above. While
most of these attempts remained unsuccessful, the suspension of beads in deionized water containing
all detergents and the suspension in deionized water containing SDS and tween 20 showed significant
improvements: the percentage of single beads improved from 66% in the suspension in PBS without
detergent to 90% and 84% respectively. Once this observation was done, the cell survival was evaluated
in the presence of different detergent concentrations ranging from 0.01% to 1%. All cells were lysed
after 2 h contact with all these detergent concentrations. DynabeadsTM of 1 μm were thus the optimum
and detergent use was abandoned. Sonication and vortex did not improve their aggregation.
References
1. Bialy, L.; Mlynarczuk-Bialy, I. Advances in Biomedical Research—Selected Topics; Wydawnictwo Naukowe
TYGIEL sp. z o.o.: Lublin, Poland, 2018.
2. Cohen, S.J.; Punt C.J.; Iannotti N.; Saidman B.H.; Sabbath K.D.; Gabrail N.Y.; Picus J.; Morse M.; Mitchell E.;
Miller M.C.; et al. Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival,
and Overall Survival in Patients With Metastatic Colorectal Cancer. J. Clin. Oncol. 2008, 26, 3213–3221.
[CrossRef] [PubMed]
3. Giuliano, M.; Giordano, A.; Jackson, S.; Hess, K.R.; De Giorgi, U.; Mego, M.; Handy, B.C.; Ueno, N.T.;
Alvarez, R.H.; De Laurentiis, M.; et al. Circulating tumor cells as prognostic and predictive markers in
metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Res. 2011, 13, 1–9.
[CrossRef] [PubMed]
4. Sinha, M.; Jupe, J.; Mack, H.; Coleman, T.P.; Lawrence, S.M.; Fraley, S.I. Emerging Technologies for Molecular
Diagnosis of Sepsis. Clin. Microbiol. Rev. 2018, 31, e00089-17. [CrossRef] [PubMed]
5. Fitzmaurice, C.; Allen, C.; Barber, R.M.; Barregard, L.;, Bhutta, Z.A.; Brenner, H.; Dicker, D.J.; Chimed-Orchir,
O.; Dandona, R.; Dandona, L.; et al. Global, Regional, and National Cancer Incidence, Mortality, Years of
Life Lost, Years LivedWith Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017, 3, 524–548.
6. Fulwyler, M.J. Electronic Separation of Biological Cells by Volume. Science 1965, 150, 910–911. [CrossRef]
7. Aebisher, D.; Bartusik, D.; Tabarkiewicz, J. Laser flow cytometry as a tool for the advancement of clinical
medicine. Biomed. Pharmacother. 2017, 85, 434–443. [CrossRef] [PubMed]
8. Brown, M.; Wittwer, C. Flow Cytometry: Principles and Clinical Applications in Hematology. Clin. Chem.
2000, 46, 1221–1229.
9. Bakke, A.C. Clinical Applications of Flow Cytometry. Lab. Med. 2000, 31, 97–104. [CrossRef]
10. Wood, B.L. Principles of Minimal Residual Disease Detection for Hematopoietic Neoplasms by Flow
Cytometry. Cytom. Part B 2016, 90, 47–53. [CrossRef]
11. Chernecky, C.C.; Berger, B.J. Laboratory Tests and Diagnostic Procedures; Elsevier Health Sciences: Saint Louis,
MO, USA, 2012.
29
Biosensors 2019, 9, 105
12. Féraudet-Tarisse, C.; Vaisanen-Tunkelrott, M.L.; Moreau, K.; Lamourette, P.; Créminon, C.; Volland, H.
Pathogen-free screening of bacteria-specific hybridomas for selecting high-quality monoclonal antibodies
against pathogen bacteria as illustrated for Legionella pneumophila. J. Immunol. Methods 2013, 391, 81–94.
[CrossRef]
13. Gan, S.D.; Patel, K.R. Enzyme Immunoassay and Enzyme-Linked Immunosorbent Assay. J. Investig. Dermatol.
2013, 133, e12. [CrossRef]
14. Piyasena, M.E.; Graves, S.W. The intersection of flow cytometry with microfluidics and microfabrication.
Lab Chip 2014, 14, 1044–1059. [CrossRef] [PubMed]
15. Gong, Y.; Fan, N.; Yang, X.; Peng, B.; Jiang, H. New advances in microfluidic flow cytometry. Electrophoresis
2018, 40, 1212–1229. [CrossRef] [PubMed]
16. Mendez-Gonzalez, D.; Lopez-Cabarcos, E.; Rubio-Retama, J.; Laurenti, M. Sensors and bioassays powered
by upconverting materials. Adv. Colloid Interface Sci. 2017, 249, 66–87. [CrossRef] [PubMed]
17. MagArray. Available online: http://www.magarray.com/ (accessed on 5 February 2019).
18. Zepto. Available online: http://www.zeptolife.com/(accessed on 5 February 2019).
19. Magnomics. Available online: http://www.magnomics.pt/(accessed on 5 February 2019).
20. Krishna, V.D.; Wu, K.; Perez, A.M.; Wang, J.P. Giant Magnetoresistance-based Biosensor for Detection of
Influenza A Virus. Front. Microbiol. 2016, 7, 400. [CrossRef]
21. Ferguson, B.S.; Buchsbaum, S.F.; Wu, T.T.; Hsieh, K.; Xiao, Y.; Sun, R.; Soh, R.T. Genetic analysis of H1N1
influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics. J. Am. Chem.
Soc. 2011, 133, 9129–9135. [CrossRef]
22. Pihíková, D.; Kasák, P.; Tkac, J. Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based
biosensors. Open Chem. 2015, 13, 636–655. [CrossRef]
23. Serrate, D.; De Teresa, J.M.; Marquina, C.; Marzo, J.; Saurel, D.; Cardoso, F.A.; Cardoso, S.; Freitas, P.P.;
Ibarra, M.R. Quantitative biomolecular sensing station based on magnetoresistive patterned arrays. Biosens.
Bioelectron. 2012, 35, 206–212. [CrossRef]
24. Fermon, C.; Van de Voorde, M. Nanomagnetism, Applications and Perspectives; Wiley: Weinheim, Germany;
2017.
25. Lin, G.; Makarov, D.; Schmidt, O.G. Magnetic sensing platform technologies for biomedical applications.
Lab Chip 2017. [CrossRef]
26. Wang, T.; Yang, Z.; Lei, C.; Lei, J.; Zhou, Y. An integratedgiantmagnetoimpedancebiosensorfordetection of
biomarker. Biosens. Bioelectron. 2014, 58, 338–344. [CrossRef]
27. Boyle, D.S.; Hawkins, K.R.; Steele, M.S.; Singhal, M.; Cheng, X. Emerging technologies for point-of-care CD4
T-lymphocyte counting. Trends Biotechnol. 2012, 30, 45–54. [CrossRef] [PubMed]
28. Barroso, T.G.; Martins, R.C.; Fernandes, E.; Cardoso, S.; Rivas, J.; Freitas, P.P. Detection of BCG bacteria
using a magnetoresistive biosensor: A step towards a fully electronic platform for tuberculosis point-of-care
detection. Biosens. Bioelectron. 2018, 100, 259–265. [CrossRef] [PubMed]
29. Lange, J.; Kötitz, R.; Haller, A.; Trahms, L.; Semmler, W.; Weitschies, W. Magnetorelaxometry—A new
binding specific detection method based on magnetic nanoparticles. J. Magn. Magn. Mater. 2002, 252, 381–383.
[CrossRef]
30. Yang, T.Q.; Abe, M.; Horiguchi, K.; Enpuku, K. Detection of magnetic nanoparticles with ac susceptibility
measurement. Phys. C 2004, 412–414, 1496–1500. [CrossRef]
31. Ludwig, F.; Heima, E.; Mä useleina, S.; Eberbeckb, D.; Schilling, M. Magnetorelaxometry of magnetic
nanoparticles with fluxgate magnetometers for the analysis of biological targets. J. Magn. Magn. Mater. 2005,
293, 690–695. [CrossRef]
32. Denmark, D.J.; Bustos-Perez, X.; Swain, A.; Phan, M.H.; Mohapatra, S.; Mohapatra, S.S. Readiness of
Magnetic Nanobiosensors for Point-of-Care Commercialization. J. Electron. Mater. 2019, 48, 4749–4761.
[CrossRef]
33. Guo, L.; Yang, Z.; Zhi, S.; Feng, Z.; Lei, C.; Zhou, Y.. A sensitive and innovative detection method for
rapid C-reactive proteins analysis based on a micro-fluxgate sensor system. PLoS ONE 2018, 13, e0194631.
[CrossRef]
34. Pekas, N.; Porter, M.D. Giant magnetoresistance monitoring of magnetic picodroplets in an integrated
microfluidic system. Appl. Phys. Lett. 2004, 85, 4783–4785. [CrossRef]
30
Biosensors 2019, 9, 105
35. Loureiro, J.; Ferreira, R.; Cardoso, S.; Freitas, P.P.; Germano, J.; Fermon, C.; Arrias, G.; Pannetier-Lecoeur, M.;
Rivadulla, F.; Rivas, J. Toward a magnetoresistive chip cytometer: Integrated detection of magnetic beads
flowing at cm/s velocities in microfluidic channels. Appl. Phys. Lett. 2009, 95, 034104. [CrossRef]
36. Loureiro, J.; Andrade, P.Z.; Cardoso, S.; da Silva, C.L.; Cabral, J.M.; Freitas, P.P. Magnetoresistive chip
cytometer. Lab Chip 2011, 11, 2255–2261. [CrossRef]
37. Walt, D.R. Optical methods for single molecule detection and analysis. Anal. Chem. 2013, 83, 1258–1263.
[CrossRef] [PubMed]
38. Helou, M.; Reisbeck, M.; Tedde, S.F.; Richter, L.; Bär, L.; Bosch, J.J.; Stauber, R.H.; Quandt, E.; Hayden, O.
Time-of-flight magnetic flow cytometry in whole blood with integrated sample preparation. Lab Chip 2013,
13, 1035–1038. [CrossRef] [PubMed]
39. Muluneh, M.; Issadore, D. Microchip-based detection of magnetically labeled cancer biomarkers. Adv. Drug
Deliv. Rev. 2014, 66, 101–109. [CrossRef] [PubMed]
40. Murali, P.; Niknejad, A.M.; Boser, B.E. CMOS Microflow Cytometer for Magnetic Label Detection and
Classification. IEEE J. Solid-State Circuits 2017, 52, 543–555. [CrossRef]
41. Giouroudi, I.; Kokkinis, G. Recent Advances in Magnetic Microfluidic Biosensors. Nanomaterials 2017, 7, 171.
[CrossRef] [PubMed]
42. Fodil, K.; Denoual, M.; Dolabdjian, C.; Treizebre, A.; Senez, V. In-flow detection of ultra-small magnetic
particles by an integrated giant magnetic impedance sensor. Appl. Phys. Lett. 2016, 108, 173701. [CrossRef]
43. García-Arribas, A.; Martínez, F.; Fernández, E.; Ozaeta, I.; Kurlyandskaya, G.V.; Svalov, A.V.; Berganzo, J.;
Barandiaran, J.M. GMI detection of magnetic-particle concentration in continuous flow. Sens. Actuators A
2011, 172, 103–108. [CrossRef]
44. Blanc-Béguin, F.; Nabily, S.; Gieraltowski, J.; Turzo, A.; Querellou, S.; Salaun, P. Cytotoxicity and GMI
bio-sensor detection of maghemite nanoparticles internalized into cells. J. Magn. Magn. Mater. 2009,
321, 192–197. [CrossRef]
45. Köhler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature
1975, 256, 495–497. [CrossRef]
46. Delahaut, P. Immunisation—Choice of host, adjuvants and boosting schedules with emphasis on polyclonal
antibody production. Methods 2017, 116, 4–11. [CrossRef]
47. Giouroudi, I.; Hristoforou, E. Perspective: Magnetoresistive sensors for biomedicine. J. Appl. Phys. 2018,
124, 030902. [CrossRef]
48. Lenz, J.E. A Review of Magnetic Sensors. Proc. IEEE 1990, 78, 973–989. [CrossRef]
49. Nabaei, V.; Chandrawati, R.; Heidari, H. Magnetic biosensors: Modelling and simulation. Biosens. Bioelectron.
2018, 103, 69–86. [CrossRef]
50. Pannetier-Lecoeur, M. Superconducting-Magnetoresistive Sensor: Reaching the Femtotesla at 77 K; Habilitation à
Diriger des Recherches en Physique, Condensed Matter, Université Pierre et Marie Curie–Paris VI: Paris,
France, 2010.
51. Issadore, D.; Chung, J.; Shao, H.; Liong, M.; Ghazani, A.A.; Castro, C.M.; Weissleder, R.; Lee, H. Ultrasensitive
clinical enumeration of rare cells ex vivo using a micro-Hall detector. Sci. Transl. Med. 2012, 4, 141ra92.
[CrossRef] [PubMed]
52. Issadore, D.; Chung, H.J.; Chung, J.; Budin, G.; Weissleder, R.; Lee, H. μHall chip for sensitive detection of
bacteria. Adv. Healthc. Mater. 2013, 2, 1224–1228. [CrossRef] [PubMed]
53. Chícharo, A.; Martins, M.; Barnsley, L.C.; Taouallah, A.; Fernandes, J.; Silva, B.F.B.; Cardoso, S.; Diéguez,
L.; Espiña, B.; Freitas, P.P. Enhanced magnetic microcytometer with 3D flow focusing for cell enumeration.
Lab Chip 2018, 18, 2593–2603. [CrossRef] [PubMed]
54. Reisbeck, M.; Richter, L.; Helou, M.J.; Arlinghaus, S.; Anton, B.; van Dommelen, I.; Nitzsche, M.; Baßler, M.;
Kappes, B.; Friedrich, O.; et al. Hybrid integration of scalable mechanical and magnetophoretic focusing for
magnetic flow cytometry. Biosens. Bioelectron. 2018, 109, 98–108. [CrossRef] [PubMed]
55. Duffy, D.C.; McDonald, J.C.; Schueller, O.J.A.; Whitesides, G.M. Rapid Prototyping of Microfluidic Systems
in Poly(dimethylsiloxane). Ana. Chem. 1998, 70, 4974–4984. [CrossRef] [PubMed]
56. Sierocki, R.; Jneid, B.; Rouaix, A.; Plaisance, M.; Féraudet-Tarisse, C.; Maillère, B.; Nozach, H; Simon, S.
An antibody targeting type III secretion system induces broad protection against Salmonella and Shigella
infections. Unpublished manuscript, 2019.
31
Biosensors 2019, 9, 105
57. Reisbeck, M.; Helou, M.J.; Richter, L.; Kappes, B.; Friedrich, O.; Hayden, O. Magnetic fingerprints of rolling
cells for quantitative flow cytometry in whole blood. Sci. Rep. 2016, 6, 32838. [CrossRef] [PubMed]
58. Lee, C.P.; Lai, M.F.; Huang, H.T.; Lin, C.W.; Wei, Z.H. Wheatstone bridge giant-magnetoresistance based cell
counter. Biosens. Bioelectron. 2014, 57, 48–53. [CrossRef] [PubMed]
59. Pannetier, M.; Fermon, C.; Le Goff, G.; Simola, J.; Kerr, E. Low noise magnetoresistive sensors for current
measurement and compasses. J. Magn. Magn Mater. 2007, 316, 246–248. [CrossRef]
60. Li, G.; Wang, S.X.; Sun, S. Model and Experiment of Detecting Multiple Magnetic Nanoparticles as
Biomolecular Labels by Spin Valve Sensors. IEEE Trans. Magn. 2004, 40, 3000–3002. [CrossRef]
61. Huang, L.R.; Cox, E.C.; Austin, R.H.; Sturm, J.C. Continuous particle separation through deterministic
lateral displacement. Science 2004, 304, 987–990. [CrossRef] [PubMed]
62. El Hasnia, A.; Göbbels, K.; Thiebes, A.L.; Bräunig, P.; Mokwa, W.; Schnakenberg, U. Focusing and sorting of
particles in spiral microfluidic channels. Procedia Eng. 2011, 25, 1197–1200. [CrossRef]
63. Salafi, T.; Zeming, K.K.; Zhang, Y. Advancements in microfluidics for nanoparticle separation. Lab Chip
2017, 17, 11–33. [CrossRef]
64. McGrath, J.; Jimenez, M.; Bridle, H. Deterministic lateral displacement for particle separation: A review.
Lab Chip 2014, 14, 4139–4158. [CrossRef] [PubMed]
65. Pamme, N.; Manz, A. On-Chip Free-Flow Magnetophoresis: Continuous Flow Separation of Magnetic
Particles and Agglomerates. Anal. Chem. 2004, 76, 7250–7256. [CrossRef]
66. Illés, E.; Tombácz, E.; Szekeres, M.; Tóth, I.Y.; Szabó, A.; Iván, B. Novel carboxylated PEG-coating on
magnetite nanoparticles designed for biomedical applications. J. Magn. Magn. Mater. 2015, 380, 132–139.
[CrossRef]
c© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Towards CMOS Integrated Microfluidics Using
Dielectrophoretic Immobilization †
Honeyeh Matbaechi Ettehad 1,*, Rahul Kumar Yadav 1, Subhajit Guha 1 and Christian Wenger 1,2
1 IHP-Leibniz-Institut für innovative Mikroelektronik, Im Technologiepark 25, 15236 Frankfurt/Oder,
Germany; yadav@ihp-microelectronics.com (R.K.Y.); guha.ihp2608@gmail.com (S.G.);
wenger@ihp-microelectronics.com (C.W.)
2 Brandenburg Medical School Theodor Fontane, 16816 Neuruppin, Germany
* Correspondence: matbaechi@ihp-microelectronics.com; Tel.: +49-335-5625 (ext. 663)
† This paper is an expanded version of “Matbaechi Ettehad, H.; Guha, S.; Wenger, C. Simulation of CMOS
Compatible Sensor Structures for Dielectrophoretic Biomolecule Immobilization. In Proceedings of the
COMSOL—Bioscience and Bioengineering COMSOL, Rotterdam, Netherlands, 19 October 2017.”
Received: 30 March 2019; Accepted: 30 May 2019; Published: 5 June 2019
Abstract: Dielectrophoresis (DEP) is a nondestructive and noninvasive method which is favorable for
point-of-care medical diagnostic tests. This technique exhibits prominent relevance in a wide range of
medical applications wherein the miniaturized platform for manipulation (immobilization, separation
or rotation), and detection of biological particles (cells or molecules) can be conducted. DEP can be
performed using advanced planar technologies, such as complementary metal-oxide-semiconductor
(CMOS) through interdigitated capacitive biosensors. The dielectrophoretically immobilization of
micron and submicron size particles using interdigitated electrode (IDE) arrays is studied by finite
element simulations. The CMOS compatible IDEs have been placed into the silicon microfluidic
channel. A rigorous study of the DEP force actuation, the IDE’s geometrical structure, and the fluid
dynamics are crucial for enabling the complete platform for CMOS integrated microfluidics and
detection of micron and submicron-sized particle ranges. The design of the IDEs is performed by
robust finite element analyses to avoid time-consuming and costly fabrication processes. To analyze the
preliminary microfluidic test vehicle, simulations were first performed with non-biological particles.
To produce DEP force, an AC field in the range of 1 to 5 V (peak-to-peak) is applied to the IDE.
The impact of the effective external and internal properties, such as actuating DEP frequency and
voltage, fluid flow velocity, and IDE’s geometrical parameters are investigated. The IDE based system
will be used to immobilize and sense particles simultaneously while flowing through the microfluidic
channel. The sensed particles will be detected using the capacitive sensing feature of the biosensor.
The sensing and detecting of the particles are not in the scope of this paper and will be described in
details elsewhere. However, to provide a complete overview of this system, the working principles of
the sensor, the readout detection circuit, and the integration process of the silicon microfluidic channel
are briefly discussed.
Keywords: biomolecules; microfluidic; dielectrophoretic immobilization; CMOS biosensor; lab-on-chip
1. Introduction
Dielectrophoresis (DEP) is the change in the dielectric behavior of the particles placed in a
non-uniform AC electric field [1]. When particles are subjected to this AC field, dipole moments are
induced in the particles. The particle movement is dependent on the polarizability of the particle
relative to its suspending medium. The DEP force is strongly dependent on the particle diameters,
E-Field vectors, frequencies, and dielectric properties of the particles and their surrounding medium.
The Clausius Mosotti (CM) factor depends on the properties of the particle and the medium, as well as
Biosensors 2019, 9, 77; doi:10.3390/bios9020077 www.mdpi.com/journal/biosensors33
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the frequency of the exciting field [2]. The permittivity of the particles is the dominating parameter
affecting the CM factor. The frequency of the DEP field is unique for every particle. The CM factor
defines the sign of the DEP force. Positive CM values lead to a positive DEP (pDEP) force on the
particles, pushing them towards the denser E-Field regions. This occurs when the polarizability of the
particle is larger than the polarizability of the fluid. Negative CM values result in negative DEP (nDEP)
and drive the particles away from the dense E-Field regions [3,4]. DEP techniques are widely used in
microfluidic biochips, so-called lab-on-a-chip (LOC) devices [4–7]. Based on the size and dielectric
properties of the particles, DEP can be applied for manipulation of the particles. In this work, positive
DEP is used to immobilize particles on the electrodes. By combining the capabilities of complementary
metal-oxide-semiconductor (CMOS) based LOC platforms with sensor elements, also called biosensors,
the microsystems enable fast diagnostic results [8–11]. The interdigitated biosensor has been previously
used to immobilize proteins [12], polystyrene beads, and biological entities [5] as well as detecting
organic fluid’s dielectric constants [13], suspended biological cells [14], and creatinine molecules [15].
Over recent decades, many investigations have been performed on the detection of bioparticles with
CMOS integrated microfluidic systems [7,13,16–21]. Among these investigations, some of the systems
were benefited from the sensing and detection on the same BiCMOS integrated platforms. However,
using a single sensor for dielectrophoretic manipulation as well as sensing/detecting accompanied by
microelectronics circuitry for readout on one single chip has not yet been explored. Table 1 presents a
comparison of the reported techniques using both DEP and without DEP on a CMOS platform for
biological applications.






















[16] Living cells 20–30 μm immobilization 102,400 actuationelectrodes optical sensor on-chip
[17] Micro-nano particles500 nm–10 μm separation L-shaped electrode IDE
1 off-chip
[18] Yeast cells immobilization octa-pole electrode trans-impedanceamplifier off-chip





















- IDE 1 on-chip
1 Interdigitated electrodes.
Originally, Otto et al. [7] described the use of DEP as a simple technique to immobilize the protein
particles on conductive surfaces of a CMOS device. These surfaces could be small active regions of
micrometer size. Moreover, antibodies were immobilized on the conductive surfaces permanently
using DEP. Although this device presented the potential for integration with the microelectronics
circuitry, the circuits for data acquisition and processing was omitted. Manaresi et al. [16] developed
a LOC architecture based on a two-dimensional array of microsites on a CMOS microsystem for
manipulation and detection of individual cells on a standard CMOS microsystem. The 8 × 8 mm2 chip
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included 102,400 actuation electrodes, embedded memory for electrode programming, and an optical
sensor. Although manipulation and detection of cells occurred in a parallel manner, generating the
electric field to create DEP cage and cell detection was obtained through different units. To create a DEP
cage, counter electrodes surrounded by in-phase electrodes were used. The optical sensor detected
the presence of the trapped cells. Miled et al. [17] proposed a microfluidic structure containing 64
electrodes for the manipulation of cells. These electrodes were capable of moving, separating, and
rotating the cells. Additionally, an interdigitated electrode was embedded in the microfluidic channel.
This electrode was responsible for detecting the microfluidic channel capacitance alteration and was
connected to a CMOS chip for data acquisition. A CMOS chip monitored the DEP dependent variables
(e.g., frequency and voltage) to evaluate the cross-over frequencies, which can be characteristic for
each cell. However, this system does not benefit from simultaneous cell manipulation and detection.
Another CMOS based LOC platform was developed in the work of Park et al. [18] for trapping, rotating,
and detecting cells and microorganism using DEP. The proposed system used octa-pola electrodes
to trap and rotate the particles. Simultaneously, these particles were detected by in-situ impedance
monitoring on the same chip. This single chip platform included an on-chip Trans-Impedance Amplifier
wire bonded to a printed circuit board (PCB) with external circuits to readout the change in impedance.
To avoid the contact of aqueous biological media with the electronics of the chip, polydimethylsiloxane
(PDMS) wells were fabricated on the chip.
Guha et al. [19–22] has extensively worked on developing single BiCMOS LOC platforms for
biological cell sensing and detection using different techniques. In all of these works, the sensing
principle of this sensor is based on the relative permittivity change of the material-under-test (MUT).
Variation in biological cell resulted in the fringing field capacity change of the sensor, which caused
capacitance variations to be detected by an associated silicon high-frequency readout circuit. By applying
electric potential to the electrodes, a non-uniform electric field between the adjacent fingers is generated.
This method is used to detect the dielectric permittivity of the MUT. Guha et al. [19] presented a CMOS
based high-frequency sensor with the capability of distinguishing the blood sample with fat and calcium
from the normal blood sample. The sensor is placed at the top and inside the wall of the catheter
and exposed to the blood. In other work [20], he proposed the integration of the silicon microfluidic
channel with a CMOS sensor circuit for cytometric applications to detect the cells concentrations using
dielectric spectroscopy. In this method, the interdigitated electrode (IDE) arrays were placed on top
of the microfluidic channel. As a result of IDE excitation, the fringing electric fields penetrate into
the fluid flowing through the channel. They also investigated the variation of the relative viscosity
in an aqueous solution [21] using radio frequency (RF) CMOS chem-bio sensor. The fringing field
between the adjacent fingers is utilized to detect the dielectric permittivity of the MUT. Furthermore, he
developed a self-calibrating highly sensitive dynamic IDE sensor in a BiCMOS based PDMS microfluidic
platform that can be applied for particle counting and single particle sensing in a fluidic system [22].
The steady flow of the particles suspended in the fluid results in capacitive pulses from the sensor
that is embedded in the oscillator. Eventually, these pulses translate to frequency modulation using an
integrated phase-locked loop demodulator.
In this work, an IDE sensor is proposed and designed to immobilize the particles using the DEP
technique. This IDE platform can be integrated with circuits and microfluidic channel by CMOS process
line of IHP-Leibniz-Institut für innovative Mikroelektronik, for simultaneous immobilization, sensing,
and detection of particles. The geometry of the IDEs has been adapted from the previous works done at
IHP [14,15]. This work aims to enable the design of an IDE with the capability to immobilize micron
and nano-sized particles. By placing an AC voltage source to the electrodes, a non-uniform electric
field is generated. The gradient of the electric field is maximized at the edges of the IDE structures.
Consequently, particles can be immobilized on the electrodes. To optimize the efficiency of the IDEs
and DEP force for immobilizing different particle sizes, numerical simulations were done to study the
effect of electric potential, frequency, fluid flow, and geometrical parameters of the IDE on particle
tracing in a feasible manner. Different geometrical parameters of the IDE, such as finger width and
35
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spacing, were modeled. Finite element analysis was performed to evaluate the best parameters for
dielectrophoretic immobilization. The first simulation model for the particle tracing was presented
previously [23]. The details of the simulation with the extended versions are presented in this work.
2. Sensing and System Overview
This section describes the subsets of the advanced technological process required for enabling
the dielectrophoretic immobilization of the bio-particles. The details of the IDE prototype used for
manipulation and sensing as well as the readout detection circuit design along with the silicon
microfluidic channel integration technology are presented below.
2.1. Silicon Interdigitated Capacitor Sensor
The IDE used in this work is similar to a sensor previously established for nearfield biosensors [14,15].
The fabrication of the IDE was performed based on the standard 250 nm high-performance SiGe
BiCMOS technology of IHP. This sensor unit is embedded in the microfluidic channel and relies on
the multi-fingered planar interdigitated capacitor arrays (see Figure 1), which are fabricated on the
topmost metal level of the back-end-of-line (BEOL) stack of the CMOS/BiCMOS process. This IDE is
used to model the dielectrophoretic structures.
Figure 1. Multi-fingered planar interdigitated electrodes (IDEs).
As shown in Figure 2a, the magnitude of the fringing electric field is enlarged between two
adjacent fingers of the IDE. As a result of the increased gradient of the E-Field at rectangular electrode
corners, the distribution of the E-Field is inhomogeneous [24]. This effect leads to attraction and
trapping of the particles to this region. As shown in Figure 2b, this E-Field magnitude exponentially
decays with increasing distance to the IDE arrays. To visualize the simulated electric field, a cut line
2D data set was used to create lines through the modeled 2D geometry, as shown in cross-sectional
schematic figures below. The electric field has been plotted along the red arrow-line, Figure 2a,b.
The distribution of the electric field is calculated based on Equation (10).
The sensing principle of the IDE is based on the variation of the fringing electric field between the
fingers of the IDE due to the permittivity change of the material (medium), as shown in Figure 3a.
The capacitance of the fringing field can be analyzed based on the quasi-static approximation of
Maxwell’s Equation [18]. The total capacitance of the two consecutive electrode fingers is equal to the
sum of the contributing capacitors, as shown in Equation (1) [14]. This capacitance results from the
penetration of the fringing field into the MUT as well as substrate and influence of the finger height on
parallel plate capacitance, Figure 3b.
Ctotal = CMUT + CSubstrate + COxide. (1)
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The capacitance of the fringing filed concerning MUT and substrate is given as below [17].









where K(k) is the parameter arising due to the conformal mapping technique. The change in total
capacitance is governed by the permittivity of the MUT, as shown in Equation (2).
 
(a) (b) 
Figure 2. (a) E-Field distribution above two adjacent fingers of IDE; (b) Electric field magnitude as a
function of distance above IDEs.
 
(a) (b) 
Figure 3. Interdigitated electrode: (a) Electric field distribution of the IDE; (b) Equivalent capacitive
contributions from IDE and material-under-test (MUT).
The sensing operation of the IDE relies on the electrodynamics of the parallel plate capacitors.
Applying an AC voltage to positive and negative terminals, a non-un electric field is created in the
vicinity of the IDE. This electric field impacts the trajectory of the particles which are suspended in the
medium above the IDE passing through the microfluidic channel. The capacitance of the IDE (sensor)
changes, as a result of the permittivity change and its geometry [25]. Thus, the varying value of the
IDE’s capacitance alters the impedance of the IDE which can, in turn, be deduced through impedance
spectroscopy. One such readout architecture which characterizes a sensor is a reflectometer. It measures
the change in reflection amplitude and phase from a sensor (here IDE), which is a function of the
change in sensor impedance. This readout scheme is elaborated further in the succeeding sub-section.
2.2. Readout Circuit Architecture
The prospective architecture of the silicon integrated readout circuit is briefly described in this
section. Deployment of a high frequency 60 GHz read-out circuit presented in [26] is projected as
it allows for miniaturization of sophisticated read-out architectures. The readout circuit is chosen to
operate at 60 GHz for it provides a good trade-off between miniaturization and power consumption.
A low-frequency implementation of the reflectometer will require a large die area. A homodyne
reflectometric scheme to sensor read-out will be accomplished, as shown in Figure 4a, in that the local
oscillator (LO) and RF input to the mixers are the same frequency. The major design blocks include
a millimeter wave oscillator source, down active conversion mixers, and high-frequency wideband
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directive elements realized as passives. The two major passives are distributed branch line couplers and
Wilkinson power dividers. These have been designed on the topmost metal layer of the technology stack
to minimize the transmission losses. The two critical power splitters deployed and indicated as branch
line couplers split the input source power for source and reflection characterization. The architecture in
Figure 4a comprises two major channels viz. source characterization I/Q mixer channel (I1-Q1) and the
reflection characterization I/Q mixer channel (I2-Q2). The source oscillator will excite the load, which is
an interdigitated capacitor sensor. Based on the dielectrophoretic action, the immobilized particles will
cause a change in impedance of the sensor, which will, in turn, produces a corresponding change in
the reflection parameters captured by the reflection channel. Thus, a varying dielectric sample on this
sensor will induce a corresponding change in the magnitude and phase of the reflected signal which
can be deduced from the reflection channel dc output voltages. The mixers form the major constituent
in this architecture and are described here briefly. An active double balanced Gilbert cell mixer is
used, and its schematic diagram is shown in Figure 4b. The transistors Q1–Q2 constitutes the input
transconductance stage of the mixer. The cascode stage constituting two pairs of transistors, i.e., Q3–Q4
and Q5–Q6, forms the commutating switch. Since the architecture is a homodyne reflectometer, the
outputs are dc voltage and are read across the resistive load RL of the mixer. For a possible operating
condition of a LO drive of −2.7 dBm and an incident RF power of −19 dBm, the transfer characteristics







Figure 4. (a) High frequency 60 GHz integrated homodyne reflectometer; (b) The Gilbert-cell mixer; (c)
Sample transfer function characteristics of the mixer.
The integration of the sensor and the high-frequency readout will be accomplished through a
dual excitation scheme, which is beyond the scope of this discussion. The measurement noise floor of
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this architecture is merely governed by the 1/f-noise of the mixers as it is a homodyne reflectometer
architecture. Since the heterojunction bipolar transistors (HBTs) have a lower 1/f-noise corner frequency
than CMOS, the deployed mixer-based architecture will offer superior noise performance. Additionally,
the load resistance of the mixer also contributes to the total output noise. The observed total output
noise in the simulation is found to be 2.2 mVrms. This governs the minimum cell concentration, which
can be reliably handled with the reflectometric readout circuit.
2.3. Silicon Microfluidic Integration
The CMOS IDE, as shown in Figure 5a, is combined with a microfluidic channel on a single chip
(see Figure 5b). This CMOS integrated microfluidic technology platform improves the functionality and
precision by combining the fluidic solution and electrical components. The major step in the integration
of the microfluidic channel into the CMOS process is the lines similar to [27] and is briefly repeated.
The technology approach integrates CMOS circuitry with microfluidics, based on the 3-wafer-stack
technique in a CMOS compatible manner.
  
(a) (b) 
Figure 5. (a) Processed IDEs (sensors) structures b; (b) Complementary metal-oxide-semiconductor
(CMOS) integrated microfluidic lab-on-a-chip device with size of 5 × 5 mm2.
State-of-the-art of our integrated silicon microfluidic CMOS lab-on-a-chip is based on the
compatibility of IHP’s CMOS as well as hetero-integration technology of the microfluidic device.
The compatibility of CMOS technology can be explained in two aspects. First, how to choose new
materials to prevent contamination issues. Second, the CMOS line packaging tool, a so-called pilot
package line. The fabrication of CMOS integrated microfluidics is performed without contamination
problems of the CMOS process line. The hetero-integrated CMOS technology enables the fabrication
of sensors, microfluidic channel, and circuitry on a single chip. This Si-based microfluidic channel is
a reliable replacement for the polymer-based microfluidic channel that lacks from the integration of
the sensor and circuitry on the same chip. The integration of CMOS circuitry, silicon channels, and
glass wafers is done by 200 mm wafer bonding technologies. First, the fabricated the CMOS wafer and
the channel wafer are bonded by plasma activated oxide-oxide fusion bonding, followed by adhesive
bonding of a glass wafer.
Figure 6 illustrates the entire process flow for microfluidic devices. The wafer with the CMOS
devices, including the BEOL sensors is processed on 200 mm Si substrates, Figure 6a (1,2). In the next
step, the inlet and outlet ports are opened from the back side of the wafer by localized backside etching,
Figure 6a (3). Another bare silicon substrate is used to structure the channel by etching, Figure 6b.
The Si-based microfluidic channel and the CMOS wafer are bonded together from their front sides
using a low-temperature fusion bonding at 300 ◦C, Figure 6c (1). After this step, the height of the
channel is adjusted by grinding the backside of the microfluidic channel, Figure 6c (2). Finally, for
encapsulating of the microfluidic channel, a glass wafer is adhesively bonded to the back side of the
channel wafer at 200 ◦C, Figure 6c (3) [28]. The transparency of the top layer enables the simultaneous
optical investigation and electrical sensing measurements. Figure 5b illustrates the fabricated 5 × 5 mm2
diced chip with the inlet and outlet and the sensors which are embedded in the channel. One of the
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noteworthy advantages of using this microfluidic integration technique is the separate interfaces for
microfluidics and the electrical connections, enabling highly miniaturized LOC systems. State-of-the-art
of this BiCMOS technology offers the opportunity of immobilizing, sensing, and detecting the particles
on the same chip. The operational simplicity and low voltage requirement of the DEP technique, as
well as the small volume of sample for testing, facilitate the portability of the LOC devices even out of
the non-laboratory conditions.
 
Figure 6. Packaging process of microfluidic lab-on-a-chip: (a) CMOS fabrication; (b) Channel formation;
(c) Bonding process by a three-wafer-stack approach [28].
3. DEP Analyses and Optimization
Based on the COMSOL Multiphysics® tool, 2D and 3D models are developed. To simulate the
dielectrophoretic immobilization of particles suspended in an aqueous solution, the fluid flow is
considered through a microfluidic channel with a single inlet and a single outlet. Arrays of IDEs are
utilized to create a non-uniform electric field that impacts the trajectory of particles due to dielectrophoretic
forces. The DEP force was optimized with respect to different geometrical parameters of electrodes,
size of the particle, and flow velocity. Figure 7a illustrates the device design in 3D geometry, while the
simulation studies were all done in 2D to reduce the computational time, as illustrated in Figure 7b.
In this simulation, different geometrical parameters of electrodes, such as width and spacing between
adjacent fingers of IDE, was studied. The electric current (ec) module and particle tracing for fluid
flow (fpt) in conjugation with drag and dielectrophoretic forces modules were used as the physics
interfaces [29].
Different equations were used to simulate the flow path of the particles suspended in the fluidic
medium and subsequently trapping them on the electrodes by DEP. The creeping flow (spf) module was
used to model the fluid flow through the channel. Fluid velocity within the channel was determined
based on the Navier–Stokes Equation shown in (3).
0 = ∇·
[




+ F∇·(ρu) = 0. (3)
Here, p is the pressure, u is the velocity vector, μ is the dynamic viscosity, and F is the volume
force vector that is acting on the fluid. When a particle is suspended in the fluid, it is affected by several
forces. One of these forces, is called the drag force, and is caused by the fluid flow and has the same
direction as the flow. The drag force is calculated based on Stokes drags law, which is also applicable
for creeping flows (Rer « 1), as shown in Equations (4) and (5).
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Figure 7. (a) 3D-geometry and; (b) 2D-geometry of the model device used to study the dielectrophoretic












where τp is the velocity response time of particles, mp is the particle mass, ν velocity of the particles, u
fluid velocity, μ fluid viscosity, ρp particle density, and dp particle diameter. Furthermore, to attract
and trap the particles, the dielectrophoretic force (FDEP) is required, which is given by Equation (6).
The particles were subjected to a non-uniform AC electric field.
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Here, rp is the particle radius, ε f is the relative permittivity of the medium, ε∗f and ε
∗
p are the
complex permittivities of the fluid and particles, respectively. E is the root-mean-square of electric field
strength. Permittivity is a complex quantity which is a function of the electric field’s angular frequency
(ω) and conductivity (σ). Based on the electric potential ( ) which is applied to the electrodes, the
electric field E, is simulated by the ec module and is calculated based on Equation (9).
E = ∇υ. (9)
The fpt module, together with the particle tracing, contains the equations governing the motion
and trajectory of particles in the fluid under the influence of a DEP force and drag force. By ignoring
the gravity force, buoyancy and Brownian motion forces, the relevant equation can be written, as
shown in (10).
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= FDEP − FDrag = FT, (10)
where, mp is the mass of particles, v is the velocity of the fluid, and FT is the total force acting on
the particle.
An electrically insulated boundary condition is applied to the fluidic boundary, which is active
on all exterior boundaries of the model. Negative and positive electric potentials were imposed on
the electrodes at the bottom of the microfluidic channel. The electric potential of zero Volt was then
applied to the electrodes as a further initial condition. The wall conditions were imposed without slip.
No slip boundary condition (u = 0) was used to model solid walls and bounce for modeling the tracing
of microscopic particles in the fluid. The position of the inlet and the outlet were perpendicular to the
device structure. The boundary condition for the fluid flow at the inlet was set as velocity and at the
outlet was set as pressure. At the inlet, the initial fluid flow velocity (v0) was set to 50 μm/s. This value
was then varied to study its impact on the immobilization of particles. To establish a fluid pressure
gradient in the channel, an initial fluid velocity was applied at the inlet and the outlet was kept to
zero fluid velocity with suppressing backflow of the medium. For tracing the particles, disappearing
or freezing wall conditions were selected at the outlet. The disappearing mode was used when the
particles leave the channel in case of deviation from the electrodes. The freezing wall condition was
used to study the velocity and the position of particles, where particles could stay frozen at the point
where they leave the channel outlet boundary.
The simulation analysis was done in three main steps. The electric current module, which
simulates the electrical potential field, was applied to the electrode to create a non-uniform electric field.
A stationary analysis was performed to simulate the flow velocity through the channel, as illustrated.
Particle tracing module was used to model dielectrophoretic force through the channel. Figure 8
describes an example of the simulation analysis steps for 3.5 μm diameter sized particles. As shown
in Figure 8a, negative and positive voltage peak values of 2.5 V and −2.5 V were applied to the
electrodes. Therefore, the total applied electric potential was 5 V peak to peak voltage ( = 5 V = Vp-p).
Figure 8b shows the electric field contour plot. Figure 8c illustrates the constant fluid flow velocity in
the middle part of the channel. The pressure was almost constant in the channel. For particle tracing
a time-dependent solution was performed using the values obtained from the frequency domain





Figure 8. Simulation analysis steps for 3.5 μm diameter size particles: (a) Electric potential distribution
in the microfluidic channel at = 5 V at a fixed frequency of 10 MHz; (b) Electric field distribution
contour plot in the microfluidic channel; (c) Velocity field across the microfluidic channel; (d) Particle
trajectories with respect to the applied electric potential and the force acting on the particles leading to
the immobilization of the particles at the surface of electrodes.
Since the objective of this study is to immobilize the particles on the electrodes, simulations
were performed systematically to optimize the electrode geometry and to find suitable electric field
frequency ranges and fluid velocities to attract different size particles.
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The particle sizes used for these simulation studies were in micron and submicron-diameter
ranges (10, 3.5, 0.5). These particles were used as models and assumed as homogeneous spheres and
non-biological. To keep the first model simple and reduce the complex parameters, it was assumed
that these particles were diluted in water. Therefore, the osmotic pressure effect can be neglected for
these simulations. Table 2, represents the properties of the particles for the simulations.
Table 2. Particle properties.
MUT 1 Particle Diameter (μm) Density (kg/m3) Permittivity Conductivity (S/m)
Particle 1 (platelet) 3.5 1000 50 25
Particle 2 0.5 1000 50 25
Particle 3
(fluorescent) 10 1050 5 0.69
1 Material Under Test.
3.1. Impact of Frequency on DEP
The choice of the operating frequency, which leads to immobilization of the particles, was based on
the Clausius Mossotti (CM) factor. CM is a frequency dependent parameter which results in negative
and positive DEP. Changing the frequency stimulate the crossover frequency between positive and
negative DEP. The value of the real part is varied between +1 and −0.5. When the real part of the CM
factor is positive, positive DEP forces act on the particle, which results in the attraction of them to the
electric field intensity maxima, i.e., electrode edges. In the opposite case (real [CM] < 0), particles
are repelled from high electric field intensity regions and consequently deviated from the electrode.
To find a suitable frequency range, the CM factors of the particles were calculated by using MATLAB®.
Figure 9 illustrates the CM factor for 10 μm diameter size fluorescent particles. Particle properties
are shown in Table 1. At positive values of the Clausius Mossotti factor (real [CM] > 1), particles are
trapped on the electrodes. The positive DEP is caused by the positive values of CM. At negative real
values [CM] < 0, negative force is acting on the particles. This leads to the deviation of particles from
the electrodes. Therefore, for reliable DEP immobilization, frequencies below 10 MHz must be chosen.
 
Figure 9. Clausius Mosotti (CM) factor for 10 μm diameter-sized particle as a function of frequency.
3.2. Impact of Voltage Variation and Particle Size
The simulated results of the improved particle tracing for 3.5 and 0.5 μm diameter-size particles
are shown in Figure 10. The immobilization of particles was positively correlated with the voltage.
For the same IDE structure, the immobilization of 3.5 μm size particles started already at 1 V, Figure 10a,
while the immobilization of 0.5 μm particles occurred at 8 V, shown in Figure 10b.
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The dielectrophoretic force which is subjected to the particles by the electric field is positively
correlated with the electric potential. In other words, for the trapping of smaller particles on electrodes,
higher voltages are required to compensate the mechanical force and overcome the drag force from
fluid flow.
Figure 10. Impact of voltage variation on the DEP force for particles at constant fluid flow velocity
(50 μm/s), geometrical parameters of IDEs (electrode width of, 30 μm, and spacing of, 20 μm) and DEP
operating frequency (1 MHz). (a) Diameter size of 3.5 μm; (b) 0.5 μm.
3.3. Impact of Fluid Flow Velocity
The maximum operating voltage of IHP CMOS technology is constrained to 5 volts. To immobilize
the submicron particle, the voltage was kept at CMOS compatible ranges, and the fluid flow velocity
was varied. The fluid velocity is inversely impacted by the immobilization of small particles. Figure 11
shows a representative simulation result for reducing the fluid velocity at a constant voltage of 5 V.
The fluid flow velocity of 50 μm/s was set as the reference. It can be seen that reducing the fluid velocity
to 30 μm/s improved the attraction of particles.
Figure 11. Influence of fluid flow velocity on tracing of the 0.5 μm particles through the microfluidic
channel at a constant voltage of 5 V and operating frequency of 1 MHz. At flow rates of: (a) 50 μm/s;
and (b) 30 μm/s.
3.4. Impact of IDE’s Geometry on DEP Immobilization Probability
In the following simulation step, the voltage, flow velocity, and the frequency were kept
constant. The impact of the geometrical dimensions of the IDE on the trajectory of particles is studied.
The immobilization probability values of each IDE’s geometrical design can be calculated by COMSOL®
applications. Based on these analyses, the immobilization probability is defined as the ratio of the number
of immobilized particles to the total number of particles suspended in the medium. The influence of the
fringing field effect with different ratios of the electrode width and spacing ( SW ) versus immobilization
probability is shown in Figure 12.
  
(a) (b) 
Figure 12. Finite element modeling (FEM) results for the immobilization probability with different
ratios of the IDE’s spacing and width ( SW ) for 10 and 3.5 μm-sized particles at 1 MHz and fluid velocity
of 50 μm/s: (a) 10 μm; (b) 3.5 μm particle.
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The width varied between 5 and 45 μm, and the spacing varied between 5 and 20 μm. These
graphs illustrate the immobilization probability (IP) of 10 and 3.5 μm size particles. For both particle
sizes, IP was larger than 0.9 for ratios below 2. At higher ratios, IP values decreased for both particle
sizes. This reduction becomes significant for smaller particles at a ratio of 4. The IDE design was
optimized when the ratio of spacing to width is smaller than 2. In the following section, this trend is
explicitly discussed and illustrated in Figures 13 and 14.
 
Figure 13. Impact of IDE’s width in symmetric structures (S = W) on immobilization probability of 10





Figure 14. Impact of IDE’s geometrical parameters on immobilization probability (IP) of particles with
diameters of 10 and 3.5 μm, keeping voltages and fluid velocities constant: (a,b) illustrate IP variations
with respect to different widths at fixed spacings of 5 and 20 μm, respectively; (c,d) show the impact of
spacing size on IP at fixed widths of 5 and 45 μm, respectively.
In the following, the IDEs are assigned into two groups of uniform and non-uniform geometries.
Uniform IDEs refers to geometries with equal sizes of width and spacing. Geometries with an unequal
size of width and spacing are referred to as non-uniform IDEs. Figure 13 shows the IP values for
uniform IDEs.
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Using the uniform electrode geometries, the immobilization probability for larger particles (10
μm) was almost 100% in all cases. For smaller particles (3.5 μm) IP increased when the electrodes
width and spacing were larger than 10 μm. For IDEs with spacing and width of 5 μm, IP was zero
for small particle, whereas for bigger particle it was almost 1. Therefore, it can be concluded that the
uniform IDEs design is optimized when spacing and width are larger than 10 μm.
Figure 14 illustrates the impact of non-uniform IDE structures on immobilization probability of
particles with sizes of 10 μm and 3.5 μm. Figure 14a,b represent the IP at a constant spacing of 5
and 20 μm. Figure 14c,d illustrate the IP at constant widths (5 and 45 μm) with respect to spacing.
The variation of spacing and width has less impact on IP of 10 μm size particles. However, for small
particle, 3.5 μm, the results were different. Keeping the spacing constant at 5 μm, IP decreased drastically,
as shown in Figure 14a. However, this effect inversely impacts the IP with respect to spacings, which
were comparatively much larger than the width (ratios over 2), as shown in Figure 14c. It can be
concluded that the impact of the geometrical parameters is dominant if small particles have to be
immobilized. Increasing spacing positively impacts the trapping of small particles for non-uniform
IDEs ratios ( SW ) below 2. In other words, the fringing field effect positively affects the probability to
immobilize smaller particles with increasing width.
Based on the results, the optimum geometrical parameters were selected and applied for the
simulation of the submicron particle (0.5 μm). These structures’ parameter with their respective spacing
to width ratios are shown in Table 3. For these simulations, the applied voltage was kept constant at
CMOS compatible range (5 V), and the fluid flow velocity reduced to 30 μm/s.
Table 3. Selected IDE geometries which are compatible with CMOS operating range (5 V).
IDE Structure Structure 1 Structure 2 Structure 3 Structure 4 Structure 5 Structure 6
Electrode width (W) 45 (μm) 40 (μm) 35 (μm) 30 (μm) 20 (μm) 15 (μm)
Electrode spacing (S) 5 (μm) 10 (μm) 15 (μm) 20 (μm) 20 (μm) 20 (μm)
Ratio = S/W 0.1 0.25 0.4 0.6 1 1.3
The tracing behaviors of 0.5 μm particles for selected geometries are shown in Figure 15. The same
tracing trends as micron-sized particles were observed for submicron-sized particles at reduced flow
rates for structures with ratios below 1. The decreased spacing to width ratios improved the tracing
and immobilization of submicron size particles. Using higher ratios, particles were repelled from the
electrodes and left the microfluidic channel.
Particle size: 0.5 μm 
  
Ratio = 0.1 Ratio = 0.25 
  
Ratio = 0.4 Ratio = 0.6 
  
Ratio = 1 Ratio = 1.3 
Figure 15. Impact of the optimized parameters (geometrical parameters and fluid flow velocity) on
immobilization of submicron particles (0.5) μm at constant voltages of 5 V and fluid flow velocity of
30 μm/s.
Therefore, it was observed that designing a better performance IDE is highly influenced by
the optimum ratio of the electrode’s spacing to width. Furthermore, the flow rate of the medium
inside the microfluidic channel impacts the particles’ movement behavior inside the electric field.
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These are important factors to consider for the immobilization of submicron and micron size particles.
The optimized IDE parameters for immobilization of submicron particles are related to IDE geometries
with ratios below one. However, for immobilization of micron size particles, the IDE is optimized for
ratios below two.
3.5. Impact of Temperature on DEP Process
An insightful study of temperature effects on IDE parameters in the vicinity of room temperature
is investigated though electromagnetic momentum simulation studies. Water was the liquid carrier
of the particles, and thus, the impact of the prospective chip self-heating on the dielectric permittivity
change is illustrated. Figure 16 shows the capacitance of the IDE due to change in water dielectric
from room temperature up to 50 ◦C. The frequency of observation remained 1 MHz, and the water
dielectric layer thickness considered here was 50 μm corresponding to the height of the microfluidic
channel. The change in capacitance due to a temperature of up to 50 ◦C was found to be only up to
3.07%. The temperature effects due to self-heating of the chip may be a pronounced issue for very long
duration measurements only. However, the use of active circuit components is judicious to be used
sparingly in the read-out circuit for particle detection. For instance, the source oscillator was an external
signal source so that one of the power-consuming blocks is eliminated from the chip.




















Figure 16. IDE’s capacitance vs. water dielectric permittivity [30] at 1MHz excitation frequency,
observed from room temperature up to 50 ◦C.
The total power consumption was merely 64.3 mW and is contributed by the mixers. Additionally,
the chip can be operated in a short duty cycle when the measurement of the change in capacitance is to
be conducted. This ensures reliable operation which is minimally impacted by the chip-self heating
and more so when the low power consumption readout circuit is placed away on the chip, relative to
the sensors.
4. Conclusions
The viability of the CMOS embedded microfluidic device for dielectrophoretic immobilization
of particles was investigated by finite element modeling (FEM) simulations. This study proposed a
sensing platform to enable the immobilization of particles with micron and submicron sizes constrained
by technological advances, such as silicon-based microfluidics and millimeter wave readout circuit.
IDE’s geometrical parameters were characterized and optimized based on essential external parameters,
such as voltage, frequency, and velocity of the fluid through the microfluidic channel. By increasing
the applied voltage trapping of smaller particles on electrodes is enhanced. The change of frequency
does not influence the DEP force for improving the immobilization of particles but rather influences
the crossover frequency between negative and positive DEP. Reducing the fluid flow velocity forces the
immobilization of submicron particles. By keeping the voltage constant at CMOS compatible range,
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the impact of IDE’s geometrical parameters on the tracing and immobilization of the particles was
investigated. The ratio between the electrodes’ spacing and the width impacts the IDE’s performance.
According to simulations, the width of the IDE’s finger has to be increased, whereas the spacing has to
be reduced. The simulation and design of planar IDEs were evaluated to maximize the immobilization
probability of submicron sized particles. The IDE design for the immobilization of micron and
submicron size particles with optimum geometrical parameters of IDE and the fluid flow rate was
demonstrated. Furthermore, a study on the impact of temperature (also due to chip self-heating) in IDE
parameters was investigated though electromagnetic momentum simulations. It was observed that the
change in impedance of IDE is only up to 3.07 from room temperature up to 50 ◦C which is less likely
to affect the short term measurements. Lastly, the presented optimized IDEs can be combined with
various readout architectures. The 60 GHz high-frequency reflectometer based architecture was chosen
to enable higher miniaturization of a sophisticated sensing platform, and its homodyne architecture
will enable a dc-in and dc-out based impedance spectroscopy.
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Abstract: The integration of microfluidics with advanced biosensor technologies offers tremendous
advantages such as smaller sample volume requirement and precise handling of samples and reagents,
for developing affordable point-of-care testing methodologies that could be used in hospitals for
monitoring patients. However, the success and popularity of point-of-care diagnosis lies with
the generation of instantaneous and reliable results through in situ tests conducted in a painless,
non-invasive manner. This work presents the development of a simple, hybrid integrated optical
microfluidic biosensor for rapid detection of analytes in test samples. The proposed biosensor
works on the principle of colorimetric optical absorption, wherein samples mixed with suitable
chromogenic substrates induce a color change dependent upon the analyte concentration that could
then be detected by the absorbance of light in its path length. This optical detection scheme has
been hybrid integrated with an acoustofluidic micromixing unit to enable uniform mixing of fluids
within the device. As a proof-of-concept, we have demonstrated the real-time application of our
biosensor format for the detection of potassium in whole saliva samples. The results show that our
lab-on-a-chip technology could provide a useful strategy in biomedical diagnoses for rapid analyte
detection towards clinical point-of-care testing applications.
Keywords: point-of-care; biosensor; hybrid integration; microfluidics; acoustofluidics; cavitation;
micromixing; optical absorbance; colorimetry; salivary potassium
1. Introduction
Point-of-care diagnostics (POCD) for health monitoring involves the evaluation of indices from
human health through tests performed outside of the clinical laboratory, typically right at the site
of patient care [1–4]. While the advantages of POCD such as rapid diagnosis, operational efficiency,
and costs have been well established [2], widespread implementation of this technology has not yet
been achieved [5]. One of the main limitations of POCD is the requirement of unprocessed test samples
drawn from patients to provide the desired sensitivity and specificity for conducting reliable assays in
situ. However, most of the currently validated clinical assays are carried out using plasma, prepared
from whole blood samples inside sufficiently equipped laboratory conditions. Here, we develop a
biosensor platform that could be reliably used for instantaneous detection of target molecules from
non-invasively obtained bodily fluid samples for real-time point-of-care testing applications.
Although whole blood assays are generally considered as the gold standard for bioanalysis, such
an approach may not be convenient to implement under all circumstances. In general, high-risk
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patients under intensive care or long-term hospitalization suffering from extremely sick conditions may
not always be able to bleed enough quantity of blood. Possible nerve damage during venipuncture [6]
could render the procedure extremely painful, traumatic and psychologically disturbing for the patients,
such that even skilled phlebotomists could face limitations to extract enough quantity of blood under
such circumstances.
One strategy to overcome the trauma associated with such painful venous blood draw procedures
could be to adopt a technique that is less invasive and utilizes smaller volumes, possibly through
a finger prick as implemented with some of the commercially available handheld blood glucose
monitors. However, a limitation with this approach is that reduced sample volumes call for greater
sensitivity of the measurement setup and may also not always contain the necessary distribution of the
target molecules under all circumstances. This could lead to inconsistent readings and false negative
results [7]. Furthermore, common clinical problems with whole blood assays such as hemolysis or
coagulation could also result in an inaccurate representation of the analyte concentration [8].
An alternate strategy would be to eliminate the necessity for whole blood, and use other test
samples for carrying out the required bioanalysis. Among the bodily fluids generally used in clinical
assays (shown in Figure 1), those commonly available through non-invasive extraction procedures
include urine, saliva [9] and sweat [10]. While inducing sweat out of hospitalized patients is practically
difficult, urinary extraction may also necessitate additional diuretics which could directly interfere
with the measurands, aside from inducing other significant side effects [11]. Considering these factors,
saliva presents a viable alternate to the traditional biofluids used in biochemical analyses.
 
Figure 1. List of commonly available bodily fluids showing their nature of the extraction procedure
and general feasibility of potassium detection from those fluids.
Saliva is considered as a filtrate of the blood representing the physiological state of the body. Given
the ability of molecules from blood to diffuse into saliva, salivary diagnostics is increasingly being
recognized as an equivalent to serum analysis [12]. Research studies using saliva as a bio-diagnostic
fluid includes works such as evaluation towards dialysis needs in renal failure patients [9] and on-site
analysis for biochemical factors [13]. The incorporation of microfluidic methods in bioassays of saliva
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has further reduced sample and reagent consumption, and has decreased the overall assay times [13].
Research studies in salivary diagnostics involving microfluidics include measurement of C-reactive
protein using an fluorometric immunoassay [14], on-chip polymerase chain reaction (PCR) system
for rapid fluorometric detection of genetic deletion [15], paper-based device for quantification of
the nitrate concentration [16], detection of thiocyanate through surface-enhanced Raman scattering
(SERS) [17], and spectrometric absorbance detection of NH3 and CO2 in saliva as a biomarker for
stomach cancer [18]. In addition, most of the reported microfluidic systems for salivary diagnostics
included integrated optical sensing for their bio-detection scheme [19].
In this work, we present the development of a simple, hybrid integrated optical microfluidic
biosensor for rapid analysis of saliva, and we have demonstrated the application of the proposed
biosensor format by detecting the presence of potassium from whole, untreated salivary samples.
Inspired by the age-old concept of colorimetry published as early as the first half of the 20th
century [20,21], we hereby show that potassium can be detected from human saliva samples through
the principle of optical absorption. A commercially available potassium detection reagent mixed
with saliva samples creates turbidity based on the potassium concentration, which could then be
measured through the absorption of light passing through this turbid path. We have implemented
this optical sensing principle on a lab-on-a-chip platform by integrating colorimetric detection within
a microfluidic system that facilitates transportation and handling of the analytes and the reagents.
Homogeneous mixing of fluids inside the microfluidic system has been achieved through the integration
of piezo-actuated acoustic micromixing. The results of this work show that the proposed hybrid
integrated device can be applied to real-time optical biosensing using whole, unprocessed samples,
which could be extremely useful for automated point-of-care testing applications.
2. Materials and Methods
2.1. Development of the Integrated Optical Biosensor
This section provides the details of the design, fabrication, integration and packaging of our
hybrid integrated optical microfluidic setup. The schematic illustration of the processes is shown in
Figure 2.
2.1.1. Device Design and Fabrication
The biosensor (schematically shown in Figure 2A) consists of a microfluidic system with two
inlets which accommodates two different types of fluids. The fluids are transported to a piezo-actuated
(acoustofluidic) micromixer unit, and upon mixing are subsequently transported to the optical
detection unit. The configuration of the bulk acoustofluidic micromixer unit was adopted from [22,23].
The optical detection unit consists of SU8 waveguides core integrated onto poly dimethylsiloxane
(PDMS) (cladding) through the inlet and outlet waveguide channels (as indicated in Figure 2A).
Convex curvatures at the end of the optical channel enable convergence of light into the fluidic
channel. Two different types of optical waveguide assembly were designed. In the configuration
used in the present work, the output waveguide was fabricated co-axially with the input waveguide.
This configuration allowed direct coupling of the input light onto the output waveguide, as required in
optical absorption measurements.
To fabricate the devices on PDMS (fabrication and integration processes schematically shown in
Figure 2B), silicon master molds with patterned SU8 (100 μm thickness) were fabricated using standard
soft lithography process. Poly dimethylsiloxane (Sylgard 184, Dow Corning, Midland, MI, USA) with
prepolymer to curing agent volumetric ratio of 10:1 was mixed, degassed and poured onto the silicon
mold. The setup was left to cure at 70 ◦C for four hours, after which PDMS was peeled off the mold and
diced to create the individual devices. To create optical waveguides, the PDMS devices were exposed
to oxygen plasma (2 min, 200 mTorr pressure, 20 cubic centimeter (ccm) flow rate, and 60 W Radio
Frequency (RF) power), and thereafter SU8-5 (Microchem, Westborough, MA, USA) with viscosity
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290 cSt, and refractive index ~1.6 was allowed to fill in the optical channels through capillary flow.
The photoresist was cured by flood exposure to ultraviolet (UV) light (12 mW/cm2) for 60 s, and the
devices were diced thereafter to enable fiber attachment with the SU8 waveguides.
 
Figure 2. (A) Schematic working principle of the acoustofluidic micromixer integrated optical sensing
for colorimetric detections. The liquid test specimen (fluid 1) and its corresponding chromogenic
agent (fluid 2) are mixed using acoustic waves generated by a piezoacuator, and the mixture is
transported into the optical detection unit, wherein the extent of color change induced due to the
presence of target analyte in the sample is sensed by the absorption of light passing through the sample.
(B) Schematic illustrayion of the fabrication and packaging of the hybrid integrated biosensor (C)
Scanning electron microscope (SEM) images showing the microfluidic channel and the optical channels
of the poly dimethylsiloxane (PDMS) device (i) before and (ii) after integration with SU8 (Scale bars
represent 500 m) (D) Micro-positioning setup for precise alignment and coupling of fibers with the SU8
waveguides. (E) Images of the functional integrated optical microfluidic biosensor (i) with one fluid
inlet and (ii) two fluid inlets.
2.1.2. Integration and Packaging
Coupling of the input and the output fibers were carried out under a stereo microscope.
FC connectorized tapered lens-ended fiber (OZ Optics, Ottawa, ON, Canada) which gives a spot size
of 5 μm, was connected to a broadband laser light source (Ocean Optics, Largo, FL, USA) for optical
input. The output collector fiber was SMA end connectorized and coupled to a handheld spectrometer
(USB 2000, Ocean Optics, Largo, FL, USA). Fiber strippers and precision cleavers (Newport, RI, USA)
were used to remove the buffer layer and cladding around the fiber. The input and the output fibers
were positioned in separate five axis fiber positioners on supporting V-grooves, so that each of the
fibers and the waveguides can be maneuvered and coupled appropriately for acquiring the maximum
optical signal. Maximum optical light coupling into the fiber was ensured by fine-tuning the position
of the fiber and by observing the maximum signal from the output fiber coupled into the spectrometer.
Thereafter, UV index matching gel (NOA60, Norland International Inc., Lincoln, NE, USA) was
applied at the tip of the fiber and the setup was exposed to UV for 60 s to bond the fiber with the
SU8 waveguides.
The device was then treated with atmospheric plasma using a handheld plasma cleaner (Plasmaetch,
Carson City, NV, USA) and the channels were sealed using a 100 μm thick glass coverslip. Piezoceramic
discs (T216-A4NO-173X, Piezo Systems Inc., Cambridge, MA, USA) used for generating the acoustic
waves were attached to this glass diaphragm using silver conductive epoxy (also used as the bottom
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electrode). The top electrode was soldered to the piezoceramic. For ease of handling, the device was
attached with a polycarbonate support using double-sided adhesive tape, without damaging the optical
fibers. A through hole drilled on the polycarbonate prior to the attachment of the optical-microfluidic
chip accomomodates the piezo actuator inside the cavity.
2.2. Chemicals and Reagents
Integrated optical-microfluidic characterization experiments were carried out with de-ionized
(DI) water and ethanol (Sigma Aldrich, St. Louis, MO, USA). Prior to introducing fluid samples into
the system, the microfluidic channels were flushed with ethanol in order to remove any contaminants
or air bubbles. Initial micromixing characterization experiments were conducted by staining the
working fluids (DI water or ethanol) with standard food coloring dyes. Preliminary experiments for
the characterization of optical absorption with integrated micromixing were conducted using glucose
enriched RPMI 1640 cell culture media (A1049101, Thermofisher, Waltham, MA, USA) as the working
fluid. Herein, the glucose present in cell culture media was tested to produce an expected colorimetric
reaction with Benedict’s reagent prepared according to the protocol described by Cochran et al. [24].
For colorimetric salivary analysis experiments, potassium colorimetric assay kit (E-BC-K279) was
procured from Cedarlane Labs (Burlington, NC, USA). Whole samples of unstimulated saliva were
collected from volunteers in centrifuge tubes by a simple spitting method, and the specimens were
vortexed thoroughly. Prior to the experiments, protein precipitant and chromogenic agents were
prepared as described in the protocol prescribed by the manufacturer. 20 μL of the saliva samples
were mixed with 180 μL of the protein precipitant and centrifuged at 1100 g for 10 min. Thereafter,
the supernatant was used in the experiments, mixed with a volumetrically consistent chromogenic
agent for the colorimetric optical absorbance measurements.
2.3. Integrated Testing and Measurement
The piezoelectric system was driven by an external signal generator (33120A, Hewlett Packard,
Palo Alto, CA, USA) and an amplifier (PCB Piezotronics, Depew, NY, USA) where a sinusoidal signal
from the signal generator was amplified 20-fold by the amplifier. Typically, the operating voltage of
100 Vp-p was used for piezo-actuation. For continuous flow experiments, liquids were injected at the
same flow rates inside the microchannel using syringe pump (KDS-210, KD Scientific, Holliston, MA,
USA). In all other cases, liquids were manually pipetted into the microfluidic channels.
The mixing efficiency was calculated based on the change in the pixel values of the respective
color fluids.
Mixing efficiency (%) = (Initial pixel count-final pixel count)/(Initial pixel count) × 100 (1)
Optical signals were collected using a handheld spectrometer (USB2000, Ocean Optics, USA).








λ—Wavelength of light used
Aλ—Absorbance
Sλ—Intensity of light passing through the sample
Dλ—Dark intensity
Rλ—Intensity of light passing through a reference medium.
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The dark intensity was recorded by measuring the optical signal intensity when the light source
was turned off. For potassium measurement experiments, the chromogenic agent was used as the
reference medium to measure the reference intensity.
2.4. Imaging and Statistical Analysis
Images were recorded using an OFV-A-534-Cax video camera inbuilt with the single point Laser
Doppler Vibrometer (LDV, Polytec, Detroit, MI, USA). Scanning electron microscopy (SEM, SU3500,
Hitachi Hi-Technologies, Tokyo, Japan) was conducted using standard protocols for variable-pressure
imaging mode (3.0 kV, 30 Pa,) allowed SEM observations of the PDMS devices without the need for
additional sample manipulation or conductive coating. The images were processed using ImageJ
(National Institute of Health, Bethesda, MD, USA), following standard protocols. All statistical
comparisons were made using one- or two-way analyses of variance (ANOVA) with Tukey post-hoc
comparisons (Prism; GraphPad Software, La Jolla, CA) with p-values < 0.05 considered significant,
and graphical data reported as means ± standard error for at least n = 3 experiments.
3. Results
3.1. Features of the Hybrid Integrated Biosensor
The SU8 waveguide (refractive Index ~1.6) integrated well onto the PDMS (refractive index ~1.4)
upon curing with UV (Figure 2C). Minor delamination of the SU8 was observed along the walls of the
PDMS in some sections, however SU8 was able to guide the input light efficiently under the PDMS clad.
The optical fiber assembly setup (Figure 2D) described earlier provides robust fiber attachment onto
the waveguides to enable optical transmission. Also, with this arrangement of the optical microfluidic
chip, the microfluidics and the micromixer modules do not interfere with the functionalities of the
optical ensembles, and thus all the components of the system remain independent. Integration of
on-chip spectrometer [25] was also tested to conduct direct fluorescence measurement that could be
used for specific immunoassays. The fully fabricated hybrid integrated optical microfluidic device is
as shown in Figure 2E.
Initial vibration analysis experiments for the mechanical characterization the piezo-actuation
system was conducted using laser doppler vibrometry. The natural frequency of oscillation of the
piezo-actuator was ~70 kHz, much higher than the intended operating frequencies of the micromixer.
As expected, the acoustic waveform generated by the piezo-actuation depends on the operating
frequency. For this device configuration, acoustic cavitation inception occurred for operating frequencies
greater than ~800 Hz. Upon cavitation inception, the rate of cavitation bubble growth and collapse was
dependent on the operating frequency, and these parameters stabilized at ~3000 Hz, beyond which no
significant differences were observed in the life-cycle or the behavior of the cavitation bubbles. On the
other hand, at lower operating frequencies (1~100 Hz), the piezo-actuation principle could be used
for transporting fluid across the channels through valveless micropumping [24]. Slight modifications
to the existing design enable the feasibility of integrating other types of optical detection techniques,
namely fluorescence or evanescence for a correspondingly appropriate type of integrated microfluidic
biosensing [26].
3.2. Acoustically Induced Cavitation Enables Rapid Micromixing
Effective mixing of fluids is important in several applications including chemical synthesis,
biochemical reactions, and clinical diagnosis. As with any biochemical assay, for accurate colorimetric
quantification sufficient mixing of fluids is important in order to homogenize the specimens with the
corresponding reagents [27]. However, one of the limitations with microfluidics is the laminarity of
flow in the device, which renders turbulent mixing difficult. Here, by incorporating a piezo-actuated
acoustic micromixer within the microfluidic design, we experimentally demonstrated the feasibility of
controlled mixing of two non-reacting liquids through the inception of cavitation bubbles.
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For convenience and ease of visualization, ethanol was stained blue and water was stained with
red dye in all the experiments. Under continuous flow, the flow of liquids inside the microfluidic
channel was extremely laminar (calculated Reynolds number ~5). The mixing ability of fluids under
flow was tested in different conditions, and no mixing was observed even for similar liquids of
very high miscibility (blue ethanol colorless ethanol) in both with or without the actuation of the
micromixer (Figure 3A(i)). For dissimilar liquids (water–ethanol), instantaneous diffusion mixing
was also negligible for both continuous flow and ‘static’ (no flow) conditions. Once the flow of
liquid in the channel was stopped, actuation of the micromixer at 1000 Hz induced the formation of
cavitation bubble in water (Figure 3A(ii)). We believe that PDMS substrates, being gas permeable
facilitates the generation of bubbles, even for such low actuation frequencies, which in this case
was useful for fluid mixing. Thereafter, reduction of the operating frequency to 800 Hz retarded
the growth of the cavitation bubble, and at the same time creating micro-vortices in the fluids to
initiate mixing. The real-time sequence of cavitation assisted fluid mixing is as shown in Figure 3B.
Mixing of the fluids was instantaneous upon the inception of the cavitation bubble. Increasing the
actuation frequency decreased the time taken for cavitation bubble inception (Figure 3C). However,
with increased frequency, the growth of the cavitation bubble was also rapid and difficult to control
precisely. Therefore, to create steady cavitation, all micromixing experiments were conducted at an
actuation frequency of 1000 Hz to initiate the cavitation bubble, and thereafter the operating frequency
was reduced to 800 Hz to allow fluid mixing. The actuation frequency of our bulk acoustofluidic
micromixer is around 100 fold lower than micromixing actuation using surface acoustic waves [27].
Lower actuation frequency could be useful for handling samples that contain living cells, as high
frequency could induce undesired effects such as cell proliferation, differentiation, lysis etc. [28].
Figure 3. (A) (i) Image of the microfluidic channel with two inlets allowing laminar flow of two shades
of ethanol (colorless and blue) without mixing when introduced from either of the inlets. (ii) Image
showing the inception of cavitation bubble in water (red) to initiate the mixing of fluids (B) Image
sequence showing the cavitation enabled mixing of water and ethanol inside the microfluidic channel.
(C) Variation of the time taken for the inception of a visible cavitation bubble with respect to the piezo
actuation frequency. Cavitation inception time was consistent (within 3% variation) for actuation
frequencies greater than 1 kHz. (D) variation in the fraction of the respective fluids mixed inside the
microchannel with respect to time. To enable this fluid mixing, caviation was initiated at 1000 Hz
actuation frequency, and the working frequency was reduced to 800 Hz, so as to retard the growth of
the cavitation bubble.
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The mixing efficiency was studied by measuring the concentration of red pixels in the section of
the microfluidic channel initially containing ethanol (blue) and the concentration of blue pixels in the
microchannel section initially containing water. Within 30 s, a mixing efficiency of more than 75% over a
volume of ~3 μL of the fluid (Figure 3D). This is comparable to some of the previously published results.
For example, Liu et al. [29] have reported cavitation assisted mixing of 22 μL of the fluids in ~105 s, and
for the system proposed by [30], the mixing efficiency is governed by the flow rate which is 8 μL/min.
Both these values are close to what we observed, thus corroborating with the efficiency achieved
through our micromixing technique. Continued operation of the micromixer produces agglomeration
of non-covalently bound particulates from the coloring dye which interfered with mixing. However,
for proof-of-concept preliminary demonstration of fluid mixing, our experiments show that efficient
mixing of small fluid sample volumes can be achieved by integrating the piezo-actuated acoustic
micromixer that generates micro-vortices through the controlled induction of cavitation bubbles.
3.3. Demonstration of On-Chip Optical Absorption
One of the major drawbacks of absorbance-based detection in microfluidics is that it is considered to
decrease in the optical path length with reduced usage of the sample volumes, which could directly affect
the sensitivity of the system [31]. Therefore, in order to ascertain whether our device configuration was
sensitive enough to support real-time optical absorption measurements, we conducted a preliminary
non-calibrated colorimetric assay. For this proof-of-concept experiment, we demonstrated the detection
of glucose [32] in cell culture media, based on its reaction with Benedict’s reagent.
It is well known that glucose, a reducing sugar, induces the conversion of cupric ions (Cu2+) to
cuprous form (Cu+) in the Benedict’s reagent [33]. This reaction brings about a change in color of the
solution mixture, with the coloration being dependent upon the amount of glucose present. To firstly
verify this principle, glucose-enriched media (hereafter referred to as glucose solution) was diluted
to varying concentrations and mixed with the Benedict’s reagent. The color changes in the mixture
samples are as shown in Figure 4A. The color observed for the reactant mixture for undiluted glucose
solution is indicated with the arrow. Upon heating the mixture, the color of those reactants changed to
dark red as expected.
Before implementing this colorimetric reaction inside the integrated optical microfluidic setup,
baseline optical absorption values at 635 nm wavelength were recorded by passing the glucose solution
and the Benedict’s reagent individually through the microfluidic channel. Thereafter, to initiate the
reaction, the liquids were pipetted simultaneously into the microfluidic chamber, and the piezoacoustic
micromixer was actuated. To the naked eye, the liquids initially appeared colorless upon entering the
micromixing chamber (Figure 4B at t = 0). However, with continued piezo-actuation, mixing of the
fluids causes an increase in the turbidity of the reaction mixture (Figure 4B).
The liquids were allowed to mix for 60 s, after which the piezo-actuation frequency was increased
to drive the liquids under supercavitation [22] through the optical detection zone and finally out
of the channels. Upon image processing, the color of this reaction mixture inside the microfluidic
chamber (Figure 4B) and the color of the ejected reaction mixture (indicated in Figure 4C) was observed
to be very close to the externally prepared reaction mixture indicated in Figure 4A, The results
for the measurement of the colorimetric optical absorption is presented in Figure 4D. As expected,
at 635 nm wavelength, the optical absorption of the blue colored Benedict’s reagent was higher than
the phenol-red tagged glucose solution (Figure 4D(i)). The initial randomness in the optical absorbance
signal for the reaction mixture (Figure 4D(ii)), is we believe, noise due to the flow of cavitation bubbles
in the reaction mixture. The mean optical absorption of the reaction mixture was significantly higher
(p < 0.001) than the both individual liquids, presumably due to the increased turbidity obtained
during the reaction (Figure 4E). The optical absorbance value of reactants mixed inside the microfluidic
channels was very close (<5% variation) to that of the reaction mixture externally prepared by manually
vortexing the reacting fluids, thereby further confirming the homogeneity of the micromixing process.
The experiment was repeated 3 times, and the results were found to be consistent. Thus, the results
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of this experiment demonstrates the implementation of optical absorption measurement, with our
micromixing-enabled optical sensing setup.
Figure 4. Implementation of Benedict’s reaction inside the optical microfluidic device for colorimetric
detection of glucose in the presence of cell culture media. (A) Change in the color of the specimens
for various concentrations of the glucose solutions, with the diluted samples showing shades of blue
color. Reaction mixture upon heating turned to brick red color as expected. Arrow indicates the color
obtained with undiluted glucose. (B) Variation, at different time points, in the turbidity of the reacting
fluids (glucose solution and Benedict’s solution) upon piezo actuated mixing inside the microfluidic
channel. (C) Reaction mixture ejected out of the microfluidic channel, indicating the same coloration as
indicated in panel-A. (D) Real-time absorbance measurements at 635 nm wavelength of (i) glucose
solution and the Benedict’s reagent and (ii) Reaction mixture upon entering the optical detection zone.
(E) Comparison of the optical absorption values of the working fluids. The reaction mixture shows a
significantly higher absorbance (p < 0.001) than both the glucose solution and the Benedict’s solution,
due to the turbidity created upon mixing, thereby validating the colorimetric detection principle.
3.4. Colorimetric Detection of Salivary Potassium
With the colorimetric detection feasibility well established through the proof-of-concept glucose
detection experiments, we further explored the possibility of implementing our microfluidics-integrated
optical detection platform for clinically relevant real-time biosensing applications. Potassium
monitoring and level correction is a routine but critical procedure carried out at the hospitals for
patients undergoing cardiac, renal or neurological related diagnoses. Altered potassium levels in the
body under hyperkalemia or hypokalemia may cause arrhythmia, abnormal blood pressure, cramping,
twitching or paralysis of muscles leading to the development of abnormal cardiac rhythms [34,35].
Since whole blood assays currently adopted in hospitals for potassium monitoring is painful and
sometimes unsuccessful, we reasoned that salivary diagnostics of potassium could be far less traumatic
and could generate rapid results when performed in a point-of-care setting. To validate this hypothesis,
we tested whole saliva samples through colorimetric optical absorption, for the measurement of
absolute salivary potassium concentration.
The absorption measurements were conducted at 450 nm wavelength, as prescribed by the
manufacturers of the potassium detection kit. Initial control experiments were conducted to measure
the optical absorbance values of test samples with known potassium concentration. Unstimulated
saliva samples were collected from random volunteers on the North Carolina A & T State University
campus. Samples were collected from 3 volunteers above the age of 65 years, 6 volunteers in the age
group of 35–65 years, and 5 student volunteers under the age of 35 years. The results of our colorimetric
potassium concentration measurement from the collected saliva samples are presented in Figure 5A.
The overall estimated mean concentration of salivary potassium was found to be well within the
range of typical salivary potassium levels as reported earlier [36]. The mean unstimulated potassium
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concentration with people between the age of 13 and 35 has been reported to be ~21 mmol/L [37]. These
observations match the data from our experimental results as well within 5% error, thereby validating
our approach for a colorimetric optical absorbance-based salivary analysis method used herein.
However, contradicting observations have been made in literature regarding exact salivary
potassium concentrations for patients with health conditions. We reasoned that there are several
factors that could influence the salivary electrolyte concentrations, and a larger data set is required
to make any robust comparison and inference using our device. However, the intent of the present
work is far from delving into detailed biochemical analyses of saliva under different conditions.
The objective of this work is to demonstrate the application of colorimetric sensing using microfluidic
mixing for optical sensing. Therefore, in order to validate our optical measurements, we measured the
optical absorbance of three random saliva samples treated with the chromogenic agents on-chip, and
compared the results to the optical absorption of those samples measured externally using a standard
spectrophotometer (Cary 6000i UV/Vis/NIR, Agilent, Santa Clara, CA, USA). The results shown in
Figure 5B demonstrate no significant difference between the absorbance values measured through
these two techniques, thereby validating our on-chip analysis approach. The time-dependent on-chip
absorbance measurements and the absorbance spectrum obtained using the spectrophotometer for one
of the samples is presented in Supplementary Figure S1A.
Figure 5. Results of the colorimetric optical absorbance detection of potassium from unstimulated
whole saliva. (A) Measurement of estimated potassium concentration among people (15 volunteers)
of different age groups indicating that older people (>65 y age) show a significantly lesser (p < 0.01)
salivary potassium content than people in the age group of 35–65; and also significantly reduced
potassium than people in 20–35 age group. In general people above the age of 35 show significantly
lesser (p < 0.05) potassium than people under the age of 35. (B) Comparison of the optical absorbance
values of salivary samples mixed with chromogenic agent measured on chip and off-chip (using an
ultraviolet/visible (UV/Vis) spectrometer) shows no significant difference (p = 0.2643 with paired t-test)
for the samples analyzed through the two measurement techniques.
Thus, the results of our work show that the colorimetric optical absorption based biosensing
principle with integrated micromixing can be readily applied to the lab-on-a-chip format for real-time
analysis of metabolites from saliva to generate diagnostic results with a quick turn-around.
4. Discussion
Salivary diagnostics is being increasingly touted as a suitable alternative to whole blood assays.
However, the study of salivary functions could also be challenging because of the high physiological
variability of saliva in comparison with other bodily fluids [38]. However, given that the saliva samples
can be obtained non-invasively, patients are much more likely to cooperate for frequent extraction of
saliva, for performing assays regularly. We also observed this trend among the volunteers, who were
unanimously relieved with the painless approach of collecting saliva samples for our experiments.
Nevertheless, to exploit this convenience of salivary analysis, it is also equally important to develop a
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suitable automated point-of-care testing methodology that would enable rapid diagnostics to reduce
the time and effort normally put into laboratory-based assays. The cumulative results of our present
work demonstrates that the hybrid integrated optical biosensing principle proposed herein could
be readily applied to potassium measurement from whole saliva samples for real-time point-of-care
testing applications based on the principle of colorimetry.
The colorimetric optical absorption-based detection principle presented here is simple and
can be easily extended to any other fluid sample. While the results of traditional point-of-care
colorimetric assays reported to the naked eye (such as pregnancy tests or blood glucose tests),
integrating smart-phones [39] for automated testings have lately been gaining huge popularity. But,
the implementation of the colorimetric technique would not be effective unless uniform, controlled
mixing of samples with the appropriate chromogenic agents is achieved. The acoustofluidic actuator
thus lends a major advantage to this device for achieving the required homogenous sample mixing.
The bulk acoustic wave micromixer configuration described in this work is simple and cost-effective to
fabricate. For the device setup presented here, the ease of operation and feasibility of seamless hybrid
integration with other complementary modules of the biosensor platform lend advantages to the
bulk acoustic wave micromixer over the popularly used surface acoustic wave micromixing formats.
However, mixing efficiency could be further improved by adopting simple modifications to the existing
setup, such as incorporation of passive microfluidic elements, surface treatment resulting in increased
hydrophobicity [40], and using acoustic index matching glues to improve piezoacoustic energy transfer.
Our initial experiments showed that the cavitation-based acoustofluidic micromixing can be used
with a wide variety of fluids with different physical properties such as miscibility, viscosities, vapor
pressures etc. (Supplementary Figure S1B). While the present work focused only on cavitation-enabled
fluid mixing, it was also observed during the initial characterization experiments that the cavitation
phenomenon also induced other physical effects in the fluids. For example, it was possible to take
advantage of the energy released from collapse of the cavitation bubbles for cleaning the surface of the
microfluidic channels to get rid of non-specifically bound adherent particles [26]. This functionality
could be extremely useful for conducting biological assays repeatedly without cross-contamination
inside the microfluidic channels.
However, there are a few shortcomings to the present approach. Firstly, the device format
in its present state does not enable the realization of cheap, disposable biosensors. But, since the
device is sterilizable for repeated use, integrating light sources and sensor units on-chip along with
suitable optoelectronic packaging could enable further help with the miniaturization of this device for
developing a more cost-effective version. Secondly, optical absorption-based detection may hit the
limits when conducting assays for measuring extremely low analyte concentrations in the samples.
Despite the relatively poor sensitivity of microfluidic absorbance detection compared to fluorescence,
the principle of working of optical absorption and its instrumentation simplicity gives it an advantage
in applications requiring point-of-use analysis. Also, wherever applicable, it is possible to carry out a
comprehensive study of time-dependent biochemical interactions using the optical absorption method.
One can also take confidence from the fact that a number of absorbance-based microfluidic point-of-care
products are commercially available [41]. Our device design also allows for implementing more than
one optical sensing principle on the same platform. In an alternate waveguide arrangement to that used
in the present work, the output waveguide was designed at an angle with respect to the inlet waveguide
so that light is not directly coupled onto the output waveguide. This configuration, although not used
in this work, could be useful for sensitive low absorption measurements or fluorescence-based optical
detections where specific emission wavelengths are sensed spectroscopically without being saturated
by the excitation wavelengths. Thus, overall our present work clearly demonstrates the feasibility
of developing integrated microfluidic optical detection systems for rapid biosensing and real-time
diagnostics, which could be incorporated into the next generation point-of-care devices.
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5. Conclusions
Saliva is a non-invasive biofluid which is easy to collect, transport, and store. Because of its
accessibility and connection to systemic diseases, saliva is one of the best candidates for the advancement
of point-of-care medicine, where individuals are able to easily monitor their health status by integrating
the salivary diagnostics with suitable biosensing systems. Our present work on the development of a
hybrid integrated optical detection based biosensor with integrated micromixing further asserts that
colorimetric salivary analysis can be conducted in real time in a dependable, noninvasive, simple,
and rapid manner using whole, unprocessed saliva samples with the appropriate chromogenic agents,
to screen for any required minerals and metabolite values Thus, this approach could come in handy for
real-time point-of-care screening applications for monitoring high-risk hospitalized patients.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6374/9/2/73/s1:
Figure S1: (A). (i) Time varying optical absorbance of a saliva sample mixed with chromogenic agent measured
on-chip using the hybrid integrated device. The mean optical absorbance value was ~2.36 (ii) Optical absorbance
measurement of the same sample measured using a UV/Vis spectrophotometer showing the absorbance value at
450 nm ~2.4. (B). Preparation of water in oil emulsion: Finer dispersion of water (blue) in the colorless oil medium
throughout the chamber is observed with the actuation of the micromixer. Much longer micromixing time (~600 s)
was required to achieve this, Figure S2: Enlarged versions of Figure 2E, Figure 4A,C.
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Abstract: We recently demonstrated that the Navier–Stokes equation for pressure-driven laminar
(Poiseuille) flow can be solved in any channel cross-section using a finite difference scheme
implemented in a spreadsheet analysis tool such as Microsoft Excel. We also showed that implementing
different boundary conditions (slip, no-slip) is straight-forward. The results obtained in such
calculations only deviated by a few percent from the (exact) analytical solution. In this paper
we demonstrate that these approaches extend to cases where time-dependency is of importance,
e.g., during initiation or after removal of the driving pressure. As will be shown, the developed
spread-sheet can be used conveniently for almost any cross-section for which analytical solutions
are close-to-impossible to obtain. We believe that providing researchers with convenient tools to
derive solutions to complex flow problems in a fast and intuitive way will significantly enhance the
understanding of the flow conditions as well as mass and heat transfer kinetics in microfluidic systems.
Keywords: microfluidics; numerical techniques; Microsoft Excel; finite difference method;
Navier–Stokes; time dependent flow; dynamic flow; initiation of flow; Poiseuille flow
1. Introduction
The fundamental physics of flows in microchannels are pivotal for the precise control of dynamic
effects underlying transport phenomena such as momentum, mass or heat transfer and ultimately
define the behavior or the system at hand for a practical application. As an example, establishing the
correct flow physics is crucial for modeling and understanding the transport kinetics of an analyte
from the bulk of the flow to the surface of, e.g., a biosensor [1]. In particular, the response dynamics of
a biosensor strongly depends on the diffusion kinetics of the analyte within the bulk of the flow of the
biosensor. The formation of the Nernst diffusion layer is the limiting factor that defines the transport
dynamics and thus the dynamic response of the biosensor [2]. This is particularly important during
the initiation of the flow and in transitions of the flow such as, e.g., at the early stage of an experiment.
These are tightly interlinked with the fluid mechanics of the system and thus a detailed understanding,
specifically of transient effects in the bulk fluid flow, is pivotal for a correct system assessment [3].
In many respects, the fluid physics of microfluidics are straight-forward. Given the low Reynolds
number flows commonly encounter in microfluidics, effects such as turbulence are rarely relevant in
microfluidic flows [4].
However, given the fact that the underlying equation of fluid dynamics, i.e., the Navier–Stokes
equation, is very difficult to solve even in (seemingly) simple channel geometries and flow conditions,
researchers commonly refer to numerical methods to model the flow physics [5]. However, correctly
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applying a complex numerical modeling or solver software package is usually beyond the scope of
application-driven research in microfluidics and adjacent fields.
We have recently demonstrated, that the simplified Navier–Stokes equation for laminar flow can
be conveniently solved in a spreadsheet analysis software such as Microsoft Excel [6,7]. Spreadsheet
tools are convenient platforms for implementing schemes in an intuitive and documentable manner.
Software packages such as Microsoft Excel are widely available, and researchers are used to working
with these packages from their daily work routine. Thus, applying a scheme which is implemented on
this platform comes with a significantly lower barrier than adopting a complex and costly numerical
solver package.
In our two most recent contributions, we demonstrated that the Poiseuille equation, a simplified
version of the Navier–Stokes equation for stationary laminar flows, can be implemented in a wide
range of channel geometries. For geometries for which analytical solutions can be obtained, the
numerical results from the spreadsheet deviate only by a few percent from the analytical solutions [6].
We also demonstrated that the spreadsheet can be used to implement different boundary conditions
besides the commonly employed no-slip (Dirichlet) boundary condition such as, e.g., Neumann-type
boundary conditions which occur on slip surfaces as well as on open channel geometries [7]. These
solutions are close-to-exact to the analytical solutions, which again, can only be derived for very
simple channel geometries, usually with a high degree of symmetry such as, e.g., in circular channel
(Hagen–Poiseuille) flows.
However, all of these solutions were derived for stationary flow scenarios, i.e., flows for which the
time-dependency of the Poiseuille equation is ignored. This case is applicable for applications where
the flow is assumed to be in steady-state and flow acceleration (i.e., during initiation of the flow by
applying a pressure drop), as well as flow retardation (i.e., during stopping of the flow by removing
the driving pressure drop) are not taken into account. However, there are many applications where
time-dependence needs to be considered, especially in applications where the momentum diffusion is
overlaid by, e.g., mass diffusion. In this paper we will show that the spreadsheets can be designed to
reflect time dependency, allowing the study of transient effects during flow initiation and retardation,
as well as intermediate changes in the driving pressure drop which modifies the flow conditions.
2. Numerical Scheme
2.1. Navier–Stokes Equation for Time-Dependent Flow
In comparison to the stationary version of the Navier–Stokes equation used in [6], we now have
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where we also note that the only driving pressure drop is the drop along the x-axis of the channel given
by ΔpΔL .
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2.2. Numerical Scheme for the Second-Order Partial Differential Equations
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This scheme uses a so-called finite difference scheme to approximate the second order partial
differential by considering the changes in the function over a finite difference in the independent
variables y and z. This scheme is a second-order scheme and thus numerically very stable.
Introducing the general notation F(t,y,z) for the value of vx at the position (y0, z0) at time point t,
F(t,y+1,z) for the value of vx at the position (y0 + hyz, z0) at time point t, F(t,y−1,z) for the value of vx at
the position (y0 − hyz, z0) at time point t, F(t,y,z+1) for the value of vx at the position (y0, z0 + hyz) at
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2.3. Numerical Scheme for the First-Order Partial Differential with Respect to Time
The second partial differential required for setting up the numerical scheme is the first-order
partial differential with respect to time. For this we expand the Fourier series in the positive direction
given by









Δxn + Onmax+1 (7)
to nmax = 1, where nmax is the “expansion order” and Onmax is the error function of order nmax. We
subsequently obtain
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(8)
which is a first-order approximation for the first derivative in time (a so-called forward Euler scheme).
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F(t+1,y,z) = F(t,y,z)(1− 4Ω) + Ω
(
F(t,y+1,z) + F(t,y−1,z) + F(t,y,z+1) + F(t,y,z−1)
)
− Γ (9)
with Ω = htΔη
ρh2yz
and Γ = htρ
Δp
ΔL , ht being the step width in time. Equation (9) is a second-order scheme
with respect to space and a first-order scheme with respect to time. It allows stepping forward in time
from a known value F(t,y,z) at the location (x, y) at time t to the unknown value F(t+1,y,z) at the location
(x, y) at time t + 1. Compared to the schemes used in [6] this scheme is not iterative as the solution at
a given time point t does not have to fulfill the Navier–Stokes equation but only Equation (8). One
point of note is the fact that the numerical scheme in time is only first-order. In order to not risk
numerical instability the step width ht in time must be chosen sufficiently small. In general, first-order
approximations are numerically significantly less stable than higher-order implementations but they
are computationally very cost-effective and thus very simple to implement. The numerical stability of
the overall scheme hinges mostly on the step width in time.
2.4. Correcting Units
Before implementing the numerical scheme we must correct for the units. We assume hxy to be
given in μm, ΔpΔL to be given in mbar/mm, ρ to be given in g/cm
3, η to be given in mPa·s and ht to be
given in μs. The unit of the dependent variable vx is mm/s and the independent variables y and z are
given in μm. In order to correct for the units, Γ has a prefactor of 0.1, whereas Ω has a prefactor of 1.
3. Implementation in Microsoft Excel
3.1. Layout of the Spreadsheet
The scheme given by Equation (9) was implemented in Microsoft Excel in a spreadsheet, which
can be downloaded from the supporting material (file “TimedependentMicrofluidicFlows.xlsx”). It
is shown in Figure 1. The numerical domain was chosen as a 40 × 40 cell grid panel with no-slip
boundary conditions. As demonstrated in an earlier contribution, different boundary conditions can
be implemented such as, e.g., flip or Neumann-type boundary conditions [7]. The values in the cells
represent the velocity of the flow at the given position in the domain. The sheet consists of three panels:
• left panel—initial conditions: these are the values of the flow in the channel at the beginning of the
calculation; for a first demonstration, we assume the flow to be non-moving, i.e., all values are 0
• center panel—velocity profile at time point t: this is the velocity profile in the channel at the
current timepoint, i.e., F(t,y,z); the scheme is assumed to step from this point to F(t+1,y,z)
• right panel—velocity profile at time point t + ht: this is the velocity profile calculated by stepping
from timepoint t via the numerical scheme of Equation (9)
The panels are color-coded to reflect areas of higher velocity in red and areas of lower velocity in
green. Next to the right-most panel, the color scale for the velocity profile for the right-most panel,
i.e., F(t+1,y,z) is displayed. Below the color scale is the section for the variables. These values can be
changed to modify, i.e., the type of fluid or the properties of the numerical scheme. The numerical
scheme is corrected for the following units:
• independent variables y and z: μm
• pressure drop ΔpΔL : mbar/mm
• step width in space hyz: μm
• step width in time ht: μs
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• density of the fluid: g/cm3
• viscosity of the fluid: mPa·s
Changing the value of the step width in space effectively increases the lateral dimension of the
channel. Changing the value of the step width in time increases the speed of the calculation by
assuming larger steps in the forward Euler scheme. However, as discussed, increasing this value may
lead to the numerical scheme becoming unstable. This can be observed by the values of the velocity
increasing continually until they overflow. Below the adjustable variables are the two variables used
as an abbreviation in Equation (9), i.e., Ω and Γ which are updated dynamically.
 
Figure 1. View of the Microsoft Excel spreadsheets with the three panels: initial conditions (left),
current time point (center) and next time point (right). (a) The evolution of the velocity profile can be
observed by pressing the F9 key. The right panel implements Equation (9) and steps forward in time.
The values are copied back to the center panel thus performing one iteration. (b) By adding any value
into the “Reset” field, the scheme is reset, the iteration counter is cleared and the values of the initial
condition (left panel) is copied into the center panel thus setting the velocity profile for time point t = 0.
3.2. Iteration
As discussed, the numerical scheme of Equation (9) does not require iteration within one time
point. This is in contrast to the schemes implemented in [6], which require the steady-state version of
the Poiseuille Equation (2) to be fulfilled for each position within the domain. Here, the scheme is
required to perform one step in time but not to iterate further.
However, due to the nature of the scheme, we require circular references in the spreadsheet, which
means we have to allow iteration. In Microsoft Excel, select “File→Options→Formulas→Calculation
options” and check “Enable iterative calculation”. Set “Maximum Iterations” to 1. This ensures that
the scheme will only perform one single iteration.
3.3. Implementation of the Numerical Scheme
The scheme is implemented in the spreadsheet by taking the initial value from the left panel and
copying the values into the center panel at the beginning of the calculation. The scheme then uses
these values to calculate F(t+1,y,z) in the right panel from the values F(t,y,z) of the center panel. For
the next step in time, the value of the right panel is copied back into the respective cell of the center
69
Biosensors 2019, 9, 67
panel. This is the single iteration which Microsoft Excel will perform—the value will not be updated
further. The formulae of the cells in the right panel implement the numerical scheme. They use the
value F(t,y,z) as well as F(t,y+1,z), F(t,y−1,z), F(t,y,z+1) and F(t,y,z−1) from the center panel, as well as the
values Ω and Γ. For each step in time, the scheme will update the values in the right panel from the
values of the center panel and write these values back to the center grip. By pressing F9 or performing
any recorded input in Microsoft Excel an additional step in time will be performed. Below the center
and the right panel are iteration counters that increment any time an input key or F9 (which triggers a
spreadsheet recalculation) is recorded. By keeping F9 pressed, the evolution of the flow profile in time
can be observed. Each step correlates to a step in time of ht. An additional field is added to calculate
the total number of microseconds passed since the beginning of the calculation.
3.4. Resetting the Calculation and Implementing the Boundary Conditions
Upon close inspection, the cells in the center panel do not simply copy the values from the right
panel. They are linked by a conditional expression. If a certain field below the center panel (the field
labeled “Reset”) is empty, the value from the right panel is copied. If the “Reset” field is not empty, the
value from the left panel is copied. This effectively resets the calculation and also clears the iteration
counters, which are implemented with a similar conditional copy operation. Writing any letter, value
or number into the “Reset” field will thus reset the calculation and copy the initial conditions into the
center panel corresponding to the velocity profile at t = 0.
4. Analytical Solution for Initiating Two-Dimensional Flow in Rectangular Channel
Cross-Sections
4.1. Derivation
In order to verify the correctness of the numerical results obtained from the implemented solver
in Microsoft Excel, we chose the case of initiating two-dimensional flow in a rectangular channel
cross-section with the no-slip boundary condition as an example. In this scenario, the flow in the
channel is originally at rest. At t = 0, a driving pressure gradient is applied along the length of the
channel thus initiating the flow whereby the characteristic velocity profile in a rectangular channel
cross-section Poiseuille flow will form. The dynamics of the evolution of this flow profile will be studied
using the derived analytical solution which yields the exact results. These will then be compared to the
numerical results obtained from the spreadsheet.
















We assume the solution to consist of a steady-state component which is time-independent and a
transient solution which is time-dependent. The latter will be dominating during the initiation of the
flow and decline as the flow achieves steady-state. Thus, the general solution will be
vx(t, y, z) = vx,steady−state(y, z) + vx,transient(t, y, z) (11)





















∂t = 0. The steady-state solution vx,steady−state for this flow case is known
and was derived in a similar case in Richter et al. [7] as Equation 13’ using an eigenvalue expansion
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for mixed boundary cases. The solution for no-slip boundary conditions is derived elsewhere ([8],
Equation 16.62)
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Equation (16) is the representation of a constant by a two-dimensional Fourier series. Details on






















Equation (18) is a homogeneous partial differential equation which can be solved by a separation
of variables approach using
vx,transient = T(t)Y(y)Z(z) (19)
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The solution to Equation (23) is straight-forward and given by integration as




The solutions to Equations (21) and (22) are given by the eigenfunctions and derived in a similar



























Inserting Equations (24), (25) and (26) into Equation (19) yields the transient solution as





















We still lack the constant Cnm, which we can derive from the initial condition of the accelerating
flow which requires the flow to be constant, i.e., vx = 0. This is the case for vx,transient(t = 0, y, z) =
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Assembling Equation (11) from Equations (13), (27) and (29) we find
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In the following, Equation (30) is visualized using a microfluidic channel with 100 μm width
and 100 μm height and choosing water (η = 1 mPa·s, ρ = 1 g/cm3) as the fluid. The Fourier series
in Equation (30) is expanded to nmax = mmax = 10. Figure 2 shows the calculated profiles for 10 μs,
100 μs and 1000 μs. As can be seen the fluid is originally at rest. Over time, the characteristic profile of
the Poiseuille flow in a rectangular channel cross-section evolves. By inspection of Equations (27) and
(30), this behavior is expected. As the solution consists of a transient and a steady-state component, the
first of which decays exponentially over time, the steady-state solution is effectively modulated by the
exponential decay of the time-dependent contribution of the transient solution.
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Figure 2. Velocity profile calculated from the analytical solution of Equation (30) for water as fluid and
a channel with 100 μm width and 100 μm height. The Fourier series is expanded to nmax = mmax = 10.
The expansion order of the Fourier series was 10 both along y and z. Velocity profiles for different
points in time are plotted: 10 μs (dark blue), 100 μs (medium green) and 1000 μs (light yellow).
4.2. Application of the Derived Spreadsheet
4.2.1. Initiating Two-Dimensional Flow in Rectangular Channel Cross-Sections
Given the analytical solution Equation (30) we now proceed to solving the same case using the
numerical solver implemented in the spreadsheet. The step width in space was chosen as hyz = 2.5 μm
and the step width in time as ht = 1 μs. Again, water as the fluid was assumed and thus η = 1 mPa·s,
ρ = 1 g/cm3 were set in the “Variables” section of the spreadsheet. For direct comparison with Figure 2,
the spreadsheet was iterated 100 times to yield the velocity profile at t = 100 μs and t = 1000 μs. The
resulting velocity profile was then compared with the analytical Page: 10 solution given by Equation
(30). Figure 3 shows the relative error of the numerical output compared to the analytical solution.
The maximum error in the whole computational domain is below 3% relative error in both cases. The
errors are strongest in regions of steep gradients in the velocity profiles, i.e., at the edges. In order to
decrease the error further, the computational domain can be increased by increasing the number of
cells. However, even on this rather coarse and compact domain, the errors fall within acceptable limits.
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Figure 3. Comparison of the results obtained from the numerical scheme implemented in Microsoft
Excel against the analytical solution of Equation (30) for time point 100 μs (a) and 1000 μs (b). The
graphs show the relative error. Both cases show very good agreements with maximum errors below 3%.
4.2.2. Complex Flow Cases: Different Channel Cross-Sections
As shown, the analytical solution can be derived for the (rather simplistic) case of rectangular
channel cross-sections. However, the availability of these solutions is limited if the channel geometries
become more complex. However, these cross-sections are straight-forward to implement in the
spreadsheet. Figure 4a shows the example of a rectangular channel with two fins constricting the flow.
 
Figure 4. Complex flow cases involving intricate domains such as a double-constricted channel
cross-section. (a) These are implemented by adding additional boundary values, i.e., by copying the
grey cell values which have static values. The image shows the flow after around 100 iterations. (b) By
simple overwriting portions of the boundary values with domain values, i.e., reimplementing the
conditional copy operation of the center values, one of the obstacles is removed at a given point in time.
The scheme can then be iterated to see how the flow adapts to the changes in boundary conditions.
These can be implemented by copying additional boundary values into the center panel.
By overwriting the formulae in these cells, the numerical scheme cannot iterate these values. However,
they influence neighboring cells and thus show up as regions with no flow in the iterated panel on the
right. Again, starting with a static flow, the scheme can be used to observe the development of the
velocity profile over time. Figure 4a shows the profile at iteration #113, i.e., at t = 113 μs. Boundary
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conditions can be changed dynamically. As an example, the lower constriction in the channel of
Figure 4a was removed at t = 113 μs. Figure 4b shows the adjusting flow 74 iterations after the object
was removed. As can be seen, the flow re-expands into the regions blocked previously. Removing a
boundary can be accomplished by simply recopying the formulae from the domain into the center
panel thus reactivating the iteration.
4.2.3. Boundary Conditions and Initial Conditions
As discussed, boundary conditions with fixed values (Dirichlet-type) can be implemented by
overwriting cells in the center panel with fixed values. No-slip boundary conditions are implemented
by setting this value to 0. Surfaces with fixed velocity as in the case of, e.g., Couette flow, can be
implemented by setting the velocity of these boundary cells to a fixed non-zero value. As demonstrated
in [7], it is possible to also implement Neumann-type boundary conditions by simply setting the
cell values of the boundary to the value of the adjacent cell within the computational domain thus
effectively generating a velocity gradient of 0 as required for, e.g., slip boundary conditions. Obviously,
the gradient can also be set to a fixed value by simply setting the value of the boundary cell to the
value of the neighboring cell within the computational domain plus a fixed offset value.
It is also possible to use non-zero initial values for computation. Until now, we assumed the flow
to be static at the beginning of the experiment and to increase due to the application of the flow as a
consequence of the application of a pressure gradient. This spreadsheet analyses the declining velocity
profile of an initially moving fluid as a consequence of the removal of the driving pressure. The initial
values are copied from a spreadsheet that iterated until the velocity profile was fully developed. The
spreadsheet of Figure 5 sets the driving pressure gradient to 0. As you can see, after 1000 iterations
the velocity profile has smeared slightly but the overall distribution is still similar to the case of the
fully-developed profile. This is to be expected from the analytical solution to Equation (27). For a
decelerating flow, the steady-state fully-developed flow profile would be modulated by an exponential
term, thus generating an exponential decay. As a consequence, the flow profiles would simply be
scaled but the shape of the profile would remain largely intact. As can be seen from Figure 5, after
1000 iterations, the maximum velocity in the channel has decreased to a value of below 0.5 mm/s.
 
Figure 5. Example of a flow case using boundary conditions. The demonstrated case is a decelerating
flow which was initially fully-defined as indicated by the initial conditions. At t = 0 the driving
pressure gradient is removed and the flow begins to stagnate. After more than 1500 iterations, the
velocity profile is smeared and the velocity profile drops to maximum values below 0.5 mm/s.
5. Conclusions
Solutions to the simplified Navier–Stokes equation in pressure-driven microfluidics, i.e., Poiseuille
flows, are difficult to derive analytically if the channel cross-sections, the boundary conditions or
the initial values do not represent trivial cases. Including time-dependency further complicates the
derivation of the analytical solutions. These cases are usually addressed using numerical solvers
and dedicated software packages. However, as we have shown, a numerical solver suitable for
solving time-dependent microfluidic flow cases in arbitrary channel cross-sections can be conveniently
75
Biosensors 2019, 9, 67
implemented using spreadsheet analysis tools such as, e.g., Microsoft Excel. By making use of a
controlled iterative calculation, the solver can be stepped in time by manual input thus allowing
a precise study of the evolving velocity profiles over time at discrete time points. No additional
software is required for obtaining results that almost exactly correspond to the precise analytical
solution. We demonstrated this using the case of time-dependent initiating flow in a rectangular
channel cross-section. The spreadsheet developed can be used to implement almost any type of
boundary condition or initial condition, as well as channel cross-section as required. We believe that
providing researchers with intuitive and widely accessible numerical tools will significantly increase
the understanding and the correct derivation of the fluid mechanics in microfluidics with implications
for applications in liquid delivery, reaction synthesis and analytical applications [9–11]. Spreadsheet
software packages such as, e.g., Microsoft Excel are widely available and most scientists are used to
working with these tools in routine lab work. Using these tools effectively to provide such detailed
insight into fluid mechanics will significantly widen the application range and provide more detailed
understanding of phenomena which are generally only accessible with specialized software packages.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6374/9/2/67/s1,
Microsoft Excel spreadsheet “TimedependentMicrofluidicFlows.xlsx”.
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Abstract: On-site therapeutic drug monitoring (TDM) is important for providing a quick and accurate
dosing to patients in order to improve efficacy and minimize toxicity. Aminoglycosides such as
amikacin, gentamicin, and tobramycin are important antibiotics that have been commonly used
to treat infections of chronic bacterial infections in the urinary tract, lung, and heart. However,
these aminoglycosides can lead to vestibular and auditory dysfunction. Therefore, TDM of
aminoglycosides is important due to their ototoxicity and nephrotoxicity. Here, we have developed a
hot embossed poly (methyl methacrylate) (PMMA) microfluidic device featuring an electrokinetic
size and mobility trap (SMT) to purify, concentrate, and separate the aminoglycoside antibiotic drugs
amikacin, gentamicin, and tobramycin. These drugs were separated successfully from whole blood
within 3 min, with 30-fold lower detection limits compared to a standard pinched injection. The limit
of detections (LOD) were 3.75 μg/mL for gentamicin, 8.53 μg/mL for amikacin, and 6.00 μg/mL for
tobramycin. These are sufficient to cover the therapeutic range for treating sepsis of 6–10 μg/mL
gentamicin and tobramycin and 12–20 μg/mL of amikacin. The device is simple and could be mass
produced via embossing or injection molding approaches.
Keywords: therapeutic drug monitoring (TDM); aminoglycosides; size and mobility traps (SMT)
1. Introduction
Personalized medicine requires healthcare customization with medical practices, treatments,
decisions, or products specific for each patient. It is most commonly associated with diagnostic
testing to detect the early onset for a change in health state. When applied to personalized therapy,
it involves choosing medication based on the patient’s genetic content to identify the correct drug
for treatment [1] and therapeutic drug monitoring (TDM) to ensure the correct dosing period
and optimum concentration to minimize toxicity and improve efficacy [2,3]. TDM requires the
monitoring of blood/plasma concentrations and is important when there is a narrow therapeutic
range. TDM has been proven to progress anticancer therapies, such as methotrexate [4], as well
as in new targeted anticancer agents, such as nilotinib, imatinib, sunitinib, dasatinib, lapatinib,
and sorafenib [5], and is critical for immunospuressants [6]. TDM also shows benefits for a wide array
of drugs, particularly antibacterials, anticonvulsants, antidepressants, antiretrovirals, antipsychotics,
and β-lactam antibiotics [7]. There are a range of methods which can be used to conduct TDM,
but it is typically carried out in a laboratory by using liquid chromatography mass spectrometry
and immunoassays [8].
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For some applications of TDM, there is a desire to either be able to test at-home, such as for
patients receiving treatment for chronic conditions, or for a rapid and quick response to enable quicker
and more efficient treatment. The most well-known example of TDM is measuring blood glucose levels
such that a diabetic can self-dose the correct amount of insulin. There are now many different blood
glucose analyzers available on the market for rapid on-site testing; however, these are predominantly
based on either an antibody or an immunoassay. For targets where there is insufficient specificity in
these approaches, they are usually analysed with a high resolution separation, which is much harder
to miniaturise than an immunoassay. This capability has been recently demonstrated through the
introduction of a portable electrophoretic device, Medimate [9], which can measure lithium levels
in blood. The Medimate is an example of a point-of-care (POC) device based on the micro total
analysis system (μTAS) concept [10]. A μTAS offers the possibility to integrate multiple procedures in
a portable, low-cost platform which is simple to utilize without affecting the results. TDM of lithium
with Medimate has been studied and recently deemed to be clinically useful [11] and is appropriate for
self-testing [12]. While the Medimate device is an impressive and important development for the field,
lithium is well-separated from other matrix components in the blood, and has a high therapeutic range,
making detection relatively simple. Other μTAS devices applicable to TDM have been developed for
glutathione [13], creatinine [14], and β-hydroxybutyrate (βHB) [15].
One of the main impediments in developing a μTAS is the complexity and size of the
instrumentation required for the on-site analysis, and for at-home monitoring, it needs to be fully
automated, simple to use, easy, and low-cost to make. Recently, Shallan et al. [16] developed a
microfluidic device featuring two nanojunctions with different pore sizes to create a size and mobility
trap (SMT) to purify and concentrate small molecules prior to an integrated electrophoretic separation.
Significantly, the nanojunctions were created by dielectric breakdown after the device containing
easier-to-fabricate micron-sized channels was bonded, providing a simpler pathway to commercial
manufacture. The potential of the device for TDM was demonstrated with the determination of
the antibiotic ampicillin from whole blood within 5 min. However, this device was fabricated in
Polydimethylsiloxane (PDMS) where large-volume production is not possible through hot embossing
or injection molding. Li et al. [17] developed a similar device incorporating two commercially
manufactured nanoporous membranes for the concentration and monitoring of albumin in urine
as a marker of albuminurea. While functional, the pore sizes were too large for small molecule
pharmaceuticals, and the additional fabrication steps to incorporate the two different membranes
would significantly increase the cost of the device.
Here, a microfluidic device with an SMT feature created by dielectric breakdown was fabricated
in PMMA instead of PDMS because of the well-known ability of hot embossing or injection molding in
this material [18]. We demonstrate that similar nanojunctions can be created in PMMA using controlled
dielectric breakdown and that a device with two different sized nanojunctions can be used for the
analysis of aminoglycoside antibiotic drugs in whole blood.
2. Experimental Section
2.1. Materials and Chemicals
All solutions were prepared using Milli-Q water (18 MΩ, Millipore, North Ryde, Australia).
PDMS (Sylgard 184) elastomer and curing agent were purchased from Dow Corning (Michigan,
MI, USA). Potassium thiocyanate (KSCN) was purchased from AJAX Chemicals (Sydney, Australia).
5(6)-Carboxy-X-rhodamine (ROX), R-phycoerythrin (RPE), fluorescein, fluorescamine, bovine serum
albumin (BSA), Ferric chloride (FeCl3), aminoglycoside antibiotics (gentamicin, amikacin and
tobramycin), hexadimethrine bromide (HDMB), hydroxypropyl methylcellulose (HPMC), sodium
tetraborate, di-sodium hydrogen phosphate, and sodium phosphate monobasic for buffer preparation
were purchased from Sigma-Aldrich (Sydney, Australia).
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2.2. Sample Preparation
Fluorescamine was prepared in acetone to obtain 3 mg/mL as a stock solution. BSA was prepared
in Milli-Q water at a concentration of 2 mg/mL and then labelled with fluorescamine at a ratio 3:1
in borate buffer at pH 9. ROX and fluorescein were prepared in Milli-Q water to get 25 μg/mL
and 200 μg/mL solutions, respectively. KSCN and FeCl3 were prepared in Milli-Q water to obtain
2.5 M and 25 mM, respectively. Aminoglycosides antibiotics (gentamicin, amikacin, and tobramycin)
stock solutions were prepared in Milli-Q water at a concentration of 500 μg/mL. These were then
labelled with fluorescamine at a ratio of 3:1 in borate buffer at pH 9. Whole blood samples from a
healthy volunteer were collected under the guidelines by the Tasmanian Health and Medical Human
Research Ethics Committee, Office of Research Services, University of Tasmania (Ethics Approval Ref
is H0016575) and spiked with aminoglycosides drugs (amikacin, gentamicin, and tobramycin) (stock
solution) in a ratio of 10:0.1 to obtain different concentrations (2, 5, 10, 15, 20 μg/mL). The mixture was
then labelled with 20 μL fluorescamine in 20 μL borate buffer pH = 9.
2.3. Fabrication of Microfluidic Device
All microfluidic devices were created on a 75 mm × 50 mm × 1.5 mm piece of PMMA (RS
Components, Melbourne, Australia) using the following procedures, with a schematic shown in
Figure S1. First, the negative template of the device was fabricated in SU-8 using previously described
processes [19,20]. Then, PDMS mixed at 5:1 (w/w) was degassed, placed on the SU-8 template,
and then heated in an oven at 70 ◦C for at least 12 h. The positive PDMS stamp was then removed from
the PMMA template and thermally aged in an oven at 250 ◦C for 30 min. The aged PDMS template
was used to hot emboss the PMMA channel plates (1.5 mm × 50 mm × 75 mm) as follows: the blank
PMMA plate and PDMS positive master were placed between two 100 mm × 100 mm × 6 mm glass
plates and put into a hot embosser (MTP-8, Tetrahedron, San Diego, CA, USA). Four steps were used
in the embossing process: Step 1: temperature increased to 130 ◦C at a rate of 92 ◦C /min, at a pressure
of 100 lbs; Step 2: increasing the pressure up to 380 lbs at a rate of 75 lbs/min at the temperature of
130 ◦C, and hold for 20 min; Step 3: the temperature was reduced at a rate of 15 ◦C /min until 60 ◦C
at 380 lbs; Step 4: the pressure was released, and the embossed device removed. The hot embossed
PMMA device was then sealed with single-sided adhesive tape (Tesa SE, Charlotte, NC, USA), with the
device’s microchannels placed downward on 1mm thick stainless steel plates. The assembly was then
fed into the officer laminator (Peach 3500, Peach, Switzerland) at a 20 ◦C temperature, speed 5 for four
passes, with 90 degree clockwise rotation at each pass.
2.4. Creation of Nanojunctions by Controlled Dielectric Breakdown
The microfluidic device is hybrid PMMA/adhesive tape with the complete microchip shown in
Figure 1a and a zoomed in image of the offset double V in Figure 1b. All microchannels had a 50 μm
depth. The separation channel was 50 μm wide and the V channels were 500 μm. The hot embossed
double-V PMMA device was used to create the SMT through the formation of nanojunctions in the
100 μm gap between the tips of the V-channels and the separation channel. This gap distance was
selected instead of 20 μm [21] or 40 μm [22] reported in the literature, to allow for a lengthened use of
higher voltages during the extraction and purification stages without inducing secondary breakdown.
The 500 μm offset distance between the tips of the Vs permitted the two nanojunctions to connect and
generate the SMT. The separation channel length was 60 mm and the effective length from the first
nanojunction (injection point) to the detection point was 30 mm.
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Figure 1. (a) Photograph image of the double-V hybrid PMMA/adhesive tape device filled with green
food dye. Scale bar = 10 mm. (b) Zoomed in microscope image of the offset double-V channel filled
with green food dye (white box in panel a). Scale Bar = 100 μm. (c) Schematic of the microfluidic
device (dimension not to scale) indicating voltages and terminating current used for generation of
the extraction nanojunction and (d) the desalting nanojunction. (e) Injection voltages (60 s) to extract,
concentrate, and desalt injected plug (blue) of small molecules (ROX and fluorescein). (f) Separation
voltages (180 s) for electrophoretic separation. Buffer (B), Buffer Waste (BW), Sample (S), and Sample
Waste (SW).
To make the nanojunctions, the separation channel and V-channel sample (S) were filled with the
breakdown electrolyte, consisting of 10 mM phosphate buffer, pH 11, while the V-channel sample waste
(SW) was filled with 100 mM phosphate buffer, pH 7. The nanochannels were created by applying
a high voltage of 4000 V over 100 μm (40 V/μm, which is above the dielectric strength of PMMA
36 V/μm [23]) to the V-sample (S) channel or sample waste (SW) channel whilst the separation channel
was kept grounded, as shown in Figure 1c,d. The current limit was varied from 0.1 μA to 5 μA by
utilizing an in-house adjustable power supply, controlled by the LabView HV V.6 program (National
Instrument, Austin, TX, USA), which terminated the voltage once the current limit was achieved.
The current limits were chosen to allow the transport of different sized molecules. The V-channels
and the separation channel were then refilled with the experimental solutions after cleaning using
Milli-Q water.
2.5. Microdevice Operation
After nanojunction creation, the sample V-channel (S) was filled with sample solution using an
autopipette. The separation channel was filled with 100 mM phosphate buffer, 0.5% HPMC, or 0.1% of
HDMB at pH 11.5, while the V-channel sample waste (SW) was filled with 10 mM phosphate buffer,
pH 11.5, similar to those reported by Shallan et al. The extraction and separation voltages were applied
using external electrodes for each reservoir, as shown in Figure 1e,f.
Visualization of ion enrichment/depletion was conducted using a Nikon high-definition colour
CCD camera head (Digital Sight DS-Fi1c, Nikon, Japan) operated with NIS-Elements BR 3.10 software
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(Melville, NY, USA) mounted on an inverted fluorescence microscope (Ti-U, Nikon, Tokyo, Japan).
Multiband pass excitation (λex at 390, 482, 563, and 640 nm) and emission (λem at 446, 523, 600,
and 677 nm) filters (Semrock, Rochester, NY, USA) were used for all the experiments. A photomultiplier
tube (PMT) (Hamamatsu Photonics KK, Hamamatsu, Japan) was used to perform the quantitative
measurements which was connected to the microscope. An Agilent interface (35900E) connected to
a laptop and operated by Agilent ChemStation for LC software (Agilent Technologies, Waldbronn,
Germany) was used for data acquisition. An in-house four-channel (0–5 kV) dc power supply was
used to apply an electrical potential to each reservoir through a custom designed interface connected
to six platinum electrodes.
3. Results and Discussions
In our previous work, we designed and demonstrated a new electrokinetic device with a
SMT for the concentration and extraction of drugs, followed by their separation by electrophoresis.
Electrophoresis is a separation mode in which ions, molecules, and particles are separated in an electric
field in a conducting liquid medium. The speed of separation can be manipulated by variation of
the liquid media composition, but is generally dependent on the charge and size of the ion/particle.
Electrophoresis is known to be simpler than liquid chromatography, the other most common separation
approach for TDM, and more easily miniaturized for portability. Here, we build on our previous
electrokinetic sample treatment strategy, and implement it in a more manufacturable material.
3.1. Nanojunction Creation and Transport Properties
Previously, Shallan et al. demonstrated the ability to make nanojunctions of different sizes in
PDMS by dielectric breakdown with termination currents from 1–5 μA [16,24]. Different charge
and size analytes, such as labelled proteins (4–10 nm), aromatic compounds (0.5–1.0 nm), and small
inorganic ions (effective hydrated radii of about 0.3 nm) [25], were used to understand whether there
were differences when compared to the previous work in PDMS. The results from these experiments
are summarized in Figure 2.
A single nanojunction was formed after the breakdown using different current limits. When the
termination current was set at 5 μA (Figure 2 top row), the resulted nanojunctions blocked
blood cells (6–8 μm) [24] and RPE (~10 nm in size) [17] from entering the separation channel,
whilst electrophoretic transport of BSA labelled-fluorescamine (2–4 nm) into the separation channel was
observed, with similar results obtained at 3 μA (Figure 2 second row). Reducing the termination current
to 1 μA (Figure 2 third row) blocked the BSA, but allowed the transport of anionic ROX, fluorescein,
and drugs. Previously, the movement of BSA was restricted in PDMS nanojunctions created with a
termination current of 3 μA [24], higher than what was achieved in this work. The different behavior
in the PMMA devices may be related to the difference in surface charge and/or the elasticity between
the two materials. To produce smaller channels, the ionic strength of the breakdown electrolyte was
increased from 10 mM phosphate to 100 mM phosphate. A termination current of 0.1 μA resulted
in restricting the transport of BSA, ROX, fluorescein, and drugs, while still transporting small ions
(thiocyanate) (~0.3 nm) (Figure 2 bottom row). Overall, based on the permeability results of different
sized molecules (Blood cell 4–6 μm, RPE ~10 nm, BSA 2–4 nm, ROX 1 nm, inorganic ions 0.3 nm),
we were able to estimate the size of fabricated nanochannels with this method.
3.2. SMT Implementation
The SMT is based on the preferential electrokinetic transport of ions through the resulting
nanojunctions. The extraction nanojunction was formed by applying a 1 μA termination current
using 10 mM phosphate pH = 11 electrolyte buffer as this allows small ions transport (e.g., ROX)
through the free transport region, while restricting cells and plasma proteins transport (e.g., BSA).
The concentration nanojunction between the separation channel and the V-sample channel was formed
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with a termination current of 0.1 μA using 100 mM phosphate pH = 7 as this prevents the transport of
target analytes (e.g., ROX), but permits the small inorganic ions (e.g., Thiocyanate).
Figure 2. Screen shots showing the transport (right column) and restriction (left column) of different
molecules through nanochannels created under different conditions. The top row shows the restriction
of Blood Cells (left) and transport of BSA (blue, right); the second row shows the restriction of PDMS
(red, left) and the transport of BSA (right); the third row shows the transport of ROX (right, Red)
and restriction of BSA (left); the fourth row shows the restriction of BSA (left) and transport of ROX
(right); the fifth row shows the restriction of ROX (left) and transport of thiocyanate (left). The first four
rows used nanochannels created using a breakdown electrolyte of 10 mM phosphate buffer, pH = 11,
and different terminating currents (5, 3, 1, and 0.1 μA), while the fifth row used a breakdown electrolyte
of 100 mM phosphate buffer, pH = 7, and a terminating current of 0.1 μA. Images on the right show
permeability (arrow), while those on the left show blocked transport. Scale Bar = 200 μm.
Figure 3 presents the ability and efficacy of the SMTs to extract and concentrate multiple small
molecules. Figure 3a is a photo taken during the extraction and concentration of fluorescein (MW 332
Da) and ROX (MW 534.60 Da) in the separation channel. Figure 3b shows the separation of fluorescein
and ROX immediately after switching the voltages from extraction and concentration to separation.
3C is the fluorescence trace collected using a PMT positioned 30 mm from the double-V intersection.
These experiments show highly efficient separations of both fluorescein and ROX, with efficiencies
of 414,000 and 203,000 plates/m, respectively. The relative standard deviation (RSD%) = 11.5 % for
fluorescein and 4.5 % for ROX (n = 3 devices).
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Figure 3. Screen shots showing (a) extraction, trapping, and (b) separation. Scale Bar = 100 μm.
(c) Detection of small molecules (fluorescein and ROX). Current limit was set at 1μA for the right
side and 0.1 μA for the left side. BGE in the separation channel is 100 mM phosphate buffer, pH 11.5,
with 0.5 % HPMC to suppress the EOF and 0.1% HDMB to reverse the EOF, while in the left V-sample
waste channel, 10 mM phosphate buffer, pH 11.5, was used without HPMC. Applied voltages were
set at −100, −700, −500, and +500 V (for the injection) and −300, +220, +2000, and −400 V (for the
separation) for reservoirs B, S, BW, and SW, respectively.
3.3. Extraction and Analysis of Aminoglycosides in Whole Blood
The purpose of the SMT is to purify and concentrate anionic pharmaceuticals with a low molecular
weight (<1000 Da) from biological fluids such as blood. The applicability of the PMMA-embossed
device for achieving this was demonstrated by the detection of the three aminoglycoside drugs
gentamicin, amikacin, and tobramycin. after derivatization with fluorescamine using both the double-V
device and a normal cross channel design with pinched injection [26]. Figure 4 shows the separation of
a standard mixture of these three labeled aminoglycosides in both the double-V device and a normal
cross-design with pinched injection. It can be seen from the figure that the peaks in the double-V
design are significantly higher than in the cross-device, demonstrating the concentration ability of the
device. A 30-fold enhancement factor was achieved without any significant broadening of the peaks.
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Figure 4. Electropherograms show the comparison of SMT (red trace) with pinched injection
(black trace) of 5 ppm Gentamicin, 20 ppm Amikacin, and 10 ppm Tobramycin after labelling with
fluorescamine. The BGE in the V- sample waste channel was 10 mM phosphate buffer, pH 11.5,
while in the separation channel, it was 100 mM phosphate buffer, pH 11.5, with 0.5% HPMC. Applied
voltages for SMT were −100, −700, −500, and +500 V for 60 s and for separation were −300, +220,
+2000, and −400 V at reservoirs B, S, BW, and SW, respectively. For pinched injection (cross-channel),
all channels were filled with 100 mM phosphate buffer, pH 11.5, with 0.5% HPMC. Applied voltages
for injection were −100, −400, −300, and +400 V at B, S, BW, and SW reservoirs, respectively,
and separation voltages were −200, +400, +1500, and +400 V at B, S, BW, and SW reservoirs, respectively.
The other function of the SMT is to purify the sample. This can be seen in Figure 5 and
Figure S2a, which show the separation of blood spiked with the aminoglycosides and then labelled
with fluorescamine. The cross device provides a clean peak for tobramycin, but interferences are
observed for gentamicin and amikacin. This is due to fluorescamine reacting with all primary
amines, including those on drugs, proteins, amino acids, etc., found in the blood. In contrast,
the double-V device containing the SMT provides clean separations due to the removal of some
of the interferences, most likely the larger proteins. Some endogenous small molecules are still
observed in the SMT, but these are well-resolved from the target drugs in this instance, allowing full
and complete quantitation of the three aminoglycosides. The device shows high recovery efficiencies
for the three drugs (Gentamicin 92%, Amikacin 98%, and Tobramycin 98%) and there were no clogging
cases observed during the analysis.
The linear calibration curve of the Aminoglycosides (gentamycin, amikacin, and tobramycin)
from blood is shown in Figure S2b. The LOD (signal to noise level of three) was 3.75 μg/mL for
gentamicin, 8.53 μg/mL for amikacin, and 6 μg/mL for tobramycin, and they are linear to 2–20 μg/mL,
which covers the therapeutic range for treating sepsis of 6–10 μg/mL gentamicin and tobramycin and
12–20 μg/mL of amikacin [27].
In comparison to current methods for these aminoglycosides, they can be analyzed by immuno-
assays, such as the Fluorescence Polarization Immunoassay (FPIA), Radioimmunoassay (RIA),
and Enzyme-linked Immunosorbent assay (ELISA). These assays have limitations. The FPIA assay
has a good reproducibility, is comparatively cheap, and is labor non-intensive [27]. Additionally,
FPIA is fully automated, but demands an IMx FPIA analyzer [28] that is relatively expensive. RIA was
successfully used to determine the aminoglycosides in biological samples, but it has problems related
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to handling radioactivity and the equipment is costly [29]. The ELISA system labeling with primary
antibodies is time-consuming and the labeling of the primary antibody from one experiment to
another is not flexible [30]. HPLC (High Performance Liquid Chromatography) is a sensitive method
for conducting the aminoglycosides, but requires expensive instruments [31] and shortening the
separation time is required [32]. By Higher Performance Liquid Chromatography (HPLC), the LOQ
for tobramycin is as low 0.05 μg/mL using 200 μL of plasma [33]; however, these low levels are not
necessary given the therapeutic range of aminoglycosides. When monitoring preterm infants, it is more
profitable to use smaller volumes of sample, which should not overtake 75 μL [34]. Here, the suggested
assay demands 20 μL of blood to give results within 3 min.
Figure 5. Electropherograms show the purification of whole blood spiked with 10 ppm of gentamicin,
amikacin, and tobramycin and derivatized with fluorescamine using a cross-chip (red trace) and the
Double V- chip (black trace). The BGE in the V-sample waste channel was 10 mM phosphate buffer,
pH 11.5, while in the separation channel, it was 100 mM phosphate buffer, pH 11.5, with 0.5% HPMC.
Applied voltages for injection were −100, −700, −500, and +500 V for 60 s and for separation were −300,
+220, +2000, and −400 V at reservoirs B, S, BW, and SW, respectively. For cross-channel, all channels
were filled with 100 mM phosphate buffer, pH 11.5, with 0.5% HPMC. Applied voltages for injection
were −100, −400, −300, and +400 V at B, S, BW, and SW reservoirs, respectively, and separation
voltages were −200, +400, +1500, and +400 V at B, S, BW, and SW reservoirs. respectively.
4. Conclusions
We have demonstrated an integrated hot embossed PMMA featuring an SMT device for desalting,
on-chip extraction, and concentration. The hot embossed PMMA controlling dielectric breakdown
enabled nanojunctions’ pore size tuning. This method permitted the analysis of aminoglycosides as
negatively charged drugs which were off-chip spiked with on-site finger prick blood (~20–100 μL)
and labelled with fluorescamine. The nanojunctions created using dielectric breakdown are achieved
simply and quickly, and the electric field controlling pore size permits their integration without
increasing the fabrication cost. The device allows a simple operation and does not rely on valves or
pumps. With integrated reagents (dried fluorescamine and liquid electrolytes) and a hand-held reader,
this would create a fully-portable screening device for POC analysis of therapeutics.
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Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6374/9/1/19/s1.
Figure S1: Schematic of the PMMA fabrication process. Figure S2: Analysis of Aminoglycosides from whole blood.
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Abstract: The chemical, temporal, and spatial resolution of chemical signals that are sampled and
transported with continuous flow is limited because of Taylor dispersion. Droplets have been used
to solve this problem by digitizing chemical signals into discrete segments that can be transported
for a long distance or a long time without loss of chemical, temporal or spatial precision. In this
review, we describe Taylor dispersion, sampling theory, and Laplace pressure, and give examples
of sampling probes that have used droplets to sample or/and transport fluid from a continuous
medium, such as cell culture or nerve tissue, for external analysis. The examples are categorized, as
follows: (1) Aqueous-phase sampling with downstream droplet formation; (2) preformed droplets
for sampling; and (3) droplets formed near the analyte source. Finally, strategies for downstream
sample recovery for conventional analysis are described.
Keywords: microfluidic probe; droplet; sampling; Taylor dispersion
1. Introduction
Biosensors have broad applications in drug discovery, medical diagnostics [1,2], environmental
monitoring and food safety [3]. The concentration of specific analytes and their reaction kinetics can
be identified in biosensors [4,5]. Biosensors using microdroplets have offered reconfigurability and
flexibility and limited contamination during sample preparation and analysis [4]. In this review, we
focus on the use of droplets to improve the temporal, spatial and chemical resolution of biosensing
measurements by compartmentalizing samples during transport from the sampling site, to the analytical
site. In doing so, it is possible to reduce Taylor dispersion.
In 1953, Taylor dispersion was described as “the combined action of molecular diffusion and the
variation of velocity over the cross section” [6]. Because of this dispersive phenomena, the distance
that chemical signals (variation in concentration with time and space) or analytes can be transported
in the continuous phase is severely limited [6,7]. The top part of Figure 1 shows pulses of imaginary
chemical A and chemical B. Initially, the pulses are separated from one another, but after a short
distance the chemical pulses have merged and spread out [8]. In contrast, the bottom part of Figure 1 [8]
shows that pulses of chemical A and B, when contained in droplets are not dispersed or merged after
transport. The sampling of tiny volumes of aqueous body fluids and their transport to systems for
precise detection or quantification is an ongoing area of activity in biomedical research [9–25].
The chemical content of a sample taken from a biological system may change, depending on
when and where the sample is taken. For example, changes in neurotransmitter concentrations in the
extracellular space around synapses are known to happen in milliseconds to seconds [26–29]. It is also
well known that several neurotransmitters coexist in a given synaptic region, and that they can be
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released at different times [28,29]. It has been shown by Bert [30] that glutamate changes occurring in
1 min can be completely dampened when samples are pooled, as opposed to discretized.
Figure 1. Schematic representation of using segmented flow to avoid the Taylor dispersion. (The vertical
white lines represent the passage of space and time (Reprinted with permission from Reference [8].
Copyright 2011 Royal Society of Chemistry).
It is reported that temporal resolution for conventional high-performance liquid chromatography
(HPLC) is minutes [31]. Such time scales make it impossible to quantify analyte concentrations that
change rapidly accurately. Droplet-based approaches can be used to effectively avoid dispersion
and improve temporal resolution by capturing and storing events that occur too quickly for a
particular analytical method [32–37]. Microdialysis sampling, coupled with droplets and direct
infusion mass spectrometry was used for acetylcholine monitoring [38] with intervals of just a few
seconds. Monitoring of real-time streptavidin–biotin binding kinetics was also achieved using droplet
microfluidics integrated with confocal spectroscopy [39]. Srinivasan et al. [40] reported the integration
of optical absorbance measurements with droplet-based microfluidics for the detection of glucose
using glucose oxidase in less than 40 s. The coupling of a digital droplet-based microfluidic device to
surface plasmon resonance (SPR) imaging has also been demonstrated [41,42].
Water-in-oil droplets are not perfect containers. Water and small molecules move through the
water-oil interface at a non-zero rate [43]. Surfactants at the interface may form micelles, leading to
another mechanism for analytes to escape droplets. Air bubbles have been used as separators between
aqueous slugs to reduce cross contamination [44], and leakage is suspected to be worse in the corners
of rectangular channels [45].
Conventional sampling tools, which can undertake a continuous sampling of body fluid, cannot
sample and transport rapid changes of chemical signals from the insertion point to an analytical
instrument without signal distortion, because of the Taylor dispersion phenomenon. Similarly, the
same signal distortion problem also occurs when delivering sequences of different drugs to the injection
point. A real-time analytical chemistry lab, small enough to fit inside the brain of a mouse does not exist.
However, we can achieve similar analytical aims if we can digitize the liquid environment from precise
locations within an organism at precise times using water-based liquids, carried by an immiscible oil
in a hydrophobic channel. In this paper, we review state-of-the-art low-volume sampling probes that
use droplets to transport signals for downstream analysis. For these sampling tools, hydrophobic and
hydrophilic surfaces are used to control the movement of liquids.
2. Theory
2.1. Taylor Dispersion
Taylor dispersion acts to enhance diffusion, which can reduce the temporal and chemical resolution
of biosensors [46–48], DNA analysis [49–51], mass spectrometry [52–54], surface patterning [55–58] and
other applications. It results from the interaction of convection and diffusion within a pipe or channel.
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Convection is the transport of fluid axially in the flow direction. The typical Poiseuille laminar
flow in a low Reynolds number channel has its maximum flow velocity in the centre of the channel and
decreases smoothly to zero at the walls. Volumes of fluid near the centre of the channel will move much
faster than those near the walls. A group of molecules, initially near one-another is, thus, spread out.
Diffusion makes the problem worse. Diffusion is driven by a gradient in the chemical concentration of
the diffusing species [59]. When considering a group of molecules forming a pulse of an analyte, the
sharper the gradient constituting that pulse, the more rapidly it disappears.
The effective diffusion in a capillary was described by Sir Geoffrey Taylor and R Aris [60], it is
as the sum of conventional axial diffusion (D) and the Taylor dispersion coefficient. Together they
are given an equation for the effective diffusion coefficient in a capillary known as the Taylor-Aris
dispersion coefficient [61,62]:








where Ped is the Peclet number, and is the ratio of convective fluxes to diffusive fluxes in the system. It
can be defined as Ped = 2rV/D where r is the channel radius, and V is the average value of the velocity
in the Poiseuille flow. Combining the two makes it clear that when the average velocity is greater than
2
√
3D/r, advection is the dominant cause of diffusion and dispersion. For a typical small molecule
of Sucrose chemicals (DSucrose = 500 μm2/s) in a 100-um-wide channel, Taylor dispersion dominates
when the average velocity is above 17 μm/s. This very low velocity highlights the futility of moving
chemical signals in microchannels using continuous flow.
2.2. Biosensing with a Chemical, Spatial and Temporal Resolution
The sampling and delivery of tiny amounts of body fluids for accurate analysis is of great interest
for fundamental biological studies, diagnostics, and therapeutics [22,25]. Specific and responsive
signals, derived from the patient’s body can help the study of fundamental biological processes, and
optimize the use of medical therapies by allowing them to be more accurately dosed and more precisely
targeted [63,64]. Effective droplet generation transport and analysis may allow advances in biosensing
through improved chemical, spatial and temporal resolution. These, in turn, can be used for a wide
range of applications.
An in vivo measurement system should be concerned with three parameters: Analytical
performance, spatial resolution, and temporal resolution. Analytical performance refers to a variety
of measurement parameters. These include the minimum concentration that can be detected (limit
of detection), the smallest difference between two samples that can be resolved (resolution), and the
ability of the measurement to respond solely to changes in the target analyte concentration (specificity
or selectivity).
Spatial resolution is a well-understood concept in imaging, where the term voxel refers to a
3D volume over which the information is averaged. The same principle can be applied to chemical
sampling, where higher spatial resolution gives more localized information. Given that chemicals can
permeate surrounding tissue, and that signals produced in one place spread, and, therefore, decrease
in concentration, we would also expect a higher spatial resolution to enable the detection of more rapid
changes in analyte concentrations from smaller sources. The cross-section of the probe in contact with
the tissue is a primary determinant of spatial resolution. However, the volume of sample extracted
will also influence the spatial resolution. Drawing a large volume with a very fine probe will average a
larger chemical voxel, than drawing a small volume with the same size probe [65–68].
Temporal resolution refers to the time taken for the measured value to change in response to
a step-change in the sample. This change may be fit to a single exponential, which allows for an
easily defined time constant [69]. Temporal resolution may also be defined as tres = Ø/f, where f is the
sampling frequency or rate (Hz), and Ø is the number of plugs required to observe a change (from 10
to 90% of a concentration step) [70]; In another example [10], Ø was defined as the number of plugs (or
samples) needed to exchange 95% of molecules of interest.
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The response time of a complete system may also be limited by reaction kinetics at a sensor
surface, but in this review, we are interested in the fundamental response time of the sampling process.
This time delay is created by the movement of molecules from the signal source to the location of
droplet break-up. Once in the droplets, we assume the droplet contents are fully mixed, and we ignore
any further chemical reactions or changes that might occur inside or between the droplets. For a probe
that extracts volume from the source, this time is approximately equal to the volume of liquid between
source and droplet, divided by the volume flow rate. The temporal resolution can be reduced by
extracting more fluid from the tissue, but this may damage or interfere with normal physiology.
For a probe that relies on diffusion across a membrane (microdialysis probes, for example),
the speed of molecular transport is proportional to the analyte gradient and permeability of the
membrane [71]. A device could sample a small percentage of the analyte with a high perfusion rate,
achieving greater temporal resolution. However, capturing a high percentage of the source signal
requires the concentrations on either side of the membrane to approach equilibrium, and, thus, a lower
perfusion rate [72], and lower temporal resolution.
In a droplet system, we should consider the sampling rate and its relationship to the rate change
of the thing being measured. Electrical engineers have addressed this problem through frequency
analysis and arrived at a sampling theorem, which states that the sampling rate (samples per second)
should be twice as fast as the fastest changing component of the signal, the Nyquist rate.
2.3. Interface Forces
Biological and chemical signals are typically generated in a continuous aqueous environment, and
most analytical processes take the same fluid phase as inputs. Transporting signals from one location
to another requires the digitizing of liquid packages at one end of the channel, analogous to an analog
to digital conversion in electronics. At the receiving end of the channel, the reverse may happen. Here,
the oil phase is removed in a process analogous to digital to analog (D2A) conversion. This packaging
and unpackaging must overcome interfacial forces, the primary one being Laplace or bubble pressure.
This pressure is controlled by three parameters: Surface tension, contact angle and hydraulic diameter.
Surface tension is the first parameter that can affect the Laplace pressure. It is defined pragmatically
as: If a line is drawn on the surface of an interface, then one can determine the equilibrium state
by assuming that the molecules on one side of the line exert a force τ per unit length of the line on
the molecules on the other side. The τ will be the surface tension, and it is directed tangent to the
surface [73]. Any work done against this force will increase the surface energy of the system. Fluid
interfaces minimize their energy by taking shapes that minimize their surface area. These shapes can
generate pressure differences across the interface. This pressure is referred to as the Laplace or bubble
pressure and is given by the following equation [73]:









where R1 and R2 are the principal radii of curvature and τ is the surface tension of the aqueous/oil






For an interface that is bounded by a solid surface, such as a microchannel or membrane pore, the







where R′ is the hydraulic diameter of the structure containing the interface, and θ is the contact angle
for the two fluids at the solid surface. This pressure must be overcome to create droplets, and it can be
used, as we shall see later, to control the movement of certain phases in a two-phase system [74–78].
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3. Sampling Devices
In this review paper, we survey examples where droplets have been applied to the delivery and/or
sampling of chemical signals. The work is divided into three categories: Aqueous phase sampling
with downstream droplet formation; preformed droplets for sampling; and droplets formed near the
analyte source.
3.1. Aqueous-Phase Sampling with Downstream Droplet Formation
This category is characterized by an aqueous phase sampling probe that draws a sample from
within the tissue, then transports it to a microfluidic device outside the tissue. The sampled fluid is
then segmented at the external microfluidic devices. Methods of obtaining a sample that we consider
here are: Diffusion through a membrane (dialysis probe) and direct fluid extraction (push-pull cannula,
push-pull microfabricated sampling probe, hydrophilic capillary tube).
3.1.1. Diffusion through a Membrane
Microdialysis is widely used as the sampling probe for in vivo monitoring [79], clinical
studies [80–82] and pharmacokinetics [83]. However, the drawback of this probe is that it has a
large sampling surface. The membrane is typically over 2 mm long and more than 200 μm in outer
diameter. This large area limits spatial resolution.
A modern trend is to apply microdialysis in various clinical situations, such as monitoring
concentrations of glucose, lactate, glutamate, and urea [84]. The microdialysis probe makes it possible
for sampling to be done frequently without any loss of the volume from the tissue. Figure 2a shows a
microdialysis probe coupled to a droplet generation chip to transport chemical signals to a distant
capillary electrophoresis system [11,85]. The device has been used for sampling of neurotransmitter
signals in a rat brain [86]. It has also been applied to an immobile live animal [87].
Figure 2. Continuous phase sampling with downstream droplet formation methods. (a) A microdialysis
probe is used for sampling, coupled with a droplet generation chip to transport chemicals to a CE
system (Reprinted with permission from Reference [85]. Copyright 2009 American Chemical Society);
(b) research on low-flow push-pull probe system worked with a droplet system (Reprinted with
permission from Reference [70]. Copyright 2011 American Chemical Society); (c) a capillary is used as
the sampling probe, and attached to a droplet generator (Reprinted with permission from Reference [88].
Copyright 2011 Springer Nature).
93
Biosensors 2019, 9, 80
3.1.2. Direct Fluid Extraction
In this method, a buffer is continuously infused (pushed) into the tissue through one tube; while
the sample is withdrawn (pulled) from a second tube that may be parallel or concentric with the
infusion tube. These push-pull sampling systems are typically assembled by hand from capillary tubes
and have been used in the brain since 1961 [89,90]. As above, the sample is segmented on a separate
device that is a short distance downstream.
A temporal response of 5 min was achieved with low flow push-pull perfusion combined with
off-chip fraction collection and analysis by capillary electrophoresis [68]. Lower temporal response
of 16 s [91] and 45 s [92,93] was also achieved by coupling low-flow push-pull perfusion on-chip
with CE for detection of samples from the eye and brain, respectively. Low-flow push-pull perfusion
using a sampling probe with a smaller dead volume can be coupled with the segmented flow to
achieve 7 s temporal response and spatial resolution of 0.016 mm2 in vivo [70] (Figure 2b). By further
miniaturizing the probe inlet from 20 μm to a 10 μm, and reducing the dead volume, the authors
showed in vitro sampling with 200 ms response time [70]. Figure 2c shows a probe with a 0.5 mm
probe combined with a downstream droplet generator [88].
Very recently, van den Brink et al. demonstrated a microfabricated silicon-based push-pull probe
with a 1 cm long probe and integrated droplet generation structure [94]. This device showed a temporal
resolution of a few seconds and a sampling area of just 0.004 mm2. The device was used to record the
glutamate level in the sensorimotor cortex of a mouse brain experiencing targeted electrical stimulation.
3.2. Preformed Droplets for Sampling
This section summarizes sampling methods that use pre-formed droplets. Song et al. used a
hydrophilic capillary tube to sample the changing concentration solution of CaCl2 (0.2–0.4 μL/min,
outside the chip. This hydrophilic capillary meets a hydrophobic channel carrying assay droplets.
The sample is merged with the assay droplets for downstream analysis. The cross-section is 100 μm
by 100 μm, but the length of the sampling capillary is unclear [95]. This length of capillary will
cause dispersion.
To solve the Taylor dispersion problem, Chen and Drew [96] and Chen et al. [10] brought droplets
to the sampling site. Chen and Drew [96] proposed a microdialysis device where a pre-formed droplet
passes a semi-permeable membrane. While on the membrane, analytes diffuse into the droplet. The
droplet then moves downstream for analysis. D. Chen built a very similar system in the same year [10].
This approach, shown in Figure 3a–c, is used for sampling and/or introducing matter (stimulating) a
planar environment, such as cell culture. A hydrophobic channel carrying oil is exposed on one side, to
cells by clamping the device against a flat surface. Droplets are generated upstream of the interaction
side. When those droplets reach the cells, they briefly make fluidic contact, exchange molecules, and
are then carried away by the continuous oil phase.
The spatial resolution of the device was around 0.08 mm2 and was set by the size of the opening.
In this work, the authors sampled at one droplet per second and showed >95% change in signal in
just two droplets. The volume of each slug was 30 nL. The temporal response is not limited by Taylor
dispersion because the sampling probe length is almost 0 (there is virtually no dead volume in the
system). It should be noted that contamination of the tissue sample is quite possible as the channel was
under positive pressure and had to be clamped to the tissue culture to prevent oil and buffer droplets
from leaking into the tissue culture.
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Figure 3. Pre-formed droplets are used to stimulate and extract analyte from a substrate, such as cell
culture. (a) schematic of a device in operation; (b) an opening in the chip allows for droplet to merge
with the hydrophilic substrate; (c) time-lapse bright-field images (side view) of the droplet extracting
contents at 0 ms, 30 ms, 60 ms and 90 ms. (Reprinted with permission from Reference [10]. Copyright
2008 National Academy of Sciences, USA).
3.3. Droplets Formed near the Analyte Source
Several researchers have developed methods that reduce the distance over which dispersion may
occur by forming droplets very near to the signal source. We can further categorize the examples by
considering whether a membrane or other barrier exists between the microfluidic channel and the
tissue to be sampled.
3.3.1. Droplets Formed near a Source without a Barrier
Figure 4a shows a device that has three channels; negative pressure is applied to the middle
channel, generating enough force to draw the sample into the device and form droplets. Other channels
supply aqueous sheath flow and a continuous phase [97]. Figure 4b illustrates a sampling probe made
using a pipette tip and a concentric co-flowing oil. With carefully balanced pressures, droplets are
formed at the tip and drawn into the Teflon tube [98]. MilliDrop (Paris France) is a commercial product
that uses a similar approach, along with an air droplet to sample liquids from by dipping the tip in and
out of the sample liquid.
Figure 4. Methods that form droplets near the analyte source: (a) The middle channel is under negative
pressure, sucking sample in through the device tip [97] (reprinted with permission. Copyright 2010
Royal Society of Chemistry); (b) droplet generated at the tip as co-flow. A Simple demonstration of
sampling at the tip for 3-bromopropan-1-ol detection (reprinted with permission from Reference [98].
Copyright 2014 American Chemical Society); (c) sampling probe from Feng et al. which uses a
microfabricated hydrophilic barrier (Reprinted with permission from Reference [69]. Copyright 2017
AIP Publishing LLC).
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3.3.2. Droplets Formed at the Source with a Hydrophilic Barrier
Examples included in this section have implemented some form of Laplace-pressure-barrier to
allow water to pass in or out of a hydrophobic channel, while retaining the oil-based continuous
phase. Laplace pressure, known as bubble pressure in membrane science, is the pressure difference
across a curved liquid interface. It manifests as a barrier to the ingress of air or oil into an already wet
hydrophilic membrane.
Our group has fabricated a silicon device for droplet-based sampling [69]. Figure 4c shows
this device, which only has 2.8 pL of dead volume between the channel and the exterior of the
device. Hydrophilic structures, at the tip, contain this dead volume, and generate the surface tension
barrier [69]. The device has been applied for on-site sampling and quantitative detection of Hydrogen
Peroxide (H2O2). H2O2 samples were drawn into the device and immediately merged with assay
droplets for reaction and downstream detection [99].
A hydrophilic membrane integrated within a planar microfluidic device has also been achieved.
In this work, water in oil droplets is transported through a hydrophobic channel to a droplet exit port.
The port is created by sealing a small section of the channel with a hydrophilic membrane. The wetted
membrane resists penetration by the oil phase, but allows droplets to exit the channel [100]. Droplet
delivery was demonstrated, but sampling was not.
4. Droplet Extraction for Downstream Analysis
A range of on-chip droplet-based detection and analysis methods are described in Qun Fang
Group’s review [101]. However, many sophisticated chemical analysis techniques are not readily
compatible with a sequence of droplets in a microchannel. Therefore, in this section, we review methods
for extracting the transported samples so that they can be subjected to more conventional analytical
methods. Three strategies are listed below that serve to remove the continuous phase that separates the
droplets. These methods leave droplets accessible for further detection [21,102]. They are: Evaporation
of the continuous phase; an oleophilic membrane to selectively extract the continuous phase; and using
negative pressure at a hydrophobic-hydrophilic interface with extract the continuous phase.
Some oils evaporate readily. In Figure 5a, the aqueous droplet phase is placed one by one on a
Matrix Assisted Laser Desorption/Ionization (MALDI) plate together with the volatile perfluorinated
oil (Perfuorohexane). Evaporation of both phases happens before the plate is loaded into the MALDI
mass spectrometer. The evaporation time can be completed within less than 60 s, or accelerated to
less than 5 s with a flow of nitrogen gas [103]. It is also possible to form segmented flows (slugs)
in liquid-gas microfluidic systems [104]. Here the water droplets can easily be isolated through
evaporation; however, the droplets themselves are less stable [105].
The oil phase can be absorbed by an oleophilic and hydrophobic membrane. Figure 5b shows that
an oleophilic membrane made of Polytetrafluoroethylene (PTFE) was used to absorb and extract the
continuous phase [106]. The aqueous phase was left suspended and placed one drop at a time on the
hydrophilic part of a MALDI plate.
The oil phase can also be removed by negative pressure with the assistance of a
hydrophobic-hydrophilic interface. Figure 5c shows a microfluidic probe (MFP) system for writing
chemical patterns [7,107]. This device uses segmented flows to allow different chemicals to be delivered
through the same orifice. Droplets were generated using a standard T-junction, and transported to the
probe tip. Negative pressure was provided at the oil removal channel of the probe’s tip to remove
the oil, while the small hydrophobic features function to retain the aqueous phase, due to the Laplace
pressure. The water-based liquids are, thereby, expelled.
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Figure 5. Off-chip water-based droplet extraction methods. (a) Schematic of droplet creation and
spotting on a MALDI plate, where the hydrophobic carrier (oil) will evaporate quickly (Reprinted with
permission from Reference [103]. Copyright 2013 American Chemical Society); (b) schematic of the
device that used oleophilic oil film to extract the oil continuous phase and left the aqueous phase to the
MALDI plate (Reprinted with permission from Reference [106]. Copyright 2013 PLOS ONE); (c) the
developed microfluidic probe (MFP) system (Reprinted with permission from Reference [7]. Copyright
2016 Royal Society of Chemistry).
5. Conclusions
Point of care diagnostic devices reduce the distance that chemical signals must travel, and
therefore, the dispersion, but for typical microchannels, it takes just millimeters for dispersion to be
significant [69]. Furthermore, not all sensors can be brought to the sampling site. There have been many
reviews of droplet-based microfluidics devices and droplet analysis methods. We focus on microfluidic
slugs or droplets as a method of transporting chemical signals to overcome Taylor dispersion, and the
devices use to capture those signals. We have surveyed examples of chemical signal sampling and
delivery and classified them into three types: Aqueous phase sampling with downstream droplet
formation; Preformed droplets for sampling; and Droplets formed near the analyte source. We pay
particular attention to the temporal and spatial resolution of each system, and explain the features that
limit each of these parameters. Strategies for downstream analysis have also been listed. We hope this
review can help to broaden the use of droplet-based sampling probes for biochemical applications,
enabling higher resolution study of fundamental processes.
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